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Abstract 
 
The work presented in this thesis contributes to long-term protein phase behavior research. 
Long-term protein phase behavior plays a pivotal role in biotechnological product and 
process development. One of the largest product groups in biotechnological industries are 
recombinant proteins. For instance, lactases for dairy processing in the food industry and 
insulin to manage diabetes in the biopharmaceutical industry. The strong market position 
of recombinant proteins is earned due to their highly specialized functionalities, such as 
the ability to target specific cells and processes in the human body. However, proteins have 
a narrow stability window. The influence of environmental conditions, such as temperature 
and pH, on conformational and colloidal stability causes proteins to lose their functionality 
outside the required environment. Deviations from their physiological environment do not 
only jeopardize product efficacy, but also product safety. The extreme sensitivity to sub-
optimal environmental conditions is particularly problematic at the end of production, after 
which protein-based products are required to remain stable during a defined shelf life of 
typically 18-24 months. Formulation studies, where protein phase behavior is monitored 
over time as a function of different environmental conditions, are needed to ensure the 
defined shelf life. These experiments must be conducted in real-time, meaning the 
experimental time equals the required shelf life of 18-24 months. Experimental time and 
effort can be reduced by means of knowledge-based experimental design, where prior 
knowledge on protein stability defines the experimental setup. Knowledge-based 
experimental design requires an understanding of the responsible forces and protein 
properties that regulate long-term protein stability as a function of environmental 
conditions. The obtained understanding can subsequently be employed to identify short-
term properties to report on long-term protein phase behavior and to work towards the 
development of predictive approaches. In order to obtain such knowledge, protein phase 
behavior studies are coupled to biophysical screenings, where responsible forces and 
protein properties are characterized. Both these experimental setups are commonly 
performed in high-throughput to screen wide ranges of environmental conditions. Such 
high-throughput experimental setups generate large data sets, which inevitably leads to a 
bottleneck on the side of data processing, analysis, and utilization. This bottleneck is 
currently present in long-term protein phase behavior analysis, and has created a need for 
computational methods to support and advance data processing and analysis.  
 
Studying protein phase behavior is commonly performed by means of protein phase 
diagrams, where protein formulations are stored for a prolonged period of time to obtain 
knowledge about the effects of the applied environmental conditions. After the storage 
period, data evaluation of such experiments typically involves manual inspection of 
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obtained formulation images, to report on the presence of instable proteins in the form of 
insoluble aggregates and their morphology. Due to the workload involved with manual 
image evaluation, most studies focus solely on the end point image, which is the image 
taken on the last day of storage. However, state-of-the-art automated imaging can record 
data during the whole storage period. For a typical protein stability experiment, this means 
that end point image evaluation only accounts for roughly 1% of the generated data. The 
end point evaluation thereby neglects the kinetic aspect of protein phase behavior 
represented by the other 99% of the images. Yet this kinetic aspect is also influenced by 
the applied solution conditions and can contribute to a more complete understanding of 
protein phase behavior. The challenge with incorporating kinetic data into a protein phase 
diagram lies in the resulting multidimensionality of the data. This dimensionality issue was 
resolved in this thesis by employing the empirical phase diagram (EPD) method, an 
unsupervised machine learning approach developed to combine multidimensional data for 
visualization purposes. The EPD method was applied to compile kinetic and end point 
image-based data from protein phase diagram studies into one figure. The resulting so-
called multidimensional protein phase diagram (MPPD) allowed for a comprehensive and 
more in-depth evaluation of protein phase behavior data under different environmental 
conditions. Another issue encountered during protein phase diagram evaluation, is the 
time-intensive task of manual extraction of kinetic and end point data in order to construct 
MPPDs. This workload can be significantly reduced with computational approaches, such 
as image recognition by supervised machine learning algorithms. Utilization of image 
recognition algorithms in the field of protein phase behavior studies is not uncommon, 
nevertheless their performance can still be improved. More advanced machine learning 
approaches, such as artificial neural networks, can be employed to improve the 
performance. However, increasing computational complexity decreases user-transparency 
and requires more expertise. Another image recognition performance enhancing approach 
is the generation of more diverse information to capture more distinctive properties 
between different protein phase behavior morphologies, without complicating the 
computational method itself. In this thesis, the advantages of incorporating multiple light 
sources (visible, UV, and cross polarized light) and kinetic data was explored to obtain 
higher image recognition accuracy. Compared to standard visible light end point image 
classification (balanced accuracy of 69.3%), an increase in balanced accuracy of 17.3 
percent point (to 86.6%) was obtained upon implementation of multi-light source and 
kinetic data. In addition, the image recognition algorithm was coupled to the construction 
of MPPDs. This combination led to a computational workflow which uses raw protein 
phase behavior images captured over time to automatically generate an MPPD, thereby 
visualizing both kinetic and end point protein phase behavior. 
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The subsequent study presented in this thesis investigated the correlation between long-
term protein phase behavior and short-term measurable forces and protein properties, 
where short-term empirical data was obtained on the same day as the formulation 
preparation. This was done as the ultimate goal in the field of formulation development is 
to control and predict protein phase behavior within a time frame of weeks, instead of real-
time storage experiments that take months to years. As the underlying forces and properties 
are not known beforehand, the required analytical techniques cannot be decided on prior 
to experimentation. Therefore, multiple analytical techniques were employed to cover a 
range of potentially responsible pathways. In this work, static light scattering, dynamic 
light scattering, Fourier transform infrared spectroscopy, intrinsic fluorescence 
spectroscopy, mixed mode measurement of phase analysis light scattering, and the 
stalagmometric method were employed. These analytical techniques monitored protein 
aggregation onset temperature, apparent hydrodynamic radius, secondary structure 
content, melting temperature, zeta potential, and apparent surface hydrophobicity, 
respectively, of hen egg-white lysozyme (HEWL) in 120 different formulations. This led 
to a collection of short-term empirical data from the sources mentioned above, which was 
processed, evaluated, and subsequently correlated to long-term phase behavior. The EPD 
multidimensional visualization method was applied to represent short-term empirical data 
in a so-called empirical protein property diagram (EPPD). This allowed for a systematic 
and data-dependent identification of short-term parameters that reported on forces and 
properties responsible for observed long-term protein phase behavior.  
 
The aforementioned computational methods were developed with the use of HEWL 
formulations. The applicability of the developed workflow for other protein formulations 
was investigated by the means of an industry case study. The objective of this case study 
was to screen glycerol-poor and glycerol-free food protein formulations, as EU authorities 
have raised concerns about the safety of high glycerol content in food products. Redesigned 
formulations were required to maintain a similar long-term protein stability compared to 
the original product, but with reduced or no glycerol content. The combination of short-
term empirical protein properties and long-term protein phase behavior revealed that 
several redesigned formulations presumably resulted in long-term stability via a similar 
pathway as the original product, as they displayed a comparable apparent protein surface 
hydrophobicity. In addition, the workflow also identified an increase of electrostatic 
repulsive forces as an alternative approach to achieve long-term stability. This case study 
illustrated how short-term empirical studies can be used to create an in-depth product 
understanding and support the design of long-term stable formulations, leading the way 
towards knowledge-based experimental design.   
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Knowledge-based experimental design is also aided by prior knowledge obtained from 
computational methods such as protein property extraction from three-dimensional (3-D) 
structures. These approaches utilize molecular dynamics (MD) to simulate 3-D protein 
structures under varying environmental conditions, which allows for the extraction of 
protein properties as a function of the simulated environment. The required 3-D protein 
structures need to fulfill certain quality parameters prior to MD simulation, as poor 
structure quality causes unreliable results. The refinement of 3-D protein structures is 
currently a bottleneck when multiple different structures are needed, since refinement is 
done via a manual multi-step procedure. An illustrative example is screening virus-like 
particle (VLP) drug candidates. VLPs are a promising biopharmaceutical product that is 
able to target multiple high-profile diseases, such as cancer and Alzheimer’s disease. 
Relatively small structural changes to the viral capsid proteins that constitute the complete 
VLP affect its efficacy, safety, and manufacturability, which typically leads to screening 
hundreds of modified structures. The required refinement of hundreds of modified 
structures to support preliminary drug candidate screening is not feasible with the current 
manual 3-D structure refinement protocol. In this thesis, an automated, data-dependent, 
and high-throughput compatible computational pipeline for 3-D structure preparation is 
presented and applied to dimeric VLP capsid protein structures. Efficiency of the 
computational pipeline was demonstrated by refining 31.2%-69.2% of the structural errors 
in only 3.6-12.5% of the total refinement time. The complete refinement was performed 
within 6.6-37.5 hours per structure and sufficient 3-D protein structure quality for MD 
simulations was obtained. In addition, a robust protein property extraction approach was 
developed, which takes into account the contribution of inherent structural fluctuations 
during an MD simulation. This was done to work towards an improved correlation between 
in silico and empirical protein properties.  
 
This thesis contributes to the field of long-term protein phase behavior by combining 
unsupervised machine learning for multidimensional data visualization and supervised 
machine learning for image recognition purposes to automatically extract end point and 
kinetic data from long-term protein phase behavior studies. Subsequently, the unsupervised 
multidimensional data visualization technique was applied to investigate the correlation 
between short-term empirical properties measured directly after formulation preparation 
and long-term protein phase behavior. This workflow was applied on a case study, which 
led to the identification of product-specific short-term properties related to long-term 
stability. This thesis also contributed to the advancement of in silico approaches and their 
role in long-term stable formulation development. This was achieved by developing a high-
throughput computational pipeline to efficiently produce high quality 3-D protein 
structures for MD simulations. The presented computational methods contribute to the 
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design of an infrastructure required to advance long-term protein phase behavior analysis 
and its prospective prediction. 
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Zusammenfassung 
 
Die in dieser Thesis vorgestellten Arbeiten tragen zum Feld des Langzeitphasenverhaltens 
von Proteinen bei. Das Langzeitphasenverhalten von Proteinen spielt in der Produkt- sowie 
Prozessentwicklung biotechnologischer Produkte eine ausschlaggebende Rolle. Eine der 
größten Produktgruppen in der biotechnologischen Industrie sind rekombinante Proteine. 
Beispiele hierfür sind Laktase zur Verarbeitung von Milchprodukten oder Insulin als 
Pharmazeutikum zur Behandlung von Diabetes. Rekombinante Proteine haben eine starke 
Marktposition, die sich aus ihrer hochspezifischen Funktionalität ergibt, die es ihnen 
ermöglicht, Zellen und Prozesse im menschlichen Körper gezielt zu beeinflussen. Zu 
beachten ist allerdings das schmale Stabilitätsfenster der meisten Proteine. 
Umgebungsbedingungen wie Temperatur oder pH - Wert haben einen signifikanten 
Einfluss auf ihre Konformations- und Kolloidstabilität und können zum Verlust der 
Proteinfunktion außerhalb passender Bedingungen führen. Abweichungen von den 
physiologischen Bedingungen des jeweiligen Proteins können sowohl die Wirksamkeit als 
auch die Sicherheit des Produktes gefährden. Die extreme Sensitivität gegenüber 
suboptimalen Umgebungsbedingungen ist besonders gegen Ende des 
Produktionsprozesses problematisch, da finale Formulierungen typischerweise für 18 bis 
24 Monate stabil sein müssen. Um die Haltbarkeit der finalen Formulierung über die Zeit 
zu gewährleisten, sind Formulierungsstudien nötig, bei welchen das Phasenverhalten von 
Proteinen in Abhängigkeit von verschiedenen Umgebungsbedienungen überwacht wird. 
Diese Experimente müssen in Echtzeit durchgeführt werden, was bedeutet, dass die Zeit 
für das Experiment der Haltbarkeitsdauer des Produkts von 18 bis 24 Monate entspricht. 
Der Aufwand und die benötigte Zeit für diese Experimente kann durch wissensbasiertes 
Versuchsdesign reduziert werden, bei dem Vorkenntnisse über die Proteinstabilität den 
Versuchsaufbau bestimmen. Derartige wissensbasierte Experimente erfordern ein 
Verständnis der Kräfte und Proteineigenschaften, welche die Langzeitstabilität 
beeinflussen. Das daraus gewonnene Wissen kann anschließend genutzt werden, um 
kurzfristig messbare Eigenschaften mit der Langzeitstabilität der Proteine zu verknüpfen 
und Methoden zur Vorhersage von Proteinstabilität zu treffen. Um dieses Verständnis zu 
erlangen, wird das Phasenverhalten der Proteine im Zusammenhang mit biophysikalisch 
messbaren Größen untersucht, wobei die relevanten Kräfte und Proteineigenschaften 
charakterisiert werden. Um eine weite Bandbreite an Umgebungsbedingungen testen zu 
können, werden sowohl das Phasenverhalten als auch die biophysikalischen Eigenschaften 
üblicherweise in Hochdurchsatzexperimenten untersucht. Hochdurchsatzexperimente 
führen unweigerlich zu sehr großen Datensätzen die verarbeitet und analysiert werden 
müssen. Dieser Engpass in der Datenverarbeitung hat die Entwicklung computergestützter 
Methoden zum Vorantreiben der Datenverarbeitung und -analyse notwendig gemacht. 
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Das Phasenverhalten von Proteinen wird in der Regel mit Hilfe von Phasendiagrammen 
untersucht. Hierzu werden verschiedene Formulierungen angesetzt und über einen 
längeren Zeitraum gelagert um Informationen über den Einfluss der 
Umgebungsbedingungen auf die jeweilige Formulierung zu erhalten. Nach der Lagerzeit 
beinhaltet die Datenauswertung typischerweise eine manuelle Auswertung der Fotos der 
Formulierungen, um das Vorhandensein von instabilen Proteinen in Form unlöslicher 
Aggregate und deren Morphologie zu erkennen. Aufgrund des großen Arbeitsaufwands bei 
der manuellen Auswertung solcher Bilder fokussieren sich die meisten Studien zu diesem 
Thema auf das Auswerten des Endpunktes, also des Fotos vom letzten Tag der Lagerzeit. 
Moderne, automatisierte Bilderfassungssysteme ermöglichen es allerdings während der 
gesamten Lagerzeit Fotos aufzunehmen. Für ein typisches Proteinstabilitätsexperiment 
beutetet dies, dass die Auswertung des Endpunktes nur ungefähr 1 % der erzeugten Daten 
verwendet. Des Weiteren vernachlässigt die reine Endpunktanalyse alle kinetischen 
Aspekte des Proteinphasenverhaltens, die von den restlichen 99 % des Datensatzes 
abgebildet werden. Da diese kinetischen Eigenschaften auch von den gewählten 
Lösungsbedingungen abhängen, könnten sie genutzt werden, um ein umfassenderes 
Verständnis des Proteinphasenverhaltens zu erhalten. Die Herausforderung der Integration 
kinetischer Daten in ein Proteinphasendiagramm liegt in der resultierenden 
Mehrdimensionalität der Daten. In dieser Arbeit wird das empirische Phasendiagramm 
(empirical phase diagram, EPD) vorgestellt, das als Ansatz für nicht-überwachtes, 
maschinelles Lernen entwickelt wurde, um multidimensionale Daten zu 
Visualisierungszwecken zu kombinieren. Das EPD wurde angewandt, um die Kinetikdaten 
und Endpunktanalyse aus den Proteinphasendiagrammen in einer gemeinsamen Grafik zu 
visualisieren. Das daraus resultierende multidimensionale Proteinphasendiagramm 
(multidimensional protein phase diagram, MPPD) ermöglichte eine tiefergehende Analyse 
des Phasenverhaltens von Proteinen bei verschiedenen Umgebungsbedingungen. Eine 
weitere Herausforderung beim Auswerten der Proteinphasendiagramme ist die sehr 
zeitintensive manuelle Extraktion der Kinetik- und Endpunktdaten zur Konstruktion der 
MPPDs. Dieser Arbeitsaufwand kann durch die Verwendung von computergestützten 
Methoden, wie der Verwendung von maschinellen Lernalgorithmen zur Bilderkennung, 
deutlich reduziert werden. Bilderkennungsalgorithmen zu verwenden, ist im Bereich der 
Proteinphasendiagramme nicht ungewöhnlich, allerdings kann ihre Leistungsfähigkeit 
noch gesteigert werden. Fortgeschrittene Methoden für maschinelles Lernen, wie 
künstliche neuronale Netze (artificial neural network, ANN), können verwendet werden, 
um die Ergebnisse zu verbessern. Die zunehmende Komplexität der Methode senkt jedoch 
die Transparenz und erfordert mehr Fachwissen vom Nutzer. Eine weitere Möglichkeit, die 
Leistung der Bilderkennung zu erhöhen, ist es von vornherein mehr Information aus den 
Phasendiagrammen zu extrahieren, um die Unterschiede prominenter herauszuarbeiten 
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ohne die Auswertemethode an sich zu verkomplizieren. In dieser Thesis wurden zu diesem 
Zweck die Vorteile der Integration von mehreren Lichtquellen (sichtbares, UV- und 
kreuzpolarisiertes Licht) mit Kinetikdaten untersucht, um eine Erhöhung der Genauigkeit 
der Bilderkennung zu erreichen. Im Vergleich zu herkömmlicher Analyse von 
Endpunktdaten basierend auf sichtbarem Licht (durchschnittliche Genauigkeit von 69,3 %) 
konnte durch die Verwendung von mehreren Lichtquellen und Kinetikdaten eine 
Verbesserung um 17,3 Prozentpunkte auf 86,6 % erreicht werden. Zusätzlich wurde der 
Bilderkennungsalgorithmus an die Erstellung von MPPDs gekoppelt. Durch diese 
Kombination wurde ein automatisierter computerbasierter Arbeitsablauf entwickelt, der 
zeitaufgelöste Rohbilder von Proteinphasendiagrammen verwendet und daraus MPPDs 
erstellt, wobei sowohl die Kinetik- als auch Endpunktdaten des Phasenverhaltens 
visualisiert werden. 
 
Die darauffolgende Studie, die in dieser Arbeit vorgestellt wird, untersucht den 
Zusammenhang kurzfristig messbarer empirischer Kräfte und Proteineigenschaften der 
Proteinformulierung mit dem Langzeitphasenverhalten, wobei die kurzfristigen 
empirischen Daten am selben Tag aufgenommen wurden, an dem die Formulierung erstellt 
wurde. Die Korrelation von kurzfristig messbaren Eigenschaften mit der Langzeitstabilität 
ist relevant, da das große Ziel in der Formulierungsentwicklung die Kontrolle und 
Vorhersage von langfristigem Proteinphasenverhalten aus kurzen Messkampagnen anstelle 
von aufwändigen Echtzeitversuchen ist. Da die zugrundeliegenden Kräfte und 
Eigenschaften vorher nicht bekannt sind, können die benötigten analytischen Methoden 
nicht vor den Experimenten festgelegt werden. In dieser Arbeit wurden deshalb 
verschiedene Analytiken verwendet, um eine große Bandbreite an möglichen Ursachen für 
das Phasenverhalten abzudecken. Dazu wurden statische Lichtstreuung, dynamische 
Lichtstreuung, Fouriertransformations-Infrarotspektroskopie, intrinsische 
Fluoreszensspektroskopie, Mixed-Mode-Messung zur Phasenanalyse der Lichtstreuung 
(M3-PALS) und die Stalagmometermethode verwendet. Mit diesen Analytiken konnten 
die Aggregationsstarttemperatur, effektiver hydrodynamischer Radius, 
Sekundärstrukturelemente, Schmelzpunkt, Zetapotenzial und die effektive 
Oberflächenhydrophobizität von Lysozym aus Hühnereiweiß (hen egg-white lysozyme, 
HEWL) in 120 verschiedenen unterschiedlichen Formulierungen gemessen werden. Diese 
führte zu einer Sammlung von kurzfristig messbaren, empirischen Datenpunkten aus 
verschiedenen Quellen, welche zusammengefasst, ausgewertet und mit dem 
Langzeitphasenverhalten korreliert wurden. Die multidimensionale 
Visualisierungsmethode EPD wurde dann verwendet, um ein sogenanntes empirisches 
Proteineigenschaftsdiagramm (empirical protein property diagram, EPPD) zu erstellen. 
Dies ermöglichte eine systematische und datenabhängige Identifizierung von kurzfristig 
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messbaren Parametern, die Hinweise auf Kräfte und Eigenschaften geben, die das 
Proteinphasenverhalten beeinflussen. 
 
Die oben genannten computergestützten Methoden wurden mit Hilfe von HEWL 
Formulierungen entwickelt. Die Anwendbarkeit der entwickelten Arbeitsabläufe auf 
andere Proteinformulierungen wurde anhand einer Fallstudie in Zusammenarbeit mit 
einem Industriepartner gezeigt. Das Ziel dieser Fallstudie war es, glyzerinarme und 
glyzerinfreie Lebensmittelproteinformulierungen zu untersuchen, da EU-
Regulierungsbehörden Bedenken bezüglich hoher Glyzeringehalte in Lebensmitteln 
haben. Die Anforderung an die für die Fallstudie zu entwickelnde neue Formulierung war 
es, trotz niedrigem oder keinem Glyzeringehalt ähnliche Langzeitstabilität zu erreichen. 
Die Kombination der Ergebnisse aus kurzzeitig messbaren empirischen 
Proteineigenschaften und langfristigem Proteinphasenverhalten ergab, dass der 
Langzeitstabilität einiger der neu entwickelten Formulierungen wahrscheinlich ein 
ähnlicher Mechanismus zu Grunde liegt wie der des Originalprodukts, da die 
Oberflächenhydrophobizität ähnliche Werte zeigten. Zusätzlich wurde durch die 
Steigerung der elektrostatisch abstoßenden Kräfte eine mögliche Alternative zur 
Steigerung der Langzeitstabilität identifiziert. Diese Fallstudie zeigt somit einen Weg auf, 
wie kurzfristig durchführbare empirische Studien verwendet werden können, um ein tiefer 
gehendes Produktverständnis zu gewinnen, die Entwicklung von langzeitstabilen 
Formulierungen zu unterstützen und den Weg zur wissensbasierten Experimentalplanung 
zu ebnen.  
 
Wissensbasiertes Experimentaldesign kann auch durch Vorwissen aus anderen 
computergestützten Methoden wie der Extraktion von Merkmalen aus dreidimensionalen 
(3D) Proteinstrukturen unterstützt werden. Bei derartigen Ansätzen werden 
Molekulardynamiksimulationen (MD) verwendet, um dreidimensionale Proteinstrukturen 
unter verschiedenen Umgebungsbedingungen zu simulieren und Eigenschaften der 
Proteine als Funktion der simulierten Umgebungsbedingungen zu extrahieren. Hierbei ist 
es essenziell, dass die Proteinstrukturen, die als Grundlage für die Simulationen verwendet 
werden, gewissen Qualitätsanforderungen entsprechen um verlässliche Ergebnisse zu 
erhalten. Die Verfeinerung der 3D Strukturen wird in einem schrittweisen manuellen 
Verfahren durchgeführt und kann dadurch leicht zum zeitlimitierenden Schritt werden. Ein 
anschauliches Beispiel ist die Kandidatenvorauswahl von virusähnlichen Partikeln (virus-
like particle, VLP) die als Pharmazeutika eingesetzt werden sollen. VLPs sind ein neues 
vielversprechendes biopharmazeutisches Produkt, das für diverse hochrelevante 
Krankheiten wie Krebs oder Alzheimer eingesetzt werden könnte. Eine Herausforderung 
bei der Produktion von VLPs ist, dass kleine strukturelle Änderungen am Kapsid, aus 
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welchen die VLPs bestehen, ihre Wirksamkeit, Sicherheit und Produzierbarkeit 
beeinflussen. Dies führt wiederum dazu, dass für eine Vorauswahl möglicher Kandidaten 
eine große Anzahl unterschiedlicher Strukturen vorbereitet werden muss, was mit 
bisherigen manuellen Methoden zur Strukturvorbereitung nicht praktikabel ist. In dieser 
Arbeit wird eine automatisierte, datenbasierte und hochdurchsatzkompatible 
Vorbereitungsmethode für die Vorbereitung der dreidimensionalen Strukturdaten 
vorgestellt und für dimere VLP Hüllenproteine angewendet. Die Effizienz der 
automatisierten Methode zeigte sich dadurch, dass 31,2 %-69,2 % der Strukturfehler in 
3,6 %-12,5 % der Vorbereitungszeit beseitigt werden konnten. Die gesamte 
Vorbereitungszeit betrug damit 6,6-37,5 Stunden pro Struktur um Strukturdaten von 
geeigneter Qualität zu erhalten. Zusätzlich wurde eine robuste Methode zur Extraktion von 
Proteineigenschaften aus Strukturdaten entwickelt, die die Fluktuationen, die während der 
MD-Simulation auftreten, berücksichtigt. Dies wurde durchgeführt, um auf eine 
verbesserte Korrelation zwischen in silico und empirischen Proteineigenschaften 
hinzuarbeiten. 
 
Diese Thesis trägt zum Feld der Untersuchung des Langzeitphasenverhaltens von 
Proteinen bei, indem nicht überwachte Methoden für maschinelles Lernen zur 
Datenvisualisierung und überwachte Lernmethoden zur Bilderkennung kombiniert 
wurden, um automatisch Endpunkt- und Kinetikdaten aus Langzeitstudien zum 
Phasenverhalten von Proteinen zu extrahieren. Anschließend wurde die unüberwachte 
multidimensionale Datenvisualisierungsmethode zur Untersuchung der Korrelation 
zwischen kurzfristig messbaren Eigenschaften, die direkt nach der Vorbereitung der 
Formulierung gemessen wurden und dem Langzeitphasenverhalten der Proteine in der 
jeweiligen Formulierung verwendet. Der Arbeitsablauf wurde auch auf eine Fallstudie 
angewandt bei der produktspezifische, messbare Eigenschaften identifiziert werden 
konnten die einen Einfluss auf die Langzeitstabilität haben. Weiterhin leistet diese Arbeit 
einen Beitrag zu computergestützten Methoden und ihrer Rolle für die Entwicklung bei der 
Verbesserung von langzeitstabilen Formulierungen. Erreicht wurde dies durch die 
Entwicklung einer hochdurchsatzkompatiblen Methode für die Vorbereitung qualitativ 
hochwertiger Proteinstrukturdaten für MD-Simulationen. Die vorgestellten 
computergestützten Methoden tragen dazu bei, die benötigte Infrastruktur zu etablieren, 
die für die Analyse des Langzeitphasenverhaltens von Proteinen und schlussendlich für 
dessen Vorhersage unerlässlich ist. 
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1 Introduction 
 
With the insertion of functional recombinant DNA into Escherichia coli in 19731, the era 
of modern biotechnology had started. Since this first genetically modified organism, 
biotechnology has expanded into a wide variety of fields. The molecular genetics field 
targeted the $1000 genome to rapidly unravel more genetic codes2. Obtained genetic codes 
map out the possible cellular protein content and contribute to the identification proteins 
of interest, for instance disease-related proteins3. Fields such as proteomics4 and systems 
biology5 put the possible cellular protein content into perspective, which allows for an 
understanding of protein production pathways, functionality, and physiological effects. In 
its turn, the field of genetic engineering uses this information to modify organisms for the 
application of interest, such as the production of biopharmaceuticals6 or crop modification7. 
The relatively young field of synthetic biology is moving towards engineering entire 
cellular systems, in order to expand the range of applications8,9. The field of biochemical 
engineering utilizes modified organisms for manufacturing of biotechnological products 
and is responsible for the design of production processes to match the consumer demand10.  
 
Considering specifically the biopharmaceutical industry, technological advances seen in 
all aforementioned fields have led to a shift of focus from drug discovery to drug 
development11,12. One of the most widely used biopharmaceutical products are 
recombinant proteins13. Beside their use as biopharmaceuticals, recombinant proteins are 
also used in other industries, such as agriculture14 and food15. Recombinant proteins are 
proteins expressed using recombinant DNA techniques for a specific environment and 
application, which is of interest for most biopharmaceuticals due to the high biological 
complexity of the human body. For example, bacterial cells are used as expression system 
to produce recombinant human insulin in order to circumvent the immune response of the 
human body to animal-derived insulin16. For successful recombinant protein drug 
development, the following three criteria should be met11: (1) safety and efficacy for the 
patient population, (2) scalable and economic manufacturing to meet production demands, 
and (3) a demonstrated shelf life of at least 18-24 months17. However, the unique 
combination of amino acid chains, the higher dimensional structure, and possible chemical 
modifications, which allow for proteins’ specific functionalities, also causes their marginal 
stability16. This means that proteins are prone to chemical and physical degradation when 
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environmental conditions deviate from their native, physiological environment in which 
they should perform their function18–20. Chemical and physical degradation usually leads 
to protein aggregation, which in turn may negatively affect product safety and efficacy21. 
Degradation susceptibility is of importance throughout product process development, as 
environmental conditions, such as temperature, pH, and additives, change throughout the 
entire manufacturing process. This includes the final product formulation22. In order to 
demonstrate the product’s relatively long shelf life, drug development efforts are 
challenged to overcome physical and chemical instability over time11.  
 
To tackle issues concerning protein product shelf life, an understanding of the 
environmental effects in relation to protein characteristics on long-term protein phase 
behavior is needed. Such formulation studies require an experimental approach to probe a 
wide range of variables, which includes the protein itself, formulation additives, and 
solutions conditions20. High-throughput biophysical characterization to monitor the effects 
of a wide variety of experimental conditions is therefore becoming increasingly 
important20. Knowledge obtained from high-throughput biophysical characterization 
experiments is also useful for long-term protein phase behavior modification, and may 
allow for its prediction in the future23. However, the typically large data sets produced by 
such high-throughput biophysical characterization experiments cannot be interpreted 
without well-designed data evaluation workflows, as was also recognized when generating 
massive data sets during the race towards $1000 genome24. With the ability to generate 
more data to study and understand long-term phase behavior of protein products, a 
bottleneck occurred on the side of data analysis20. In the following sections, a theoretical 
background of protein stability is presented, as well as an overview of analytical techniques 
employed in this thesis to monitor protein stability. The final section addresses data 
analysis techniques required to correlate theoretical information to empirical data in more 
detail.  
 
1.1 Protein stability 
Protein stability is a complex phenomenon, as each protein is chemically and physically 
unique, which consequently results in unique stability behavior18,21. Despite proteins’ 
distinct behavior, common stability characteristics have been identified. In order to 
evaluate protein stability and the effects on long-term protein phase behavior, an overview 
of general aggregation pathways and environmental effects is presented in the following 
sections.  
 
 
 
3 
 
1.1.1 Aggregation pathways 
The ability of proteins to form aggregates is determined by either conformational stability 
or colloidal stability, or both, where the predominant factor depends on environmental 
conditions18. In Figure 1.1 an overview of the main aggregation pathways is shown. A 
schematic describing colloidal and conformation stability of a protein is shown in Figure 
1.1 as well.  
 
 
Figure 1.1: (a) Colloidal stability: interaction energy (W) as a function of surface distance between two 
spherical particles. The total W is the sum of the electrostatic repulsion and the van der Waals attraction, 
and ΔW1 represents the maximum interaction energy barrier. (b) Conformational stability: protein 
aggregation reaction coordinate diagram with curved lines as transition energy barriers, and an indication 
of the activation energy for unfolding (ΔGunf) and aggregation (ΔG‡). (c) Flowchart of aggregation 
pathway 1, 2 and 3. Different protein state abbreviations are listed. (d) Schematic of aggregation pathway 
4 and 5. This figure is adapted from literature18,25,26. 
 
Figure 1.1a depicts colloidal stability, where the protein-protein interaction as a function 
of the distance between particles is described by the Derjaguin-Landau-Verwey-Overbeek 
(DLVO) theory27,28. The DLVO theory takes into account the contribution of electrostatic 
double-layer repulsive forces and van der Waals attractive forces on colloidal stability of 
proteins, which are considered to be hard spheres. The schematic in Figure 1.1a shows that 
the total interaction energy becomes smaller for shorter distances, as van der Waals 
attractive forces become more dominant. At larger distances, a positive total interaction 
energy indicates prevention of particle interaction by electrostatic double-layer repulsive 
forces. In short, colloidal stability decreases with decreasing particle distance, where 
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particle interaction occurs when the maximum interaction energy barrier (ΔW1) is 
overcome. This achieved by screening of electrostatic repulsive forces, domination of van 
der Waals forces, hydrophobic interactions, crowding effects, or excluded volume 
repulsion12.  
 
Conformational stability of protein is illustrated in Figure 1.1b by means of activation 
energies for conformational transitions of a protein. The native structure (N) can transform 
to a denatured state (D) or intermediate state (I) when overcoming the unfolding activation 
energy (ΔGunf) or activation energy (ΔG‡), respectively. For the intermediate state (I), it is 
assumed to be thermodynamically favorable to move towards an aggregated product (AI 
and A)18. The value for ΔGunf and ΔG‡ depends on multiple forces contributing to protein 
folding, such as disulfide bonds, electrostatic interactions, hydrophobic interactions, 
hydrogen bonds, and van der Waals interactions19. These forces can be influenced by 
environmental factors, such as pH, salt type and concentrations, and temperature.  
 
Simply stated, a protein molecule needs to overcome ΔW1 or ΔG‡ in order to form 
aggregates. The formation of aggregates can follow one of the five main aggregation 
pathways26,29, which are depicted in Figure 1.1c and Figure 1.1d. The first pathway results 
in aggregation through partial unfolding, which means ΔG‡ should be overcome. The 
protein surface can become more hydrophobic upon unfolding, which consequently 
decreases colloidal stability20. Previously, it was thought that completely unfolded protein 
structures (indicated by state D in Figure 1.1d) should display similar behavior as the 
intermediate state, but it has been noted that mainly intermediate states are prone to 
aggregation18,20,26. Nevertheless, the D state are able readily aggregate and undergo 
chemical degradation26, as indicated by Figure 1.1d. The second pathway results in 
aggregation through self-association. This means that ΔW1 is overcome and colloidal 
instability dominates. Self-association of proteins is usually an effect of environmental 
conditions, but self-association can also occur by chemical linkage, such as disulfide bonds. 
The third pathway involves chemical degradation, for instance oxidation, deamidation, or 
hydrolysis23. Chemical degradation changes the protein molecule and may cause a decrease 
in colloidal and conformation stability20. The fourth pathway typically occurs during the 
formation of visible or insoluble precipitates. Here, addition of monomers to a critical 
nucleus, an aggregate of a particular size or an impurity, is thermodynamically favored 
over the formation of smaller aggregates out of monomers. The fifth pathway occurs due 
to presence of surfaces or interfaces, such as an air-water interface. Interaction with a 
surface or interface decreases conformation stability in order to increase the protein-surface 
contact area. Conformational changes can result in aggregate formation while the protein 
is still in contact with the surface/interface or when the altered structure is released back 
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into solution. Within these five common pathways, a distinction between reversible and 
irreversible aggregation can be made. Reversible aggregation, where aggregates can 
dissociate into the native form, typically occurs when no or minor structural changes lay at 
the foundation of aggregation and when aggregates are still small26.  
 
1.1.2 Factors influencing protein aggregation 
The previously presented protein aggregation pathways can be induced or prevented by 
various environmental factors, such as temperature, pH, salt, protein concentration, and 
additives18. Combining information on the aggregation pathway with the point of 
engagement of these environmental factors contributes to understanding long-term protein 
phase behavior, as it allows for the identification of the underlying causes. Therefore, the 
effects of common environmental variables are presented in the following sections.  
 
1.1.2.1 Temperature 
Increasing the temperature influences conformational and colloidal stability of proteins by 
secondary structure disruption, activation energy (ΔGunf and ΔG‡) reduction, increased 
diffusion which leads to more energetic collisions between protein molecules (thereby 
overcoming ΔW1), and increased chemical degradation rates18,21,26,30. Not only high 
temperatures, but also low temperatures affect colloidal and conformational stability. For 
example, at temperatures below the freezing point of water, proteins can adsorb to the 
solid-liquid interface of ice crystals31. In addition, ice formation changes the liquid 
environment in such a way that unfavorable high protein, salt, or additive concentrations 
may occur32. Conformational stability can decrease as a result of cold denaturation. This is 
caused by preferential hydration of the protein’s nonpolar groups at low temperatures, 
which makes the unfolded state thermodynamically favorable33.  
 
1.1.2.2 Solution pH 
The solution pH influences the type (positive or negative), the distribution, and net protein 
charge by determining the protonation state of amino acid residues34. The resulting charge 
characteristics affect both conformational and colloidal stability18. For increasing net 
charge within the protein, conformation stability decreases. This is due to a greater charge 
density of the native structure in comparison to the charge density of the denatured 
structure. This means a state of lower electrostatic free energy is found for the unfolded 
structure, and therefore thermodynamically favorable35. Contrarily, conformational 
stability can be enhanced by specific interactions of charged ion pairs present on the protein 
surface35. Colloidal stability is equally dependent on the net protein charge type and its 
distribution, and therefore influenced by solution pH as well18,20. For a relatively smaller 
net charge, the electrostatic double-layer repulsion is minimized and ΔW1 is reduced. From 
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this point of view, the isoelectric point (pI) should theoretically result in the lowest 
colloidal stability as the net protein charge equals zero at this solution pH. However, 
different protonation states of amino acids along the protein surface can still result in a 
charge distribution over the protein surface at a pH equal to the protein pI. Such a protein 
surface charge distribution has been shown to maintain colloidal stability36,37. 
 
1.1.2.3 Salt 
Salt ion concentration can affect both conformational and colloidal stability. Colloidal 
stability can be decreased by lowering ΔW1 as a result of screening protein surface charges, 
and thereby diminishing electrostatic repulsive forces28. At low salt concentrations 
shielding is the predominant effect, but at higher salt concentrations preferential binding 
can decrease the thermodynamic stability of the native conformation18. In addition to 
concentration, the salt type plays a role as well. Depending on the salt ion type, 
conformational instability may result as an effect of preferential binding to the nonnative 
protein state18. On the other hand, conformation stability may be enhanced when salt ions 
are preferentially excluded by the protein38.  
 
Not only the various influences of salt ions on protein stability, but also its dependence on 
protein charge, makes the influence of salt a highly complex phenomenon. For example, 
solution pH influences the effect of anions on colloidal stability, which is often ranked 
according to the Hofmeister series39. Initially, the Hofmeister order was considered an 
effect of disruption or ordering the hydrogen bond structure of water, thereby preventing 
or promoting protein-protein interaction, respectively. However, it has been demonstrated 
that the hydrogen bond structure of water is not influenced outside of the first solvation 
shell of the salt ion40. Other research demonstrated the specific influence of pH for different 
anions, where the direct Hofmeister order is followed when the solution pH is above the 
protein pI and anions serve as counterions. A reverse order of the Hofmeister series was 
found for solution pH values below the protein pI, when anions serve as co-ions41. In 
addition, salt concentration effects on the Hofmeister order have been reported42. 
Currently, there is no universal explanation of the direct or reverse Hofmeister series under 
varying conditions43. 
 
1.1.2.4 Protein concentration 
When higher protein concentrations are used, the distance between protein molecules 
decreases and their collision frequency increases26,44. Both these effects decrease colloidal 
stability. In addition, the self-association aggregation pathway is promoted due to excluded 
volume effects, where the systems free energy is reduced by minimizing the total excluded 
volume44. 
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1.1.2.5 Additives 
Additives can be used to prolong shelf life by influencing protein stability, where some 
additives stabilize the native structure, some destabilize the native structure, and others are 
used to suppress protein-protein interactions45. In this work, additives are defined as all 
molecules that are added to formulations in addition to protein, salt, and buffer 
components. A comprehensive overview of additives used for protein-based products can 
be found elsewhere, where key mechanisms such as electrostatic interactions, preferential 
hydration, dispersive forces, and hydrogen bonding are discussed as well46. 
 
Widely used solution additives include sugars, polyols, amino acids, surfactants, and 
preservatives. Additives such as sugars and polyols are preferentially excluded from the 
protein surface46–48. This promotes conformation stability, as the total effect is to increase 
the energy gap between the native and denatured state, which translates to an increase in 
ΔGunf and ΔG‡ 23. However, this may decrease colloidal stability as the free energy is also 
reduced by self-association45. Amino acids, such as histidine and methionine, can increase 
protein stability via preferential binding, their buffering capacity, or chemical degradation 
prevention, such as oxidation46. Addition of non-ionic surfactants, such as polysorbate 8049, 
prevents aggregation as a result of surface adsorption. Protein unfolding is prevented by 
outcompeting protein molecules for hydrophobic surfaces, such as air-water interfaces or 
hydrophobic surfaces during processing. Non-ionic surfactants can also directly interact 
with hydrophobic regions of the protein, thereby preventing hydrophobic protein-protein 
interactions46.  
 
Besides chemical and physical protein stability, microbial stability is also of importance 
for successful product development. The focus of this thesis is on protein stability, but 
additives utilized to prolong product shelf life by ensuring microbial stability, such as 
benzyl alcohol, have been reported to affect protein aggregation18. This indicates the 
importance of evaluating all additives that are part of the final product formulation, and not 
only additives that are used to ensure long-term chemical and physical protein stability. 
 
1.2 Analytical characterization 
Information on the nature and magnitude of inter- and intramolecular forces that determine 
long-term protein phase behavior contributes to its overall understanding. Analytical 
techniques applied in this work to obtain such information, are presented in the following 
four sections. In the first section, long-term protein phase behavior experiments are 
discussed. The second and third sections present the applied analytical techniques to 
monitor colloidal and conformational stability, respectively. The fourth section presents 
the analytical techniques applied to determine protein surface properties.  
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1.2.1 Protein phase behavior 
Protein phase behavior as a function of time is studied in formulations that contain water, 
protein, and additives in combination with buffer components to obtain a protein phase 
diagram50,51. Four main techniques can used to generate such diagrams, namely vapor 
diffusion, free interface diffusion (FID), batch, and dialysis52. A schematic protein phase 
diagram is shown in Figure 1.2, as well as the pathways of these four main techniques 
through the protein phase diagram. 
 
 
Figure 1.2: (a) Schematic protein phase diagram indicating the pathway of four main crystallization 
techniques: free interface diffusion (FID), dialysis, vapor diffusion, and batch. Undersaturation and 
supersaturation are separated by the solubility line (broad dashed line). In the supersaturation zone, the 
metastable (above the broad dashed line), nucleation (above the dashed line), and precipitation zone (above 
the dotted line) are indicated. (b) Pictograms of the four crystallization techniques. This figure is adapted 
from literature52. 
 
As depicted in Figure 1.2a, a protein phase diagram contains two main zones, namely the 
undersaturated zone and the supersaturated zone. The undersaturated zone contains 
conditions where proteins remain in solution, while the supersaturated zone contains 
solutions where protein aggregation occurs. The supersaturation zone is 
thermodynamically unstable and will move towards an equilibrium53. This equilibrium is 
found at the protein solubility concentration where aggregation and dissociation rates are 
equal51. This equilibrium is represented by the solubility line (broad dashed line in Figure 
1.2a). Subzones such as the metastable, nucleation, and precipitation zone have been 
incorporated in Figure 1.2a to represent different aggregation kinetic stages52. In the 
metastable zone, supersaturation is too low for nucleation to take place within a reasonable 
amount of time. In the nucleation zone, crystal nuclei are spontaneously formed. In the 
precipitation zone, the level of supersaturation is too high for structured aggregation and 
precipitation occurs. It should be noted that the qualitative boundaries of these zones are 
kinetic phenomena and not well-defined50,52.  
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Different techniques can be employed to obtain information about protein phase behavior, 
of which four are shown in Figure 1.2b. The difference between the techniques is the 
method to reach supersaturation to induce protein aggregation. FID uses diffusion to mix 
a protein solution with a precipitant solution, thereby allowing the solution to move into 
supersaturation. Dialysis uses diffusion to increase the precipitant concentration in the 
protein solution to reach supersaturation as well, but by means of a semi-permeable 
membrane. Vapor diffusion is based on the diffusion of volatile species (usually water) in 
a closed system. Dehydration of a sitting or hanging formulation drop occurs as vapor 
equilibrium occurs between the undersaturated drop and the reservoir containing a higher 
precipitant concentration. Dehydration of the formulation drop results in a protein and 
precipitant concentration increase towards supersaturation. For batch experiments, solution 
conditions are not altered during the experiment and supersaturation is reached directly 
after formulation preparation. Batch experiments are employed in this work. Despite the 
different approaches to reach supersaturation, a common disadvantage of the presented 
techniques is the lack of fundamental information that can be extracted from the observed 
protein phase behavior. Protein phase diagrams may provide some insight in the 
responsible aggregation pathways, as some assumptions about protein conformation or 
colloidal instability have been correlated to observed insoluble aggregate morphologies54. 
However, fundamental knowledge, such as the forces responsible for conformational or 
colloidal instability, cannot be directly extracted from protein phase diagrams. Another 
common disadvantage of the presented techniques, the element of time, may be eliminated 
with a more complete understanding of the fundamental forces. Currently, accelerated 
studies are performed but remain solely applicable as support for long-term stability 
studies17. This is due to the inherent assumption during accelerated studies that the external 
stress applied to induce protein aggregation in a shorter amount of time (such as 
temperature increase or pH stress) results in a comparable mechanism of physical or 
chemical degradation as the protein would experience over prolonged periods of time. 
However, this is usually not the case26,30. Understanding fundamental forces which lie at 
the basis of observed protein phase behavior may allow for the identification of short-term 
parameters, obtained under comparable conditions, which correlate well to long-term 
protein phase behavior. 
 
1.2.2 Colloidal stability 
This work employs static light scattering (SLS) and dynamic light scattering (DLS) as 
analytical techniques to monitor colloidal stability. A variety of other analytical techniques 
to monitor colloidal stability are elaborately discussed elsewhere29,55,56. 
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1.2.2.1 Static light scattering 
SLS uses the relationship between light scattering intensity and particle mass and 
concentration57, where the scattering intensity is proportional to the sixth power of the 
particle diameter58. This technique is often used to determine the colloidal stability of 
proteins in defined formulations under the influence of thermal stress. A schematic 
representation of SLS is shown in Figure 1.3. 
 
 
Figure 1.3: Overview of static light scattering (SLS) measurement results to determine the aggregation 
temperature (TAgg). (a) Depiction increasing scattering intensity as a result of aggregation due to increasing 
temperature. (b) Schematic of a typical SLS measurement result. Scattering intensity at 473 nm or 266 nm 
is obtained for different temperatures, where the start of the intensity gradient is defined as TAgg. Pictogram 
is adapted from 59. 
 
As mentioned previously, increasing temperature causes protein structure unfolding and 
increases aggregation propensity. As scattering intensity is related to the size of particles, 
the scattering intensity increases for increasing temperature due to the increasing presence 
of the aggregated proteins, as depicted in Figure 1.3a. Temperature ramps are used to 
extract the onset aggregation temperature (TAgg), which is defined as the starting point of 
scattering intensity increase. This is depicted in Figure 1.3b. TAgg is used as a measure of 
colloidal stability, where a higher TAgg value reflect a higher colloidal stability. 
 
1.2.2.2 Dynamic light scattering 
DLS monitors scattered light fluctuations as a result of the Brownian motion of protein 
molecules57. Brownian motion causes scattered light fluctuations over time due to changing 
distances between particles. Monitoring such fluctuations allows DLS to obtain 
information about the time scale of the movements, which in turn correlates to particle size. 
A schematic overview of DLS is shown in Figure 1.4. 
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Figure 1.4: Overview of a dynamic light scattering measurement to determine the (apparent) 
hydrodynamic radius (RH). (a) Effect of Brownian motion on the scattering intensity over time for two 
particle sizes. (b) Scattering intensity over time for multiple measurements are correlated into a 
correlogram. The correlogram can be used in combination with (c) Equation 1 and 2 for (d) cumulant 
analysis to obtain an average RH (z-average) and polydiversity index (PDI), or for (e) distribution analysis 
to obtain a RH distribution. Graphs were adapted from literature60. Equations were obtained from 
literature57. 
 
As depicted in Figure 1.4a, smaller particles move relatively fast, which leads to a faster 
change in scattered light. Figure 1.4b shows how the scattering changes over time, where 
the decrease of the correlation coefficient relates to particle speed. With the use of the 
decay rate (Equation 1, Figure 1.4c) and Einstein-Stokes equation (Equation 2, Figure 
1.4c), the diffusion coefficient and hydrodynamic radius (RH) can be calculated, 
respectively. Two types of analysis are applicable to the measured data, the cumulants 
analysis and distribution analysis. As depicted in Figure 1.4d, the former is used to 
determine the sample’s average particle size (z-average) and the polydiveristy index (PDI), 
which represents the sample’s diversity of particle sizes. The latter analysis results in an 
intensity-based size distribution, as depicted in Figure 1.4e. This allows for the 
identification of multiple particle sizes present in a sample instead of solely an average 
particle size.  
 
Equation 2 in Figure 1.4c reveals that DLS measurements are influenced by solution 
viscosity, temperature, protein size, and protein shape. What is not covered by this 
equation, is the fact that RH is also dependent on protein-protein interactions
61. Protein-
protein interactions result in larger apparent particle sizes, as movement is reduced by 
attractive forces. Vice versa, repulsion between particles may cause an underestimation of 
particle size. Therefore, it must be considered that DLS often provides solely an apparent 
RH when measuring at non-dilute conditions, and not a true RH, as found for dilute 
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systems55. For this work, DLS is applied to determine the presence of larger protein species, 
to represent aggregates, and detect minor changes in hydrodynamic radius as an effect of 
protein-protein interactions.  
 
1.2.3 Conformational stability 
An overview of available techniques to monitor conformational stability can be found 
elsewhere19,23,56. Fourier transform infrared (FTIR) spectroscopy and intrinsic fluorescence 
spectroscopy were used in this thesis and are described below. 
 
1.2.3.1 Fourier transform infrared spectroscopy 
FTIR spectroscopy uses the unique stretch vibrations of molecular bonds to identify the 
presence of secondary structural elements in proteins, such as an α-helix or β-sheet19. The 
measured stretch vibrations are a result of molecular bonds undergoing a change in dipole 
moment upon infrared radiation absorbance. The most distinct stretch vibration for proteins 
is found for the carbonyl group, referred to as the C-O stretch62,63. Secondary motifs present 
in protein structures have been empirically correlated to particular wavenumbers that fall 
within the FTIR spectral range of the C-O stretch, referred to as the Amide I region64. A 
schematic overview of an FTIR spectroscopy measurement is shown in Figure 1.5. 
 
 
Figure 1.5: Overview of a Fourier transform infrared (FTIR) spectroscopy measurement. (a) Depiction of 
the carbonyl groups (highlighted in blue) in secondary structure motifs that influence the Amide I band. 
(b) Sample and background interferograms are transformed with a fast Fourier transform (FFT) into single 
beam spectra. (c) The background and sample single beam spectra are ratioed to obtain a transmittance 
spectrum, which can be converted into an absorbance spectrum. (d) 2nd derivative of the absorbance 
spectrum in the Amide I range is used to identify present secondary structure motifs listed in (f). (e) 
Common data preprocessing steps used for the construction of (d). Graphs and pictogram were adapted 
from literature65. Data in (f) was obtained from literature64. 
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Figure 1.5a shows a schematic overview of the α-helix, β-sheet, and β-turn, and highlights 
the different position of the carbonyl group. The different positions of the amino acids and 
corresponding hydrogen bonds influence the stretch vibrations. Figure 1.5b shows an 
interferogram, the raw signal obtained from an FTIR measurement. This signal is 
transformed using a fast Fourier transform (FFT) into a single beam spectrum. To obtain 
an infrared absorbance spectrum, the single beam spectrum of the background and the 
sample are ratioed to obtain the transmittance spectrum. In turn, the transmittance spectrum 
is converted into an absorbance spectrum. This procedure is depicted in Figure 1.5c. The 
C-O stretch vibrations are mainly captured in the Amide I wavenumber range, 1700 cm-1 
to 1600 cm-1, which is highlighted in the exemplary absorbance spectrum in Figure 1.5c. 
With use of the listed data preprocessing steps in Figure 1.5e and the second derivative of 
the absorbance for the Amide I band, the spectrum in Figure 1.5d is obtained. The second 
derivative absorbance spectrum is the typical data format used to identify peak area and 
location, which corresponds to the relative amount and type of secondary structure motifs, 
respectively64. Figure 1.5f shows a comprehensive overview of wavenumber (WN) 
positions of several secondary structural motifs. 
 
1.2.3.2 Intrinsic fluorescence spectroscopy 
Intrinsic fluorescence spectroscopy utilizes the influence of environmental polarity on 
tryptophan fluorescence, namely the red shift (shift to a higher wavelength) of its intensity 
maximum for increasing polarity66,67. This shift is used to determine tertiary structure 
stability as a function of thermal stress. Thermal stress is gradually applied to induce 
structural unfolding, which can be monitored by fluorescence as tryptophan’s environment 
becomes more polar due to increasing solvent exposure. A depiction of an intrinsic 
fluorescence measurement is shown in Figure 1.6. 
 
 
Figure 1.6: Overview of intrinsic fluorescence spectroscopy measurement results to determine the protein 
melting temperature (TM). (a) Depiction of the change in fluorescence intensity wavelength upon protein 
unfolding. (b) Exemplary plot of fluorescence intensity obtained for two different temperatures. The 
wavelength peak position for each temperature is plotted and the derivative is calculated to determine the 
maximum gradient of the peak position plot. The maximum gradient is defined as TM. The pictogram is 
adapted from literature59. 
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Figure 1.6a depicts how the maximum tryptophan fluorescence intensity shifts towards a 
wavelength of 350 nm due to protein unfolding. Figure 1.6b shows a simplified spectrum 
at a starting temperature and a higher temperature, where a shift in absolute intensity and 
intensity maximum is depicted. The maximum intensity wavelength, referred to as the peak 
position, is extracted and plotted against the applied temperature gradient. This data is used 
to extract the temperature at which ΔGunf is zero. At this point, where native and unfolded 
proteins are present in equal amount, is referred to as the melting temperature (TM). TM is 
defined as the maximum gradient in the peak position-temperature plot and can be 
determined by means of its derivative, as shown in Figure 1.6b. The TM of a protein is a 
measure of its conformational stability, where a higher TM value indicates higher 
conformational stability. It has been observed that aggregation propensity often correlates 
inversely to the relative TM
20. However, it should be noted that TM cannot be used as an 
aggregation propensity predictor when the dominant aggregation pathway is not dependent 
on (partial) protein unfolding68. 
 
1.2.4 Protein surface properties 
Protein surface properties, such as charge and hydrophobicity, play a significant role in 
protein aggregation. Two surface properties are monitored in this work, namely the zeta 
potential and apparent surface hydrophobicity. These properties are determined by mixed 
mode measurement of phase analysis light scattering (M3-PALS) and the stalagmometric 
method, respectively. Both methods are described below. A presentation of other analytical 
techniques to determine protein charge and hydrophobicity can be found elsewhere69,70. 
 
1.2.4.1 Mixed mode measurement of phase analysis light scattering 
M3-PALS utilizes light scattering to track the movement of charged proteins under the 
influence of an electric field. Protein motion caused by means of an electric field is called 
electrophoretic mobility71. Electrophoretic mobility is induced during M3-PALS by 
switching poles, referred to as field reversals, which causes the protein to change its 
direction. The magnitude and nature of the protein surface charge can be extracted by 
tracking protein movement as a function of field reversal, as it determines the speed and 
direction of the motion, respectively. An overview of an M3-PALS is depicted in Figure 
1.7. 
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Figure 1.7: Overview of a mixed mode measurement of phase analysis light scattering (M3-PALS) to 
determine the zeta potential (ζ). (a) Depiction of different potentials as a function of the protein surface 
distance. (b) M3-PALS includes a slow field reversal (SFR) and fast field reversal (FFR), where the blue line 
indicates electroosmosis. Phase shift between the sample and reference beam is recorded over time. This 
provides information on (c) the mean electrophoretic mobility (UE) and (d) its distribution, respectively. The 
combination of FFR and SFR results in (e) a UE-intensity distribution. The ζ can be calculated with (f) the 
Henry equation, Equation 1. Pictograms and graphs were adapted from literature60,72. 
 
Figure 1.7a shows a schematic representation of the electrical double layer that exist around 
a charged protein. The first layer, the Stern layer, is a layer of relatively strong bound ions, 
which carry the opposite charge of the protein charge. The second layer is called the diffuse 
layer, where weakly associated ions are found. Upon movement of a protein through a 
solution, there is a boundary between the ions in the diffuse layer that move with the protein 
and ions that do not. This boundary is the so-called slipping plane. The potential at the 
slipping plane is the zeta potential. The nature and magnitude of the zeta potential play a 
role in electrostatic repulsive forces, which in turn influence colloidal interactions55.  
 
Figure 1.7b depicts how M3-PALS is used to determine electrophoretic mobility. Two field 
reversal methods are applied during a measurement, namely the fast field reversal (FFR) 
and the slow field reversal (SFR). The two field reversal approaches are used in order to 
determine an accurate and precise electrophoretic mobility, respectively. Light scattering 
fluctuations due to the subsequent protein movement is determined by comparing the phase 
of the light from a beam passing through the sample to the phase of a reference beam that 
did not pass the sample. This results in a phase plot as depicted in Figure 1.7b. FFR allows 
for the determination of an accurate mean electrophoretic mobility (Figure 1.7c), as it 
prevents the influence of electroosmosis73. Electroosmosis is the movement of liquid under 
the influence of an electric field. For each field reversal speed, electroosmosis is 
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schematically depicted by the blue line in Figure 1.7b. This liquid movement influences 
protein movement and causes an overestimation of its electrophoretic mobility. However, 
the order of magnitude at which a liquid reacts to a field reversal is roughly in the order of 
ten milliseconds72. As the response of protein particles to the field reversal is faster, an 
accurate particle electrophoretic mobility can be determined with FFR. Nonetheless, a 
precise electrophoretic mobility cannot be obtained with FFR as the velocity distribution 
is unavailable. A precise electrophoretic mobility distribution is measured with SFR 
(Figure 1.7d). A both accurate and precise electrophoretic mobility distribution can only 
be obtained by combining both results, as depicted in Figure 1.7e. The zeta potential can 
be calculated from the electrophoretic mobility, using the Henry equation (Equation 1 in 
Figure 1.7f), wherein the measured electrophoretic mobility depends on the zeta potential, 
the applied electric field strength, dielectric constant of the solution, and the solution 
viscosity. In addition, Henry’s function (f(Ka)) shows the influence of the protein radius 
(a) and the Debye parameter (K), which represents the thickness of the electrical double 
layer.  
 
1.2.4.2 Stalgmometric method 
The stalagmometric method depends on the relationship between the required gravitational 
force to detach a formulation droplet and the adhesive force of the droplet to the dispensing 
tip to determine the apparent protein surface hydrophobicity74. A schematic overview of 
the stalagmometric method is shown in Figure 1.8.  
 
Figure 1.8: Overview of the stalagmometric method to determine the apparent surface hydrophobicity. (a) 
Depiction of the air-liquid interface for different droplet sizes. (b) Overview of equations used to determine 
the surface tension. (c) Solutions required during a measurement with the stalagometric method. (d) Schematic 
of typical measurement results, where the mass of dispensed droplets is plotted over time. The average mass 
of a single droplet (mdrop) is defined as the difference between the mass plateaus. 
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Figure 1.8a depicts two formulation droplets, where the upper droplet shows a formulation 
without protein interface adsorption, and the lower droplet shows a formulation with 
protein interface adsorption. The adhesive forces, FA, are dependent on the radius of the 
dispensing tip (r) and the formulation surface tension (γ), as shown by Equation 1 in Figure 
1.8b. FA equals the weight forces (F’W) upon droplet detachment, where F’W is defined by 
the droplet mass (mdrop), the gravitational acceleration (g), and an instrument correction 
(finst), as indicated by Equation 2 in Figure 1.8b. Thus, the mass of a detached droplet is 
proportional to the surface tension, which described by Tate’s law75 (Equation 3, Figure 
1.8b). The resulting formulation droplet mass decreases for decreasing surface tension. 
Figure 1.8d shows an exemplary result of a stalagmometric measurement, where droplet 
mass is measured over time by means of an automated liquid handling station76. Each 
plateau indicates a droplet falling on a precision scale, which measures the weight 
continuously. The obtained average droplet mass, defined as the average difference 
between the plateaus, is used to determine the surface tension. This is done by comparison 
to a reference solution, typically water, and Equation 4 in Figure 1.8d. Figure 1.8c shows 
three different droplets to be measured to gain information on the apparent protein surface 
hydrophobicity. Besides the reference solution (water) and the formulation itself, a blank 
sample is measured. The difference between a blank droplet and a formulation droplet 
provides information on the contribution of protein molecules to the surface tension.  
 
1.3 Data handling 
Experiments employing multiple analytical techniques to monitor various biophysical 
protein properties, in combination with kinetic long-term protein phase behavior, result in 
large and multidimensional data sets. Such multidimensional data sets to study protein 
stability can be found throughout literature77–82, but interpretation of these data sets is not 
straightforward. The following three sections describe procedures of computer-assisted 
mining and interpretation of such data sets. It has been stated that this type of computational 
support is of great importance for the advancement of the biotechnological field83. The first 
section presents data processing steps, the second section discusses approaches for data 
visualization, and the third section presents approaches to utilize the generated data for 
mining and prediction purposes.  
 
1.3.1 Data processing 
Raw experimental data is usually not immediately suitable for evaluation. Data 
preprocessing is the first step to obtain data that can be utilized for information mining 
purposes. Data preprocessing usually involves, among others, data transformation, data 
normalization, standardization, smoothing, and outlier detection84. After preprocessing, 
one can decide whether further processing is needed or not. One optional additional 
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processing step is called feature extraction, which can be performed in a supervised or 
unsupervised manner. The terminology supervised and unsupervised will be discussed in 
more detail in section 1.3.3. Feature extraction is often applied when the data format is 
inconvenient, such as the case for image data, or when data includes redundant 
information85,86. Besides extraction of relevant information, feature extraction has also 
shown to reduce model training times, enhance prediction performance, and lower 
computation expenses associated with generation, storing, and processing of data sets87. 
 
1.3.2 Data visualization 
Creating a comprehensive visual representation of experimental data is of importance for 
obtaining a deeper understanding, as well as to present data to external parties. The 
applicability of particular data visualization techniques is dependent on data 
dimensionality. For example, histograms are applicable for univariate data sets, while 2-D 
scatterplots are suitable for bivariate data sets. An overview of applicable visualization 
techniques when handling multidimensional data sets can be found elsewhere88. In this 
work, the empirical phase diagram (EPD) visualization technique was used to represent 
multidimensional data sets78,89. This unsupervised machine learning method employs a 
data dimension reduction approach. This allows for the representation of multidimensional 
data in three dimensions, which is converted into an RBG color code for simplified 
interpretation of trends based on colors. Other biopharmaceutical studies that have 
successfully employed the EPD method are listed elsewhere90. An expansion of the EPD 
method to enhance data interpretation, involving the representation of reduced 
multidimensional data by means of radar charts91, has also been applied in this work.  
 
1.3.3 Data utilization 
The combination of machine learning and experimental data can be applied for data 
visualization, but also for data utilization. The term data utilization means employing 
mined data sets for pattern recognition or training of predictive models. In general, this is 
achieved using two main machine learning approaches, namely supervised and 
unsupervised learning. A schematic workflow for each machine learning approach is 
shown in Figure 1.9. 
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Figure 1.9: Schematic workflow of (a) supervised and (b) unsupervised machine learning algorithms, 
where supervised machine learning involves model training and validation. The last panel indicates what 
types of algorithms are used for each machine learning approach, where (a) employs classification or 
regression algorithms and (b) employs clustering algorithms. 
 
Figure 1.9a illustrates supervised machines learning and Figure 1.9b depicts unsupervised 
machine learning. The main difference between supervised and unsupervised is the 
labelling of the input data for supervised learning. The goal of supervised machine learning 
is to predict a class or value, which is achieved by training and validating algorithms with 
said labelled input data. The resulting predictive models can be categorized as classification 
or regression models, which are applicable for discrete or continuous output data, 
respectively. Typical algorithms that are used for classification are support vector 
machines, discriminant analysis, decision trees, or neural networks. Regression models can 
include linear regression, ensemble methods, or neural networks. An overview of 
classification and regression algorithms can be found elsewhere92–95. To prevent 
overfitting, model bias, or overoptimistic model performance, it is essential to carefully 
select the size and class or value distributions of the training and validation sets96,97. In 
addition, corresponding model evaluation parameters need to be selected in order to 
describe the outcome of both internal and external validation of the model, and to evaluate 
the overall model performance. It is also possible to evaluate the prediction confidence, 
which allows for the identification of possible prediction errors92.  
 
For unsupervised machine learning approaches, the goal is to identify patterns in the data. 
This approach is often applied for data exploration to extract labels that may define 
different groups92. Such labels, often comprised of different data features, should therefore 
contain information that can separate objects from one another and identify similarities to 
recognize similar objects. There are several algorithms that can be used for this application, 
such as k-means clustering, principal component analysis, singular value decomposition, 
and neural networks. An overview of applicable algorithms can be found elsewhere92,93. 
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Protein phase behavior is a multidimensional phenomenon and therefore the corresponding 
data required for investigating protein phase behavior is multidimensional as well. Even 
though this has been recognized in the field, there are still opportunities to implement 
computational methods, such as machine learning approaches, to advance protein phase 
behavior analysis. Opportunities lie in the comprehensive visualization of protein phase 
diagrams, where not only protein phase behavior after a prolonged storage time should be 
visualized, but where also the kinetic phenomena monitored during storage are depicted. 
Data mining from protein phase diagram experiments (image-based data) remains a 
manual, time-consuming, and subjective procedure98. Therefore, data mining in protein 
phase behavior studies would greatly benefit from supervised image recognition 
algorithms, especially in combination with automated feature extraction approaches. 
Opportunities in data utilization can also be found for characterizing protein phase behavior 
by means of the responsible forces and protein surface properties. As multiple analytical 
techniques are needed to monitor the possible aggregation pathways, this thesis presents a 
machine learning workflow that can correlated short-term empirical properties to long-term 
protein phase behavior in order to generate a better understanding of environmental effects 
on the observed protein phase behavior.  
 
Another interesting subject where computational workflows could be incorporated in the 
field of protein phase behavior, is in silico extraction of protein properties obtained from 
molecular dynamics (MD) simulations. By employment of supervised machine learning 
approaches, protein surface properties based on three-dimensional (3-D) protein structures 
can be used to model experimental observations or serve as an additional, new source of 
knowledge to obtain an efficient experimental design. However, the computational 
extraction of such properties is highly dependent on the quality of the 3-D protein structures 
that are used during MD simulations99. In addition, in order to obtain reliable models, a 
large amount of structures is needed to determine the statistical significance of the 
correlation between theoretical and experimental data100,101. Preparation of 3-D structures 
for MD simulations is typically a manual procedure. This hampers the implementation of 
MD simulations as supportive computational method during formulation development, as 
it currently cannot compete with the screening numbers achievable with high-throughput 
experiments. 
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2 Thesis outline 
 
2.1 Research proposal 
Protein-based products are developed in biotechnology sectors such as agriculture, food, 
and biopharmaceutics. Stability for each protein-based product needs to be demonstrated, 
where the desired protein phase state, such as soluble or crystallized protein, should be 
maintained over a prolonged period of time (e.g., months or years) in order to assure its 
safety and functionality. High-throughput and accelerated experiments were implemented 
during product development to minimize material use as well as experimental time required 
to perform long-term protein phase behavior screenings. Consequently, optimizing these 
screenings led to an increase of available experimental data. Upon evaluation, 
interpretation, and understanding the generated data, a knowledge-based approach can be 
adopted to further accelerate protein-based product development. This leads to the 
identification of short-term empirical parameters which correlate to long-term protein 
phase behavior, targeted phase behavior modification, and partially paves the way for 
protein phase behavior prediction. However, the generated information is not used in its 
complete capacity due to insufficient data extraction and data analytical techniques. The 
full potential of knowledge-based experimental design will only be realized when the gap 
between data acquisition and data utilization is bridged.  
 
The objective of this research is to develop computational methods that advance long-term 
protein phase behavior analysis. Protein phase behavior is a multidimensional 
phenomenon, where an interplay between a multitude of environmental factors, such as 
additives and pH, and protein-specific properties, such as charge and size, determines the 
protein phase outcome. To understand, modify, and ultimately predict a multidimensional 
phenomenon such as protein phase behavior, computational approaches are required that 
incorporate complexity while maintaining a straight-forward data interpretation. In 
addition, a data-dependent design of said approaches is required to ensure its applicability 
for a wide range of protein-based products. However, extensive data extraction and 
processing increases the experimenters’ workload. This is prevented by implementation of 
automated approaches, which simultaneously controls objectivity and standardization, 
which is hard to enforce with manual approaches. Besides protein phase behavior data 
evaluation, the ability to characterize the observed protein phase behavior is required to 
2 
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obtain a more in-depth understanding. A more in-depth understanding of protein phase 
behavior will allow for identification of short-term protein phase behavior optimization 
targets and a decrease in experimental work. Furthermore, a broader understanding serves 
as a stepping stone towards the design of in silico descriptors suitable for protein phase 
behavior prediction. To generate such in silico descriptors, a computational pipeline that 
allows one to process the in silico equivalent of high-throughput experimental data is 
required in order to become a helpful tool during product development.  
 
To bridge the gap between data acquisition and data utilization for long-term protein phase 
behavior experiments, the first part of this work focusses on data-dependent visualization 
of image-based protein phase behavior data. The aim was to prevent information loss 
during data evaluation by combining static and kinetic long-term protein phase behavior 
data. The visualization method was subsequently coupled to an automatic data extraction 
algorithm, where protein phase behavior was classified using data obtained with a hardware 
combination of multiple light sources. Identification of short-term protein properties 
responsible for long-term protein phase behavior was established by combining the 
multidimensional image-based protein phase behavior data with empirical protein 
properties obtained directly after formulation preparation. A case study was performed to 
illustrate the application of this approach for formulation development. In this case study, 
novel formulations were identified based on short-term properties which led to similar 
phase behavior over time as the original formulation properties. Short-term protein 
properties that determine long-term protein phase behavior are potential parameters that 
can be used for protein phase behavior prediction based on in silico descriptors extracted 
from 3-dimensional (3-D) protein structures. To move towards such short-term descriptor 
predictions, a high-throughput 3-D protein structure preparation pipeline was developed. 
This computational pipeline was designed to support high-throughput structure processing, 
data-dependent structure curation, and robust in silico descriptor extraction. 
 
  
23 
 
2.2 Manuscript overview 
This subsection presents a compendious list of manuscripts written within the scope of the 
thesis. The corresponding chapter and page number are indicated per manuscript, followed 
by a brief summary.  
 
Chapter 3. Application of empirical phase diagrams for multidimensional data 
visualization of high-throughput microbatch crystallization 
experiments...........................................................................................................25 
M.E. Klijn, J. Hubbuch 
Journal of Pharmaceutical Sciences (107), 2018, p. 2063-2069 
This paper presents a data visualization methodology, which allows for the representation 
of kinetic and static protein phase behavior data in one figure without the loss of 
information or comprehensiveness. Subsequently, this multidimensional protein phase 
diagram was used to discuss the observed static and kinetic protein phase behavior of 
model protein hen egg-white lysozyme in the context of environmental changes. This 
resulted in a detailed interpretation and understanding of the obtained protein phase 
behavior data. 
 
Chapter 4. Time-dependent multi-light source image classification combined 
with automated multidimensional protein phase diagram construction for 
protein phase behavior analysis………………..………………………………37 
M.E. Klijn, J. Hubbuch 
Journal of Pharmaceutical Sciences, In Press 
This study shows an automated workflow which starts with raw images obtained from 
long-term protein phase behavior experiments and visualizes multidimensional protein 
phase behavior. This was accomplished by enhancing automated image classification with 
static and kinetic image-based features obtained from visible light, cross polarized light, 
and ultraviolet light. Predicted classification data was subsequently used to automatically 
construct a multidimensional protein phase diagram. 
 
Chapter 5. Correlating multidimensional short-term empirical protein 
properties to long-term protein physical stability data via empirical phase 
diagrams................................................................................................................57 
M.E. Klijn, J. Hubbuch 
International Journal of Pharmaceutics (560), 2019, p. 166-174 
This paper investigates the usability of the empirical phase diagram method to overcome 
common shortcomings during protein phase behavior characterization, such as limited data 
set size or simplistic visualization. This resulted in a systematic and data-dependent 
24 
 
workflow which created a comprehensive overview of short-term protein properties in an 
empirical protein property diagram. These short-term properties could be partially related 
to trends observed in long-term multidimensional protein phase diagrams, which led to a 
straight-forward characterization of long-term protein phase behavior. 
 
Chapter 6. Redesigning food protein formulations with empirical phase 
diagrams: A case study on glycerol-poor and glycerol-free formulations…...75 
M.E. Klijn, J. Hubbuch 
Food Research International (125), 2019, p. 108609 
The case study presented in this manuscript served as an example of an industrial 
application for the methodology presented in Chapter 5. The combination of short-term 
empirical protein property data and long-term protein phase behavior was utilized to 
redesign a protein-based food product formulation. The combination of an empirical 
protein property diagram and multidimensional protein phase diagram led to the 
identification of new long-term stable formulations based on short-term properties similar 
to the original formulation. 
 
Chapter 7. High-throughput computational pipeline for 3-D structure 
preparation and in silico protein surface property screening: A case study on 
HBcAg dimer structures………………………………..……………..…..……95 
M.E. Klijn†, P. Vormittag†, N. Bluthardt, J. Hubbuch (†contributed equally) 
International Journal of Pharmaceutics (563), 2019, p. 337 - 346 
This manuscript describes a computational pipeline which automatically performs 
homology modelling and subsequent data-dependent curation of 3-D protein structures. 
Such a preparative pipeline is required before predictive descriptors can be extracted from 
the 3-D protein structures, but this is usually a manual procedure. An automated approach 
is of interest when a large amount of candidate structures is screened, as seen during the 
development of hepatitis B core antigen (HBcAg) virus-like particles. Fast curation 
simulations, relatively high quality structures, and surface charge descriptors that 
correlated to experimental data indicated the potential of the proposed pipeline. 
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3  Application of empirical phase diagrams 
for multidimensional data visualization of 
high-throughput microbatch crystallization 
experiments 
 
Marieke E. Klijn1 and Jürgen Hubuch1 
1 Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe 
Institute of Technology (KIT), Germany 
 
Abstract 
Protein phase diagrams are a tool to investigate cause and consequence of solution 
conditions on protein phase behavior. The effects are scored according to aggregation 
morphologies such as crystals or amorphous precipitates. Solution conditions affect 
morphological features, such as crystal size, as well as kinetic features, such as crystal 
growth time. Commonly used data visualization techniques include individual line graphs 
or phase diagrams based on symbols. These techniques have limitations in terms of 
handling large data sets, comprehensiveness or completeness. To eliminate these 
limitations, morphologic and kinetic features obtained from crystallization images 
generated with high-throughput microbatch experiments have been visualized with radar 
charts in combination with the empirical phase diagram method. Morphologic features 
(crystal size, shape, and number, as well as precipitate size) and kinetic features (crystal 
and precipitate onset and growth time) are extracted for 768 solutions with varying chicken 
egg white lysozyme concentration, salt type, ionic strength, and pH. Image-based 
aggregation morphology and kinetic features were compiled into a single and easily 
interpretable figure, thereby showing that the EPD method can support high-throughput 
crystallization experiments in its data amount as well as its data complexity. 
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3.1 Introduction 
Protein phase behavior is of interest for formulation, purification process development, and 
3-dimensional (3D) structure analysis. Protein phase behavior is dependent on protein 
properties, such as net surface charge and structural stability, which are in turn influenced 
by physical and chemical parameters of the solution18,102–104. Resulting protein-protein (PP) 
and protein-solvent (PS) interactions determine protein phase behavior. The desired protein 
phase behavior can differ between applications. For example, interplay of PP and PS 
interactions ideally results in long-term stable pharmaceutical formulations105,106, whereas 
particular purification processes are dependent on phase transitions such as 
crystallization107. Crystallized proteins can also be used to obtain 3D structure 
information108,109. Although the application defines the desired phase behavior, finding 
corresponding solution conditions is carried out using a similar approach. Solution 
conditions are varied to map their effect on protein phase behavior, where protein 
concentration, additive type, additive concentration, pH, pressure, or temperature are 
altered110–115. Ternary (e.g., water, additive, and protein concentration)112,116 or binary (e.g., 
temperature-pressure or protein-additive concentration)51,117 protein phase diagrams are 
frequently used to present optically visible protein phase behavior effects. This information 
is not only used to identify optimal solution conditions but is also used as a basis for 
understanding107,112,115,118, manipulation119,120, and prediction77,82,121,122 of protein phase 
behavior. The visible effect on protein phase behavior is scored in the following 
morphology categories: clear solution, crystallization, precipitation, skin formation, 
gelation, or phase separation54,123. Different morphological subtypes have been observed 
within these morphology categories77,114,124. For example, crystal subtypes may include 
micro crystals, sea urchins, needles, plates, and 3D crystals123,125,126. These crystal types 
differ in growth rates, size, and morphology, which are dependent on the growth 
mechanism and thus dependent on underlying PP and PS interactions110,111,118,127–130. 
Aggregation mechanisms can also determine precipitation size, color, and texture. 
Amorphous precipitation is considered to originate from nonnative aggregation and 
appears in darker colors while crystalline precipitation permits native conformation and 
has a more sandy appearance54,131,132. Details of phase behavior morphology provide 
necessary information that leads to better understanding of PP and PS interactions.   
 
Detailed information on protein phase behavior under multiple conditions, such as 
morphology subtypes and kinetic features, results in a multidimensional dataset and that is 
not easily visualized or interpreted. The most simple visualization approach is plotting a 
single morphologic or kinetic feature as a function of 1 to 3 different solution 
conditions110,111,127,130,133–137. Visualizing high-throughput data with this approach, where 
more than 3 solution conditions are varied, would result in multiple different figures per 
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feature. This leads to a loss of overview on trends between observed features as well as 
their connection to all tested solution conditions. Alternatively, symbols are used to capture 
the morphology effects of solution conditions in binary phase diagrams82,115,138. Here, 
different symbols are used to represent 6 general morphology categories. Adaptations of 
symbol-based phase diagrams use more symbol types to represent morphology 
subclasses121,139. Symbol-based phase diagrams are easy to interpret and compatible with 
large data sets. However, kinetic features are not included, and subsetting of morphologic 
categories is prone to subjectivity98. To account for the former, symbol sizes have been 
scaled to represent kinetic information140. Capturing morphology subclasses as well as 
kinetic parameters results in numerous symbol types and sizes. This makes figures more 
difficult to interpret, and subjective subsetting is not eliminated. Next to symbols, 
crystallization images itself have been used to show morphological features and kinetic 
features, where kinetic features are presented by showing images taken at multiple time 
points114,124,125,127,129,135,137,141,142. Crystallization images contain all desired information, 
but the data format is inconvenient. Next to the required image size for proper morphology 
visualization, the use of multiple images over time for high-throughput data becomes 
highly impractical. This leads to showing examples instead of the complete dataset. The 
need and generation of experimental protein phase behavior data has become a 
multidimensional problem but means for data visualization and interpretation are currently 
insufficient. This makes data evaluation challenging and potentially incomplete. Therefore, 
a high-throughput compatible comprehensive figure that can present a complete 
nonsubsetted data set is required143,144. 
 
A method of combining multidimensional data into one comprehensive figure is the 
empirical phase diagram (EPD). The EPD was originally developed to combine data 
obtained from high-throughput experiments on protein conformational states as a function 
of solvent conditions and stress78,89. Multidimensional data is reduced to 3 dimensions, 
which provides the means to visualize and interpret data with the use of colors, where 
changes in colors represent differences in underlying features. Three adaptations of the 
EPD have been previously explored91. The first alternative includes a color indexed EPD 
using predefined colors that correspond to specific protein structural states. The other two 
proposed adaptations use arbitrary colors in combination with radar plots or Chernoff 
diagrams to represent underlying multidimensional data. The Chernoff diagrams do not 
allow for easy interpretation as facial features are used to represent underlying data changes 
instead of axis, as seen for radar charts. Combining the EPD and radar chart offers the 
possibility to visualize a large image-based protein phase behavior data set without 
compromising in data completeness or ease of interpretation. This has not been achieved 
in previous protein phase behavior studies.  
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This study uses data on phase behavior of chicken egg white lysozyme during a long-term 
storage (40 days) microbatch crystallization experiment under 768 different solution 
conditions at 20 °C. Solution conditions cover 4 pH values (pH 3, 5, 7 and 9), 2 salts 
(sodium chloride and ammonium sulfate), 12 ionic strengths (0 – 275 mM), and 8 protein 
concentrations (5-125 g/L). These solution conditions are selected to capture a wide pH 
range and incorporate 2 commonly used salts which reportedly have ion specific effects116. 
Increments of 25 mM in ionic strength have been chosen to challenge visualization of 
subtle ionic strength effects, and a wide range of lysozyme concentration is to cover both 
low and highly concentrated protein solutions. Long-term storage under the selected 
variety of conditions results in multidimensional data, which challenges previously 
discussed shortcomings of visualization techniques. Morphologic and kinetic feature 
extraction was used to prevent loss of protein phase behavior information and minimize 
subjective morphology category subsetting. Morphologic features describe absolute 
average crystal size, variation in crystal axial ratio, and the amount of crystals. Precipitation 
features describe size and color intensity. Kinetic features include onset and growth time 
of precipitates and crystals. This data set is used to show the benefits of multidimensional 
visualization techniques for comprehensive and complete presentation of detailed protein 
phase behavior data using the EPD method in combination with radar plots. For 
convenience, the term multidimensional protein phase diagram (MPPD) is used for the 
EPD, which represents the protein phase behavior information. 
 
3.2 Material and Methods 
3.2.1 Buffer preparation 
The effect of buffer components on protein phase behavior was excluded by using a 
multicomponent buffer with a 10 mM buffer capacity145. Buffer components were CHES 
(6.13 mM; Applichem), TAPS (14.61 mM; Applichem), MOPS (7.00 mM; Roth), sodium 
acetate trihydrate (3.01 mM; Merck) and citric acid monohydrate (13.86 mM; Merck). The 
pH was adjusted using 4 M sodium hydroxide (Merck) as titrant, using a five-point 
calibrated pH-meter (HI-3220; Hanna Instruments, Woonsocket, RI) equipped with a 
SenTix 62 pH electrode (Xylmen Inc., White Plains, NY). The pH was adjusted to 3, 5, 7, 
or 9 with ±0.05 pH unit accuracy. The effect of ionic strength for each buffer was excluded 
by adjusting conductivity of each buffer to the conductivity measured for the pH 9 buffer. 
Buffer conductivity was measured with a conductivity probe (Radiometer Analytical, Lion, 
France). Sodium chloride (Merck) or ammonium sulfate (Applichem) was used for 
conductivity adjustment. Afterwards, the buffers were filtered using a 0.2 μm cellulose 
acetate filter (Sartorius, Göttingen, Germany). This buffer served as buffer with a relative 
ionic strength of 0 mM. A stock buffer with a relative ionic strength 1050 mM was made 
with sodium chloride and ammonium sulfate for each pH. 
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3.2.2 Protein stock preparation 
A stock solution of 150 g/L lysozyme from chicken egg white (Hampton Research, Aliso 
Viejo, CA) was made. Lysozyme was weighed and dissolved in the appropriate 0 mM ionic 
strength buffer. The protein solution was filtered using a 0.2 μm cellulose acetate filter 
(VWR, Radnor, PA). The filtered protein solution was desalted with a PD-10 column (GE 
Healthcare Life Sciences, Uppsala, Sweden), employing the manufacturer’s centrifugation 
protocol. The concentration of the stock solution was determined with a Nanodrop 2000c 
UV-Vis spectrophotometer (Thermo Fischer Scientific, Waltham, MA). An E1% (280 nm) 
extinction coefficient of 22.00 was used. The protein stock solution was prepared on the 
same day of crystallization plate preparation. 
 
3.2.3 Long-term storage 
All protein solutions were stored in duplicate for 40 days at 20°C in a Rock Imager 54 
(Formulatrix, Bedford, MA). The long-term storage experiment was carried out according 
to the method described by Baumgartner et al. with the following adaptations. Salt and 
protein dilutions were mixed in a 1:5 ratio by pipetting up and down twice, with a final 
volume of 24 μL per well. This resulted in lysozyme concentration of 125, 112, 100, 75, 
50, 25, 12, and 5 g/L and a relative ionic strength of 0 to 275 mM sodium chloride or 
ammonium sulfate with a 25 mM step size. Each well was photographed daily during 
storage with visible light, and more frequently during the first 8 days. All visible light 
photographs consisted of five focus levels to obtain an averaged sharp picture. After 40 
days of storage, UV light imaging was used additional to visible light. UV light exposure 
time was set to 400 ms, signal amplification (gain) was set to 14.92 dB, and midtone 
contrast adjustment (gamma) was set to 1.4. A 2.5X zoom was used, and 12 focus levels 
per well were taken. 
 
3.2.4 Image Features 
Precipitation onset time is defined here as the time point when first light precipitation was 
observed. Precipitation growth cessation time is defined as the time point when the 
precipitate stopped to change in size and intensity. Crystal onset time is the time point when 
nuclei were first optically visible (minimum detectable size of ~5 μm). The corresponding 
growth cessation time is defined as the time point when crystal dimensions did not increase 
anymore. The difference between the onset and cessation time of precipitates and crystals 
was calculated as their growth time. Crystal dimensions and precipitate diameter were 
measured in μm with the ruler tool in the Rock Maker software (version 2.3.0.83). Four 
crystals were selected to extract their dimensions to form a representative sample group. 
Four crystal lengths were averaged to represent the absolute average crystal size. In 
addition, 4 axial ratios were calculated as quantification of crystal shapes. Subsequently, 
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the interquartile range of these values was calculated to represent the diversity of crystal 
shapes. 
 
3.2.5 Multidimensional data visualization 
Each extracted image feature was averaged between the duplicates and normalized between 
zero and one. A representation of duplicate data is shown in Supplementary Figure A1. 
Before construction of the MPPDs, all features were evaluated based on internal correlation 
using the Pearson correlation coefficient. The EPD construction method used is described 
in literature78,91. In short, the dimensionality of the data was reduced to 3 dimensions using 
singular value decomposition (SVD). The (x,y,z)-values of the 3D data were normalized 
between zero and one to obtain (x,y,z)-values that can be used as a RGB color value. The 
optimal number of clusters between 1 and 9 was selected by the function evalcluster, 
available in Matlab, version 2016b. Cluster evaluation used the k-means cluster algorithm 
with a silhouette criterion based on squared Euclidean distance metric. The optimal cluster 
number was used as input for the k-means clustering function (kmeans, available in Matlab, 
version 2016b) to cluster the 3D SVD data using 100 replicates, a maximum of 1000 
iterations, and randomly chosen initial cluster centroid positions. The average RGB color 
value for each cluster was calculated using the normalized (x,y,z)-values of each data point 
within the cluster. With R (version 1.0.136, using ggplot2 and fmsb library) each data point 
was plotted against all solution conditions (pH, salt, ionic strength, and protein 
concentration) and colored with their corresponding average cluster color. In addition, a 
radar plot was constructed for each cluster to represent the median value of the image 
feature, as well as the median absolute deviation to represent distribution of the image 
feature.  
 
3.3 Results and Discussion 
3.3.1 Image scoring 
Images obtained with visible and UV light were used for morphology and kinetic feature 
extraction after 40 days of storage. One application of UV light images was to determine 
whether observed change in phase behavior was a result of protein or non-protein 
insolubility109,146. Examples of visible and UV light images for comparison between clear 
solutions, crystallized solution, non-protein precipitation, and protein precipitation are 
depicted in Supplementary Figure A2. Absence of UV signal indicated that all precipitation 
observed under visible light images were non-protein. On the contrary, all crystals were 
visible under UV and thus consist of protein. Apart from 3D crystals, no other 
morphological crystal subtypes were seen in this dataset. 
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3.3.2 Data treatment and clustering 
The use of various features may result in features to correlate to one another and 
subsequently favor a certain phase behavior property within the dataset. 
Overrepresentation of a phase behavior property was evaluated based on internal 
correlation using the Pearson correlation coefficient. The Pearson correlation coefficient 
matrix is shown Supplementary Table A1. The set threshold of 0.850 was violated by 
precipitate intensity and precipitation diameter, indicating that precipitate intensity 
increased as size increased. Precipitate intensity was therefore removed from the dataset. 
Remaining image features, their corresponding absolute value ranges, and phase behavior 
property descriptions are summed up in Figure 3.1a. Normalized values of the listed image 
features were used for SVD dimension reduction. This resulted in a 3D data set with an 
energy value of 95%, which means a 5% loss of information on data variance. This falls 
within the general rule, where an energy value of 90% is considered the minimum for 
reduced dimension data representation147. An optimal number of 5 clusters was determined 
with this three dimensional dataset. 
 
The median cluster value for each image feature is represented within the radar charts using 
a colored surface, shown in Figure 3.1b. Dispersion of image features in each cluster, 
represented by the median absolute deviation, is shown as a dotted lined. Cluster 1 
corresponds to clear solutions, as all extracted features are equal to zero in images without 
crystals and precipitates. Coexistence of protein crystals and non-protein precipitation is 
represented by cluster 2. Here, protein crystals fill roughly 50% of the crystallization well 
after storage. Crystal nuclei form after 350 ± 40 h and grow for 300 ± 70 h to a reach 
median size of 48 ± 6 μm. Non-protein precipitation appears after 120 ± 15 hours and grows 
65 ± 10 h. The median precipitation diameter is 345 ± 30 μm. Solely crystallized solutions 
are represented by clusters 3, 4, and 5. Similar to cluster 2, cluster 3 crystals fill half of a 
crystallization well. Crystal nuclei are observed after 175 ± 20 h of storage, which is earlier 
compared to cluster 2. Crystals grow for 240 ± 20 h to a size of 36 ± 5 μm. In cluster 4 an 
increase in crystal number is seen, where wells were almost completely filled after 40 days 
of storage. A crystal onset time of 90 ± 17 h is lower compared to cluster 3. Growth time 
is increased to 720 ± 50 h, which resulted in a median crystal size of 96 ± 6 μm. Cluster 5 
shows entirely filled wells, where crystals are formed within the first few hours of storage. 
Growth time has a median of 3 ± 3 h, and the median crystal size is 36 ± 3 μm. The axial 
ratio interquartile range varies between 0.124 ± 0.06 for cluster 5 to 0.279 ± 0.235 for 
cluster 2. Crystal shape diversity shows only small deviations for each identified cluster. 
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3.3.3 Multidimensional protein phase diagram 
Results of long-term chicken egg white lysozyme storage at 20 °C using chicken egg white 
lysozyme under 768 different solution conditions are represented by MPPDs in Figure 3.1c. 
The top row of Figure 3.1c shows MPPDs for protein solutions containing ammonium 
sulfate and the bottom row presents the MPPDs where sodium chloride was added to 
protein solutions. For each individual MPPD, the y-axis indicates lysozyme concentration 
(ranging 5-125 mg/mL) and x-axis indicates ionic strength of the corresponding salt 
(ranging 0-275 mM, 25mM increments).  
 
In protein phase diagrams an undersaturated and supersaturated zone can be identified50. 
The undersaturated zone, represented by cluster 1, contains solutions conditions where no 
change in protein phase behavior is observed. The supersaturation zone, clusters 2-5, 
represent solution conditions causing protein aggregation. Figure 3.1c shows cluster 
transformation and increasing supersaturated zone area for increasing pH values, for both 
ammonium sulfate and sodium chloride. Solubility dependency on pH is expected as pH 
affects amino acid residue protonation states34. This determines the type, total, and 
distribution of protein surface charge. In turn, these surface properties influence how the 
protein electrostatically interacts with the solvent and other solutes. Under these conditions, 
the surface charge of chicken egg white lysozyme (theoretical isoelectric point (pI) of 
11.35148) shifts from highly positively charged towards less positively charged (pH 3-pH 
9). Protein solubility decreases for solution pH values close to the protein pI as repulsive 
electrostatic forces diminish. Solubility is at a minimum at a pH equal to the pI26,34. In this 
work, increasing pH values decrease protein solubility and therefore cause larger 
supersaturated zones.  
 
Protein solubility can also be influenced by specific ions and their ionic strength26,118. 
Proteins can display increasing and decreasing solubility for increasing ionic strength, 
called salting-in and salting-out, respectively149. Solutions containing sodium chloride, 
depicted in bottom MPPDs in Figure 3.1c, show only salting-out for all pH values. Salting-
out becomes more effective for increasing pH indicated by increasing supersaturation zone 
area. Both observations are in agreement with previously published work116,150. On the 
contrary, ammonium sulfate has no effect on protein solubility at pH 3 and pH 5, whereas 
salting-in for pH 7 and pH 9 is observed. Salting-in becomes less effective for increasing 
pH values. Salting-in and salting-out effectiveness of anions and cations is related to its 
position in the Hofmeister series41. Currently, there are many conditions for which a direct 
or an inverse effectiveness order has been identified151. Lysozyme with a net positive 
surface charge and in presence of relatively low ionic strength range (<300 mM) follows a 
reversed Hofmeister series42,152.   
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Figure 3.1: (a) Overview of symbols and descriptions of image features including the absolute value range. 
(b) Radar charts for color based clusters with a legend to indicate the position of image features. The 
colored surface indicates the normalized median image feature for each cluster. The dotted line indicates 
the image feature median absolute deviation. (c) Empirical protein phase diagram for lysozyme under 
varying protein concentrations (y-axis), salt ionic strengths (x-axis), pH values (grid columns), and salts 
(grid rows). Five identified color clusters are indicated by mean color as well as a cluster number. Dashed 
lines are added to highlight regions and guide the eye. 
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The existence of reversed Hofmeister series has indicated that the classic theory, where 
only salt hydration properties influences protein solubility based on ion-water interactions, 
should be expanded by including cosolutes-protein surface interactions38,41,151,153,154. In this 
work, a dominant role of protein surface charge is highlighted by increasing salting-out 
and decreasing salting-in effectiveness for increasing pH values. However, a unified 
molecular interaction mechanism explaining salting-in and salting-out is still unknown154. 
Possible molecular salting-in and salting-out mechanisms of lysozyme under tested 
conditions are interesting phenomena, but it is considered to be outside the scope of this 
study and therefore not further discussed. The focus lies on combining morphologic and 
kinetic image-based features into a complete and comprehensive multidimensional protein 
phase diagram to support straight-forward accessibility of protein phase behavior 
information via appropriate data visualization. 
 
Figure 3.1c shows cluster transformations from cluster 3 to 5 in direction of higher 
lysozyme concentrations and higher sodium chloride ionic strength. For ammonium 
sulfate, a similar cluster transformation is seen in direction of higher lysozyme 
concentration but, in contrast to sodium chloride, for lower ammonium sulfate ionic 
strength. The similarity in cluster transformation shows that there is no ion specific effect 
on the resulting morphology and kinetics. The transformations are similar, but respective 
cluster areas are different for each salt. For example, cluster 5 is dominating the 
supersaturation zone at pH 9 in combination with sodium chloride, whereas cluster 4 and 
5 are equal in size for pH 9 in combination with ammonium sulfate. This shows that the 
degree of supersaturation is affected by ion type when all other solution conditions are kept 
constant. Higher degrees of supersaturation, increasing lysozyme concentration at similar 
solubility or lowering solubility (e.g. by pH or salt) at equal lysozyme concentration, 
increases the probability for spontaneous homogeneous crystal nucleation50,155. Higher 
probability results in faster nuclei formation and higher crystal numbers, which 
corresponds to the differences in both crystal onset time and crystal abundance between 
cluster 3, 4, and 5 as well as the respective cluster identification at increasing protein 
concentration, ionic strength, or pH. Previously reported positive correlations between the 
effects of increased crystal nucleation and degree of supersaturation are in agreement with 
this observation111,134–136,156,157. The change in crystal onset time and crystal abundance 
between cluster 3, 4, and 5 is also accompanied by a difference in average absolute crystal 
size. Crystal size is dependent on growth duration as well as speed, which in turn relies on 
underlying growth mechanisms, response on surface poising (i.e., impurity incorporation 
or incorrect molecule positioning on the surface), or available amount of protein127,155,158. 
Differently from nucleation, crystal size is not directly correlated to the degree of 
supersaturation158. For pH 3, 5, and 7, crystal size and crystal growth time increase in the 
direction of higher supersaturation, but at pH 9, the crystal size and crystal growth decrease 
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in the same direction. This is represented by the transformation of cluster 3 to cluster 4 and 
cluster 4 to cluster 5, respectively. Such an optimum in lysozyme crystal size has been 
reported before under different conditions136. Clusters 3 and 5 both represent similarly 
small crystals (~36 μm) in different parts of the supersaturated zone. The combination of 
kinetic data and crystal size suggests that solubility limitations and underlying growth 
mechanisms are responsible. Cluster 3, identified at the frontier of the supersaturation zone, 
shows a growth time of ~240 h before it reaches its terminal crystal size. An increase in 
protein concentration leads to crystals identified by cluster 4, where crystal growth time 
and crystal size increase simultaneously. Crystal growth cessation can occur when protein 
molecules still in solution reach the solubility limit as a result of crystal growth155. It is 
suggested that crystal size in cluster 3 was limited by the amount of available material as a 
lysozyme concentration increase for similar conditions results in further crystal growth. On 
the other side of the crystal size optimum, at higher supersaturation, cluster 5 is identified. 
Size limitation may be because of high supersaturation, which increases the number of 
crystal nuclei. Growth of many nuclei may not be supported by the available amount of 
material which causes growth cessation135,158. However, protein concentrations ranging 
from 25 to 125 g/L belong to cluster 5, but a lysozyme concentration increase under similar 
conditions does not influence crystal size or growth time. This indicates that the underlying 
growth mechanism is limiting. Formation of well-ordered crystals requires proper 
molecule positioning155. Proper molecule positioning on the crystal surface is achieved by 
moderate interaction between available crystal contacts and the molecule. This should 
allow for rearrangement of less favorable orientations before incorporation. Strong 
attractive interactions, which occur at higher supersaturation, may trap molecules in a less 
ordered state. Such changes to the crystal surface can cause growth cessation155. The 
maximum crystal size of ~96 μm, identified in cluster 4, lies within a region where growth 
can be supported in terms of available material without extreme nucleation and strong 
interactions as seen for higher supersaturation. This combination is suggested to be the 
cause of the crystal size optimum. 
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3.4 Conclusion 
This study shows that multidimensional data visualization using the EPD method allows 
for comprehensive and complete representation of lysozyme phase behavior under 768 
unique solution conditions using 4 morphological and 4 kinetic image-based features in a 
single figure. Data-dependent clustering resulted in 4 of 5 clusters for a single crystal 
subtype. This indicates that subtle changes in protein phase transitions, such as crystal onset 
time, growth time, and crystal size, can be identified. Feature differences as an effect of 
protein concentration, salt type, ionic strength, and solution pH are easily identified with 
colored clusters. The combination of morphologic and kinetic features gave insight into the 
route of crystal formation belonging to a similar morphology subcategory. It was shown 
that MPPDs are capable of handling large amounts of phase behavior data without 
challenging data interpretation, a characteristic currently missing in high throughput 
protein phase behavior experiments. In terms of data handling, improvements are 
necessary. Image feature extraction was preformed manually for this study, which is time 
and labor intensive and prone to subjectivity. Image recognition algorithms to substitute 
manual morphology and kinetic feature extraction would greatly improve time and labor 
consumption. Image recognition algorithms would also offer the opportunity to use image 
recognition based features to describe protein phase behavior more systematic and 
accurate. 
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Abstract 
Image-based protein phase diagram analysis is key for understanding and exploiting 
protein phase behavior in the biopharmaceutical field. However, required data analysis has 
become a notorious time-consuming task since high-throughput screening approaches were 
implemented. A variety of computational tools have been developed to support analysis, 
but these tools primarily use end point visible light images. This study investigates the 
combined effect of end point and time-dependent image features obtained from cross 
polarized and UV light features, supplementary to visible light images, on the classification 
of protein phase diagram images. In addition, external validation was performed to evaluate 
the classification algorithm’s applicability to support protein phase diagram scoring. The 
predicted protein phase behavior classes were subsequently used to automatically construct 
multidimensional protein phase diagrams (MPPDs) to prevent image information loss 
without complicating the employed image classification algorithm. Combining end point 
and time-dependent features from three light sources resulted in a balanced accuracy of 
86.4 ± 4.3%, which is comparable to or better than more complex classifiers reported in 
literature. External validation resulted in a correct formulation classification rate of 91.7%. 
Subsequent automated construction of the MPPDs, using predicted classes, allowed 
visualization of details such as crystallization rate and protein phase behavior type co-
existence. 
 
 
  
4 
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4.1 Introduction 
Protein phase behavior plays an important role in various sectors of the biopharmaceutical 
field. Knowledge on protein phase behavior indirectly aids in unraveling protein’s three 
dimensional structure which requires a crystalline phase108,109, but is also essential for 
downstream processing107 and formulation development105,106. Protein phase behavior is 
often characterized with protein phase diagrams, which are used as a source of information 
on protein solubility159, insoluble aggregate morphology114,115,119, and aggregation 
kinetics160 .  
 
Currently, most protein phase diagram data is obtained via automated imaging systems161. 
Subsequent scoring and analysis of the obtained image datasets is a time-consuming task 
as typical screenings with an automated imaging system consist of a multitude of 96-well 
plates. In addition, scoring subjectivity has been raised as a concern. Subjectivity can 
influence the number of scoring classes that are used, but also the consistency of scoring 
by experimenters162,163. Workload and error reduction by means of computational 
classification algorithms has therefore been explored in the field. This resulted in a variety 
of protein phase behavior image classification approaches. An elaborate overview of 
published work regarding image classification approaches can be found elsewhere164. The 
amount of reports shows how desirable an accurate classification algorithm is for protein 
phase behavior research. However, some classification algorithm properties and 
classification performance measures are specifically designed for certain protein phase 
behavior applications. For example, most classification algorithms focus on the 
identification of optimal crystallization conditions165, preferably applicable in real-time 
during experiments166,167. The work presented in this paper focuses on the application of 
an image classifier to aid protein phase behavior analysis after conclusion of experimental 
work. This work aims to use the retrieved information to understand effects of different 
environmental factors to manipulate and potentially predict protein phase behavior. 
Computational speed is less important here than for real-time applications, as the retrieved 
empirical data is examined after experiments instead of during experiments. In addition, 
not solely the identification accuracy of crystals but the identification accuracy of all types 
of protein phase behavior morphologies is considered important.  
 
One of the major issues in protein phase behavior image classification is the number of 
protein phase behavior types, sub-types, and the co-existence of these (sub)types168. For 
example, crystallization can be in the form of needle crystals or three dimensional crystals. 
In addition, these subtypes can co-exist in a single formulation or co-exist with another 
protein phase behavior type, such as precipitates. Incorporation of more classes to cover 
the wide variety of possible morphology types has shown a decrease in classification 
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accuracy compared to simpler class systems169–172. However, high accuracy for more 
advanced approaches is required to fully capture the complexity of protein phase behavior. 
A strategy to improve the accuracy of classification models is the employment of different 
data sources, which have been explored to find more distinctions between protein phase 
behavior (sub)types. Evaluated sources include, but are not limited to, protein trace-
labeling in combination with green fluorescence168,173,174, second-order nonlinear imaging 
of chiral crystals (SONICC)175, ultraviolet (UV) light176,177, and two-photon excited UV 
fluorescence178. Despite these alternatives, the main data source remains images obtained 
with visible light. Another property of the majority of image classification studies is the 
use of one image per formulation, which is usually the image taken at the end of a protein 
phase behavior experiment (end point image). However, incorporation of information 
obtained during protein phase behavior experiments (time-dependent information) has 
shown to aid crystallization screenings98,179.  
 
To explore improvements of protein phase behavior classification, this study aims to 
combine time-dependent and end point features obtained from multi-light source images 
and assess the impact by means of a random forest classification algorithm. A random 
forest classification algorithm was selected because the optimization of protein phase 
behavior classification via more complex algorithms was considered outside the scope of 
this work. Light sources used in this study are visible light, cross polarized light, and UV 
light. To the best of the authors’ knowledge, no previous studies report on the effects of 
features extracted from this combination of light sources for protein phase behavior 
classification. The use of time-dependent data for protein phase behavior classification 
purposes has also not been reported on before. To evaluate the impact of multiple light 
sources and time-dependent information on protein phase behavior classification, internal 
validation of the classification performance has been compared to performances using only 
end point features obtained from visible light images and performances reported in 
literature. External validation, by means of scoring 96-well format microbatch 
experiments, was used to evaluate the applicability of this classification approach for 
scoring protein phase diagrams.  
 
The classification algorithm in this work used four classes (clear, crystal, precipitate, and 
other). Classification of protein phase behavior images with a 4-class system generates 
information on aggregate morphology. However, protein phase diagram images captured 
over time contain information on aggregate properties and kinetics as well, which is lost 
when scoring solely protein phase behavior types. Construction of multidimensional 
protein phase diagrams (MPPDs) allows for the objective representation of aggregate 
properties and kinetics180. This can include aggregation extent, aggregate size, and 
40 
 
aggregate growth time. In previous work, MPPDs were constructed with manually 
extracted image-based features180. In this work, the extraction of the image features has 
been automated. The combination of image classification and subsequent MPPD 
construction was investigated to determine its potential to aid and innovate computational 
protein phase behavior classification. By focusing on main protein phase behavior types 
during classification, the accuracy of the classifier is thought to remain relatively high, 
while an objective interpretation of the classified protein phase behavior properties can be 
obtained from the corresponding MPPD.  
 
In total three topics are covered in this study. First, the impact of multi-light source and 
time-dependent image features on protein phase behavior classification was evaluated via 
interval validation. Second, an external validation is performed to assess the applicability 
of the image classification model for scoring protein phase diagrams. Third, MPPDs were 
automatically constructed using the predicted classes from external validation, where class-
based extraction of aggregate growth time and dimensions was used to visualize details on 
protein phase behavior. The combination of these three topics exemplifies the diversity of 
image classification approaches, the advantages of additional image sources, and the 
potential of expanding classification algorithms with automated visualization of 
multidimensional image-based data. 
 
4.2 Material and Methods 
4.2.1 Image dataset 
Images were obtained with microbatch crystallization experiments, where 96-well MRC 
Under-Oil crystallization plates (Swissci, Neuheum, CH) were placed in the automatic 
image system Rock Imager 54 (Formulatrix, Bedford, MA, USA). Storage time was either 
14 days or 30 days. Visible light images were taken at least daily, and cross polarized and 
UV light images were taken at least six times during the storage period. A total of 57 and 
67 images per well were taken during 14 and 30 days of storage, respectively. A detailed 
overview of the employed image schedules can be found in Supplementary Table B1. The 
settings for each light source have been previously described180. After storage, the end point 
image (i.e., the image taken at the last time point) of each well was scored using a 4-class 
system: “clear”, “precipitate”, “crystal”, and “other”. Scoring was performed based on 
visual inspection of the corresponding visible, cross polarized, and UV light images. In 
addition, the difference between initial formulation protein concentration and supernatant 
concentration after storage (data not shown) was taken into consideration. The class “other” 
was assigned to formulations which did not remain clear over time, but showed no 
illumination in the UV images and no change in supernatant protein concentration 
compared to the starting formulation protein concentration. Formulations where co-
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existence of precipitates and crystals occurred were scored as “crystal”. This resulted in a 
4-class dataset of 4416 formulations (~63% “clear” (2797), ~3% “precipitate” (149), ~24% 
“crystal” (1039), and ~10% “other” (431)). An example image of each class for each light 
source is shown in Supplementary Material Figure B1. 
 
4.2.2 Feature extraction 
Image features were extracted from thumbnail images (200x150 pixels) using MATLAB 
(version R2015b, MathWorks, Natick, MA, USA). Boundaries of the well and plate were 
replaced with black pixels (i.e., masked) for each visible light and cross polarized image in 
order to remove irrelevant information from the image. An example of the masked-out 
region can be found in Supplementary Figure B2. This was not needed for the UV light 
images, as a 7x zoom was used during UV light imaging instead of 2.5x zoom during 
visible light and cross polarized light imaging. The applied 7x zoom eliminated the well 
walls from the images. Feature extraction for an entire 96-well plate took ~200 seconds 
(14 days of storage) and ~400 seconds (30 days of storage). Two types of images features 
were extracted per well: (1) end point features and (2) time-dependent features. All features 
were extracted for each of the three light sources. The end point features resulted in 
extraction of 150 features from the final image. These features can be subdivided in three 
categories: (1) histogram features, (2) blob features, and (3) gray-level co-occurrence 
matrix (GLMC) features. A complete list of extracted image features can be found in 
Supplementary Material Table B2. Histogram features were extracted for each color level 
and the gray image employing the MATLAB function imhist. The gray image was obtained 
using the MATLAB function rgb2gray. Blobs were identified by using the Sobel edge 
detection method with a diamond as structural element set with a distance of 2 pixels from 
the origin to the points (MATLAB function strel). After edge detection, the edges were 
closed (MATLAB function imclose) and filled (MATLAB function imfill). After closing 
and filling, a second mask (with a smaller radius: original mask + 2 pixels) was added to 
remove the edges of the initial mask from the blob identification. Similar to the initial 
masking, the second mask was not used for UV light images. Blob properties were 
retrieved with MATLAB function regionprops, and the total pixel area and blob count were 
calculated. The GLMC of each image was obtained with the MATLAB function 
graycomatrix. Corresponding features were extracted with function GLCM_Feature1, 
which is available via MathWorks file exchange181. For the time-dependent feature, every 
image was subtracted from the first image of the corresponding formulation. This was done 
to determine the mean pixel intensity change over time. The mean pixel intensity of the 
end point difference image (start point image – end point image) was used in the classifier 
as time-dependent feature. The course of mean pixel intensity of difference images over 
time was used for the construction of multidimensional protein phase diagrams. The mean 
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pixel intensity of each individual image was also determined at each time point, where the 
start point and end point intensity were used for the construction of the multidimensional 
protein phase diagrams.  
 
4.2.3 Feature selection 
All computational steps after feature extraction were performed with MATLAB version 
R2018b. Feature selection was performed via two subsequent steps. First, the internal 
correlation between features was used as a filter to minimize overrepresentation of 
particular system characteristics. The Pearson correlation coefficient was determined for 
the complete feature dataset. A threshold of 0.950 for positive and negative linear 
dependency between features was set. All features with a Pearson correlation coefficient 
outside this threshold were eliminated. The remaining features were processed with the 
second step. To minimize the incorporation of noise, features were evaluated and selected 
based in their feature importance for the classification problem under investigation. This 
was done with an embedded feature selection method by employing the MATLAB function 
TreeBagger. A bagged (bootstrap aggregated) random forest consisting of 100 trees was 
built and the relative importance of each feature during classification was extracted. The 
number of trees was determined by inspection of the obtained out-of-bag error as a function 
of number of incorporated trees. The results used to select the number of trees can be found 
in Supplementary Material Figure B3. A cut-off feature importance value was set for the 
selection of features. The cut-off value was defined as the 50th percentile of the feature 
importance values of the entire feature set. All features with a feature importance value 
above the threshold were selected for training the classification model.  
 
4.2.4 Cross-validation 
A stratified 10-fold cross-validation was used to evaluate the image classification model 
performance. Each cross-fold preformed feature selection, as described in Section 4.2.3, 
and trained a random forest classification model using the selected features and the 
MATLAB function TreeBagger. Similar to feature selection, 100 trees were used in the 
classification model. The evaluation parameters to quantify the classifier performance were 
recall, precision, accuracy, and balanced accuracy, as defined by equation 4.1, 4.2, 4.3, and 
4.4, respectively. 
 
𝑅𝑒𝑐𝑎𝑙𝑙   
𝑇𝑃
𝑇𝑃 +  𝑁
 (4.1) 
𝑃 𝑒𝑐𝑖𝑠𝑖𝑜𝑛   
𝑇𝑃
𝑇𝑃 +  𝑃
 (4.2) 
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𝐴𝑐𝑐𝑢 𝑎𝑐𝑦   
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 +  𝑃 +  𝑁
 (4.3) 
𝐵𝑎𝑙𝑎𝑛𝑐𝑒𝑑 𝑎𝑐𝑐𝑢 𝑎𝑐𝑦   
𝑃 𝑒𝑐𝑖𝑠𝑖𝑜𝑛 + 𝑅𝑒𝑐𝑎𝑙𝑙
 
 (4.4) 
 
The evaluation parameters were defined by the true positive count (TP), the true negative 
count (TN), the false positive count (FP), and the false negative count (FN). These variables 
were obtained from a confusion matrix after classification. To determine the overall 
performance after cross validation, an overall average of each evaluation parameter was 
calculated using the evaluation parameters per class.  
 
4.2.5 External validation 
Next to 10-fold cross-validation, the performance of image classification was evaluated for 
an experimental dataset by means of external validation. The dataset was divided into a 
model training set and external test set. Three 96-well crystallization plate results (plate A, 
B, and C) were selected as external test set and the rest of the images (4128 images) were 
used as model training set. These three plates were selected based on the observed protein 
phase behavior after storage, to ensure the inclusion of all identified classes during external 
validation. Plate A contained formulations classified as “clear”, “precipitate”, and 
“crystal”. In addition, plate A showed formulations with precipitate and crystal co-
existence. Plate B contained “crystal” and “clear” formulations, and plate C contained 
mostly “clear” and “other” formulations. The external validation image classification 
model was trained with similar settings as mentioned for the 10-fold cross-validation in 
Section 4.2.4. External validation was evaluated based on the correct classification rate 
within an entire 96-well plate, and quantified by percentage of correctly scored 
formulations per plate. Data was visualized by representing the classes obtained from the 
external validation model as symbols in a 96-well plate format: a scatter plot with eight y-
axis values and twelve x-axis values. Class determination by the external validation model 
returned the probability of the identified class as well (i.e., the probability of the 
observation to truly belong to the returned class). This classification probability was 
incorporated in the scatter plot by adjusting the size of the symbol that indicates the position 
of the formulation in the 96-well plate. This was carried out by multiplying the probability 
value, when it fell below 0.750, with the default symbol size. This means smaller symbols 
were obtained for lower probability values. The overall probability of the classification was 
quantified by the mean value of all 96 probability values. 
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4.2.6 Automated multidimensional protein phase diagram (MPPD) construction 
An MPPD was automatically constructed to retrieve detailed information on the classified 
formulations. Automated construction of an MPPD was performed with end point and 
time-dependent features. An overview of the employed image features for the MPPD can 
be found in Supplementary Figure B3. Each of the listed features were extracted for all 
three light sources. This means that each main feature listed in Supplementary Figure B3 
consisted of three sub-features, namely one for each light source. After extraction, the three 
sub-features were averaged to represent the corresponding main feature. The time-
dependent feature growth time was determined as follows. The intensity difference over 
time (extraction is explained in Section 4.2.2) was fitted with a smoothing spline function 
by employing the MATLAB function fit and a smoothing parameter of 1·10-4. The fitted 
function was used to calculate the first derivate. The first zero value (in time) of the 
derivative was extracted, which represents the point in time at which intensity change 
ceased. This point in time was used as the definition for the end of aggregation growth, and 
thus aggregation growth time. If a zero point could not be found, the last time point was 
set as growth time.  
 
The image features listed in Supplementary Table B3 were extracted for formulations that 
were scored as “precipitate” or “crystal” by the external validation classification model. 
Formulations scored as “clear” or “other” were not included during feature extraction for 
the MPPD data set, as aggregate properties are non-existent in these formulation. All values 
for “clear” and “other” classified formulations were set to zero. The data of all three plates 
was used to construct an MPPD for each plate. Methods used to obtain the MPPD, such as 
dimensionality reduction and visualization, have been previously been described by Klijn 
et al.180. The optimal cluster number was set to range from 1 to 6 and a Pearson correlation 
coefficient cut-off value of 0.850 was used. 
 
4.3 Results and Discussion 
4.3.1 Feature set evaluation by 10-fold cross-validation 
The effect of incorporating different light sources and a time-dependent image feature on 
the classification of protein phase diagram images was evaluated. This was done by 
performing 10-fold cross-validation for multiple image feature sets and determining the 
accuracy, balanced accuracy, precision, and recall. Balanced accuracy (the average of 
recall and precision) was used as an evaluation parameter because protein phase diagram 
image datasets often deal with a class imbalance168,182. This class imbalance is not only an 
aspect to take into account during model training via proper class representation, but also 
during model evaluation. Six feature sets have been evaluated in this study: (1) image 
features extracted from visible light end point images (Vis); (2) Vis feature set combined 
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with a time-dependent image feature extracted for all three light sources (Vis+Time); (3) 
Vis feature set combined with image features extracted from cross polarized end point 
images (Vis+CP); (4) Vis feature set combined with image features extracted from UV 
light end point images (Vis+UV); (5) all features extracted from end point images for each 
light source (Vis+CP+UV); and (6) time-dependent features combined with the fifth 
feature set (Vis+CP+UV+Time). For each feature set, and each fold during cross-
validation, feature selection and classification model training was performed. It was 
observed that feature selection did not return different features between the 10 folds for the 
same feature set (data not shown). An overview of the selected image features per evaluated 
feature set can be found in Supplementary Figure B4. Figure 4.1 shows the mean evaluation 
parameters for each feature set after 10-fold cross-validation. Accuracy was added to the 
evaluation parameters as it is often used in studies when evaluating image classification 
models. Therefore, accuracy may be of interest for other work as comparable evaluation 
parameter. However, for the reasons mentioned above, the balanced accuracy will be used 
as the overall performance measure in the discussion of this work.  
 
 
Figure 4.1: Recall, precision, accuracy, and balanced accuracy in percentages for six different feature set. 
Vis: visible light end point image features; Time: time-dependent feature from each light source; CP: cross 
polarized light end point image features; and UV: ultraviolet light end point image features. Error bars 
represent the standard deviation calculated for each evaluation parameter obtained after internal 10-fold 
cross validation. 
 
The poorest classification model performance was obtained for the Vis feature set. The 
evaluation parameters show a recall, precision, and balanced accuracy of 63.0 ± 6.8%, 75.5 
± 5.6%, and 69.3 ± 4.3%, respectively. Note that evaluation parameters are mentioned as 
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mean ± standard deviation which was calculated with the evaluation parameters of each 
fold and each class obtained during 10-fold cross validation. The performance of all other 
feature sets are compared to performance of the Vis feature set, as visible light end point 
images are most often used to classify protein phase behavior images. An increase in 
classification model performance was seen for each addition to the Vis feature set. The 
addition of end point image features obtained with cross polarized light (Vis+CP) showed 
the smallest increase. The balanced accuracy increased from 69.3 ± 4.3% (Vis) to 70.7 ± 
4.6% (Vis+CP). Recall and precision increased with 0.5 percent point and 2.4 percent 
point, up to 63.5 ± 5.6% and 77.9 ± 5.4%, respectively. The addition of time-dependent 
features (Vis+Time) showed a 4.9 percent point increase in balanced accuracy (74.2 ± 
4.5%) compared to the classification using solely Vis (69.3 ± 4.3%). Recall and precision 
increased from 63.0 ± 6.8% and 75.5 ± 5.6% to 68.1 ± 5.8 and 80.3 ± 5.5%, respectively. 
The largest increase compared to Vis was seen for the addition of features extracted from 
the end point images obtained with UV light (Vis+UV). Balanced accuracy increased up 
to 82.2 ± 4.7%. Recall and precision showed an increase of 14.3 percent point (77.3 ± 
6.4%) and 11.6 percent point (87.1 ± 4.4%), respectively, compared to the performance 
when using Vis. The addition of cross polarized light feature images to the Vis+UV feature 
set, to obtain the Vis+CP+UV feature set, resulted in a classification performance 
comparable to the Vis+UV feature set. The observed increase of 0.2 percent point upon 
comparison of Vis+UV and Vis+UV+CP in terms of recall, precision, and balanced 
accuracy falls within the standard deviations of the performance evaluation parameters of 
the Vis+UV+CP feature set (77.4 ± 5.5%, 87.3 ± 4.1%, and 82.4 ± 4.0%, respectively). 
This observation corresponds to the small increase in performance when comparing the 
Vis and Vis+CP feature set. The lack of relevant information from cross polarized light 
images in this classification problem may be due to the limited dataset size and diversity. 
It could also be due to the extraction of similar features for each light source. Future work 
can determine whether specific image-based features for specific light sources increases 
the light source’s relevance. Addition of time-dependent features (Vis+CP+UV+Time) 
resulted in the best performance of all tested feature sets. A balanced accuracy of 86.6 ± 
3.9%, a recall of 83.4 ± 6.2%, and precision of 89.8 ± 3.7% were obtained. The evaluation 
parameters of Vis+CP+UV+Time showed a relatively small increase from the 
Vis+CP+UV feature set, namely an increase of 5.9, 2.5, and 4.2 percent point, respectively. 
Nevertheless, compared to the Vis feature set, addition of different light source features 
and time-dependent features resulted in an overall increase of 20.4, 14.3, and 17.3 percent 
point for recall, precision, and balanced accuracy, respectively. 
 
Table 4.1 lists the mean evaluation parameters for all four classes obtained during 10-fold 
cross-validation with the Vis+CP+UV+Time feature set. The evaluation parameters per 
class are shown for this feature set as it showed the best classification performance in this 
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study. Mean evaluation parameters obtained during cross-validation per class for all other 
feature sets can be found in Supplementary Table B5. 
 
Table 4.1: Average recall, precision, accuracy, and balanced accuracy listed in percentage per protein 
phase behavior class obtained for 10-fold cross-validation using the image feature set containing visible, 
cross polarized, ultraviolet light image features in combination with a time-dependent feature. The values 
are listed as mean ± standard deviation. This was calculated based on the 10 folds obtained from internal 
cross-validation. 
 
Table 4.1 shows that the “other” class resulted in the lowest performance. This is 
represented by a recall and precision of 66.9 ± 7.3% and 77.9 ± 5.9%, respectively. The 
accuracy does not reflect this poor performance (95.1 ± 0.9%), which highlights the role 
of an imbalanced class distribution on performance evaluation. The balanced accuracy 
paints a more realistic picture of the classification model performance, with 72.4 ± 5.3% 
for the “other” class. The balanced accuracy also reflects that the classifier performs well 
for classes “clear” and “crystal”, represented by 93.8  0.8% and 92.6   1.6%, respectively. 
However, recall for the “crystal” class is lower than the “clear” class (86.4   3.0% versus 
96.9 ± 1.1%), while the opposite is seen for precision (90.8   1.5% for “clear” and 96.8   
1.6% for “crystal”). This reflects that crystal formulations show a higher false negative 
rate, which means that crystallized formulations are more often missed than clear 
formulations. On the other hand, “clear” formulations showed a higher false positive rate. 
The higher false positive rate of the “clear” class and the low performance of the “other” 
class are both attributed to misclassifications between “clear” and “other” images. This can 
be deducted from the individual confusion matrices of the Vis+CP+UV+Time feature set, 
shown in Supplementary Material Table B6. The “precipitate” class showed a moderate 
balanced accuracy of 88.6 ± 7.8%. A recall of 83.2 ± 13.6% reflects a relatively high false 
negative rate and a large deviation between the folds. The large deviation is presumable 
due to the small contribution of the “precipitate” class to the total dataset (~3%). The 
corresponding precision for the “precipitate” class of 93.9   5.8% reflects a low false 
positive rate.  
 
A considerable amount of research has been published concerning image recognition for 
protein phase behavior studies164. However, due to the wide range of classification classes, 
image sources, training/test sets sizes, algorithms, and classification optimization targets, 
it is difficult to put new protein phase behavior classification work into perspective. Three 
 Recall [%] Precision [%] Accuracy [%] Balanced Accuracy [%] 
Clear 96.9 ± 1.1 90.8 ± 1.5 91.8 ± 1.1 93.8 ± 0.8 
Precipitate 83.2 ± 13.6 93.9 ± 5.8 99.1 ± 0.6 88.6 ± 7.8 
Crystal 86.4 ± 3.0 96.8 ± 1.6 96.2 ± 0.7 91.6 ± 1.6 
Other 66.9 ± 7.3 77.9 ± 5.9 95.1 ± 0.9 72.4 ± 5.3 
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studies have been selected to put the work presented in this study into perspective. The data 
is shown in Table 4.2. The studies have been selected based on the available data, number 
of classification classes, and type of classifier. The available published performance 
parameters have been converted to match the definitions as described in Section 4.2.4. The 
number of classification classes are considered as a selection criterion, as the number of 
classes shows a large influence on the evaluation parameters. High class systems tend to 
show a poor performance, while two class systems show a relatively good performance.  
 
Table 4.2: Overview of the average recall, precision, accuracy, and balanced accuracy in percentages for 
literature data and the work presented in this study. The values are given in mean ± standard deviation, 
which are determined based on the corresponding evaluation parameters for all considered classes. 
 
The work of Bruno et al. employs similar classes (“clear”, “crystal”, “precipitate”, 
“other”)167, while Sigdel et al. and Cumbaa et al. employed a 3-class system (“clear”, 
“crystal”, “other”)168,171. In addition to the classes, the type of classifier was taken into 
account. As listed in Table 4.2, deep convolutional neural networks (CNNs) were used by 
Bruno et al., while a random forest classifier was used by the Sigdel et al. and Cumbaa et 
al. The type of classifier is of interest because of the required computational time and 
expertise to design and train a classification model. Deep CNNs classification algorithms 
are considered advanced and computational expensive, while random forest classification 
algorithms are considered more transparent and computational inexpensive. For the 
application of a classification model in a laboratory with powerful yet ordinary computers 
and scientists with moderate programming skills, it would be beneficial to keep algorithms 
computational inexpensive and accessible. However, simpler classification algorithms tend 
to be less accurate.  
 
Table 4.2 shows deep CNNs as the best performing classifier. The percent point difference 
between the work by Bruno et al. and the work presented here is 5.3, 3.1, and 4.2 for the 
average recall, precision, and balanced accuracy, respectively. Even though the deep CNNs 
performance is better on average, the simplistic approach and basic features that are used 
in this study already result in a classification performance that lies within the standard 
deviation range. This highlights the potential of time-dependent and multi-light source data 
 
Bruno et al.167 Cumbaa et al.171 Sigdel et al.168 This study 
 
Classified type CNN RF RF RF 
Number of training images 442930 124816 714 4234 
Number of classes 4 3 3 4 
Recall [%] 88.7 ± 11.3 87.5 ± 7.9 85.6 ± 14.3 83.4 ± 6.2 
Precision [%] 92.9 ± 3.2 80.0 ± 16.9 87.9 ± 8.4 89.8 ± 3.7 
Accuracy [%] 97.2 ± 1.0 91.0 ± 4.0 96.5 ± 2.3 95.5 ± 0.8 
Balanced accuracy [%] 90.8 ± 7.2 83.7 ± 10.9 86.8 ± 10.3 86.6 ± 3.6 
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for image classification accuracy improvement, while employing a simple and transparent 
classification algorithm. The use of more complex features from visible light end point 
image by Cumbaa et al. resulted in 4.1 percent point higher recall compared to the study 
presented here. Contrarily, the precision and balanced accuracy are 9.8 and 2.9 percent 
point lower for the work by Cumbaa et al., respectively. Performance parameters of Sigdel 
et al. are comparable to performance parameters of the current study. The main difference 
between the current study and the work presented by Sigdel et al. is the higher standard 
deviation reported for the latter. This is represented by an 8.1, 4.7, and 6.7 percent point 
higher standard deviation for recall, precision, and balance accuracy, respectively. In 
general, the standard deviation for the current study is smaller compared to the three 
literature studies, which indicates that the performance between classes is more consistent.  
 
Presented internal validation results and the subsequent comparison with previously 
published work shows the advantage of information obtained from multiple light sources 
as well as information obtained over time for protein phase behavior image classification. 
The full potential of this classification approach can be assessed in future work, where the 
effects of more complex and light source-specific features, a rigorous feature optimization 
workflow, and a larger and more complex image dataset should be investigated.  
 
4.3.2 Protein phase diagram prediction 
Cross-validation was performed to obtain an estimation of the model performance, but the 
application of the classification model would be to classify protein phase diagram images 
after an experiment is completed. To evaluate the performance for this application, an 
external validation was carried out using the best performing feature set during internal 10-
fold cross-validation, namely the combination of visible light, cross polarized light, UV 
light, and a time-dependent feature. To evaluate the external validation, images obtained 
from three 96-well microbatch crystallization plates were selected to be classified. These 
plates were selected so that all four classes were part of the external validation. All other 
4128 formulations were used to train the classification model. Before training the external 
validation classification model, feature selection was performed. Feature selection resulted 
in the removal of 94 features based on internal correlation coefficient and 28 based on 
feature importance. The corresponding correlation coefficient matrix and feature 
importance graph can be found Supplementary Figure B4 and Figure B5, respectively. A 
total of 28 features remained to train the classification model, which are listed in Table 4.3. 
The resulting classification of the three excluded plates by the obtained classification 
model is depicted in Figure 4.2.  
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Table 4.3: Overview of selected image feature for the external validation classification model. 
Number Feature description Light source 
1 - 3 Entropy color level red, green, and blue 
Visible light 
4 Mean pixel intensity color level red 
5 - 6 Pixel variance color level red and blue 
7 Total count of blobs 
8 Contrast obtained from GLMC 
9 Correlation obtained from GLMC 
10 Cluster shade obtained from GLMC 
11 Energy obtained from GMLC 
12 Entropy obtained from GMLC 
13 Measure of correlation 2 obtained from 
GLMC 
14 Total intensity difference 
15 Entropy color level red 
Cross polarized 
light 
16 Total area of blobs 
17 Total intensity difference 
18 Entropy color level red 
UV light 
19 Mean pixel intensity color level red 
20 - 21 Skewness and kurtosis color level red 
22 - 23 Total area and count of blobs 
24 Contrast obtained from GLMC 
25 Correlation obtained from GLMC 
26 Cluster shade obtained from GLMC 
27 Energy obtained from GMLC 
28 Total intensity difference  
 
Colored symbols in Figure 4.2 represent the predicted class, where the size of the symbol 
is adjusted for its classification probability. A smaller symbol represents a lower 
classification probability, which was thought to help identify a possible misclassification. 
A circle around the symbol indicates that the formulation was incorrectly classified. The 
true class can be identified by the color of the circle, which is similar to the color of the 
symbol classes. The correct classification rate and mean probability of the entire plate is 
shown below each plate. Figure 4.2a shows a correct classification of 94.8% and a 
corresponding mean probability of 0.919 for plate A. For plate B in Figure 4.2b, 3 out of 
96 formulations were incorrectly classified, represented by a correct identification value of 
96.9%. Figure 4.2c (plate C) shows an incorrect classification of 16 out of 96 formulations, 
which is reflected by a correct identification percentage of 83.3%. The overall probability 
is also lowest for plate C, with a value of 0.770. The misclassifications in plate C 
correspond to confusion matrices obtained after 10-fold cross-validation (Supplementary 
Table B6) for the Vis+CP+UV+Time feature set. Confusion matrices show that “other” 
misclassifications are most often classified as “clear” and vice versa. In combination with 
a mean recall of 66.9   7.3% it is not unexpected that 8 out of 23 (~35%) of the “other” 
formulations were misclassified.  
51 
 
 
Figure 4.2: Classification results of external validation for (a) plate A, (b) plate B, and (c) plate C. The 
correct classification percentage and total plate probability is listed below each plate. Symbols represent 
the four predicted classes: (1) clear (blue dot), (2) precipitation (red asterisk), (3) crystal (yellow diamond), 
and (4) non-protein (gray dot). Symbol size is adjusted to the individual classification probability. Open 
circles represent the true class in case of misclassification. Colors represent the four true classes: (1) clear 
(blue), (2) precipitation (red), (3) crystal (yellow), and (4) non-protein (gray). 
 
Misclassification of crystallized formulations in plate A (B10 and B12) was most likely 
due to inability to recognized ~7 small crystals (<50 μm) in co-existence with precipitation. 
Considering the misclassified crystallized formulation in plate B (C9, C12, D4) and plate 
C (A1), which also contains a few small crystals, it can be concluded that the classifier 
does not perform well for the classification of a few small crystals. A hardware related 
limitation was found when inspecting the other misclassified crystallized formulation in 
plate A (D6). This formulation showed small crystals near the well walls, which are missed 
by the UV light images. This is due to the available minimal zoom for UV light images (7x 
for UV light versus 2.5x for visible and cross polarized light images), which results in an 
image lacking the outer part of the liquid formulation. Precipitates and crystals occurring 
at the well wall are therefore not captured in UV light images. It is assumed this issue can 
be resolved by applying a smaller zoom to capture the entire liquid formulation in UV light 
images. Class probability was incorporated in the symbol-based protein phase diagram to 
target uncertain model classifications for closer manual inspection more easily. However, 
external validation showed that not all incorrect classification have a corresponding low 
probability. For plate A, the probability for the misclassifications ranges from 0.570 to 
1.000 with a mean of 0.760. Plate B shows a range from 0.580 to 1.000, with a mean of 
0.810. Plate C shows a wider range of 0.500 to 0.970, with a mean of 0.720.  
 
External validation resulted in an overall correct classification value of 91.7% and overall 
classification probability of 0.881. These results indicate that the classification model in 
A B C
Clear Precipitation Crystallization Non-protein
Predicted class True class
Correct: 96.9% Total probability: 0.953Correct: 94.8% Total probability: 0.919 Correct: 83.3% Total probability: 0.770
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the current state is applicable as a fast, but solely preliminary assessment of protein phase 
diagrams. Elimination of human interpretation is not yet possible. Further development, as 
suggested in Section 4.3.1, is required to obtain a more reliable classification model. An 
additional approach that would be of particular interest to enhance the identification of 
uncertain classifications in protein phase diagrams, is the use of two or more parallel 
classification algorithms as presented by Buchala and Wilson172. The combined probability 
of multiple classifiers could enrich the classification outcome by a more accurate 
representation of classification uncertainty. 
 
4.3.3 Automated multidimensional protein phase diagram (MPPD) 
Image-based protein phase diagram studies are information-dense experiments. Besides 
information on the resulting protein phase behavior, imaging experiments contain 
information on aggregate dimensions such as crystal size, as well as information on 
aggregation kinetic properties, such as growth time. In previous work, construction of 
MPPDs showed how this rich information can be visualized and how MPPDs can aid 
protein phase diagram interpretation180. Extraction of aggregate dimensions and kinetic 
properties was previously done manually. In this work, results obtained from the protein 
phase behavior classification algorithm allowed for subsequent automated extraction of the 
information required to construct an MPPD. MPPD construction resulted in the clustering 
of features describing the total aggregated area (image feature: total blob area), the crystal 
count (image feature: number of blobs), the crystal length (image feature: mean blob major 
axis length), and the aggregation growth time (image feature: time point at which no 
intensity change was observed anymore). These features were reduced to three dimensions, 
with an energy loss of 1.4%. This energy loss falls within the accepted 10% energy loss 
after dimension reduction147. The obtained three dimensional dataset was used to cluster 
formulations together that show similar properties. These clusters are displayed as a 
uniform group in MPPDs. The results for plate A, B, and C are shown in Figure 4.3.  
 
Figure 4.3 shows three MPPDs (left) and five radar charts to represent data-dependently 
identified formulation clusters (right). Radar charts show a median value for each extracted 
feature as a color surface and a dashed line to indicate the median absolute deviation within 
clusters. Cluster 1 represents the formulations that were classified as “clear” or “other” as 
all image feature values equal zero. Cluster 2 represent “precipitate” formulations, as 
crystal specific features equal zero. Cluster 3, 4, and 5 represent “crystal” formulations. 
The fact that three clusters were identified to represent “crystal” formulations, shows that 
more information can be obtained without complicating the initial protein phase behavior 
classification algorithm. 
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Figure 4.3: Multidimensional protein phase diagrams for plate A, B, and C. Formulation clusters are 
indicated by color and number. Clusters are separated by a dashed line to guide the eye. Formulation 
cluster numbers correspond to radar chart numbers. Each radar chart represents the median value of the 
image features shown in the legend radar chart with a colored surface. The black dashed line inside each 
radar chart represents the median absolute deviation. 
 
Crystal length is comparable (~7 pixels) for all three crystal clusters, but differences were 
observed for aggregated area, growth time, and crystal count. Cluster 3 formulations 
showed a median aggregated area of 280 ± 101 pixels, with a median crystal count of 22 ± 
11 which grew for a median of 90 ± 16 hours. Note that cluster values are mentioned as 
median ± median absolute deviations. Cluster 4 formulations show a larger aggregation 
area (median of 291 ± 157 pixels) compared to cluster 3 formulations, which was obtained 
over a longer period of time (median of 279 ± 21 hours). However, cluster 4 formulations 
contained a comparable crystal count (median of 21 ± 9) as cluster 3 formulations. A 
comparable crystal count and crystal length combined with a larger aggregation area is 
presumably a consequence of the co-existence of crystals and precipitates, which was not 
seen for cluster 3 formulations. Results for cluster 4 indicate that co-existence can 
potentially be excluded from image classifiers as a (sub)class and be identified with 
complementary MPPDs. This benefits protein phase behavior classification, as recognition 
of co-existing phases is one of the main issues168. Cluster 5 shows a further increase in 
aggregated area (median of 771 ± 101), which was obtained in 94 ± 25 hours. The increase 
of crystal count (54 ± 10) indicates that the increase in aggregated area is a result of 
increased formation of crystals, and not co-existence with precipitates as seen for cluster 
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4. In addition, the higher crystal count also represents an increased nucleation rate for 
cluster 5 formulations compared to cluster 3 and cluster 4. The quantification and 
visualization of nucleation rates allows one to assess the level of super saturation.  
 
The discussed workflow from raw multi-light source images to symbol-based protein phase 
diagrams and complementary MPPDs showed the diversity of image-based information in 
the field of protein phase behavior studies. Prior to application of the proposed workflow 
for classification of screening experiments, the impact of the employed UV light on the 
protein in question should be assessed beforehand. This is noted as protein aggregation 
propensity may be affected by the use of UV light imaging183. Future work should focus 
on optimized MPPD information extraction for each light source and test a larger image 
database with more protein phase behavior (sub)types. The small scale and relative 
simplicity of the presented study indicates that more advanced techniques and data sets 
could increase its potential to aid analysis of protein phase behavior studies. 
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4.4 Conclusion 
This study presented three topics concerning image-based data for protein phase behavior 
analysis. The first topic demonstrated that combining multiple light sources (visible, cross 
polarized, and UV light) with time-dependent features improves the classification accuracy 
of protein phase behavior images. A balanced accuracy of 86.4 ± 3.9% was achieved during 
10-fold cross-validation. This was a 17.3 percent point increase compared to 10-fold cross-
validation with only visible light image features extracted from end point images. 
Evaluation of multiple image feature sets showed that features obtained from UV light 
images were most influential, followed by the time-dependent feature. The second topic 
covered the external evaluation of the image classification model to determine its 
applicability to protein phase diagram scoring. External validation resulted in an overall 
correct protein phase behavior classification of 264 out of 288 formulations (91.7%). The 
third topic used the external validation classification results to investigate the combination 
of image classification and objective multidimensional data visualization to exploit the 
information-rich image data without complicating the classification algorithm. It was 
shown that automated MPPDs can complement automatically classified protein phase 
diagrams by distinguishing phase co-existence and changing nucleation rates within the 
“crystal” class. The results presented for these three topics indicate that merging different 
approaches allows protein phase behavior research to benefit from the strength of each 
aspect. Hardware variety aids the distinction between protein phase behavior types, 
employing different visualization techniques allows one to capture several levels of 
information, and implementation of automated computational approaches minimize the 
workload. 
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Abstract 
Identification of long-term stable biopharmaceutical formulations is essential for 
biopharmaceutical product development. Reduction of the number of long-term storage 
experiments and a well-defined formulation search space requires knowledge-based 
formulation screenings and a detailed protein phase behavior understanding. To achieve 
this, short-term analytical techniques can serve as predictors for long-term protein phase 
behavior. Protein phase behavior studies that investigate this concept commonly display 
shortcomings such as limited and small datasets, sample adjustments, or simplistic data 
analysis. To overcome these shortcomings, 150 unique lysozyme solutions were analyzed 
using six different short-term analytical techniques. Lysozyme’s structural properties, 
conformational stability, colloidal stability, surface charge, and surface hydrophobicity 
were obtained directly after formulation preparation. Employing the empirical phase 
diagram method, this short-term data was correlated to long-term physical stability data 
obtained during 40 days of storage. Short-term protein properties showed partial 
correlation to long-term phase behavior. Identification of different structural conformations 
related to changing surface properties, colloidal stability, and conformation stability as a 
function of formulation conditions. This study contributes to long-term protein phase 
behavior research by presenting a systematic, data-dependent, and multidimensional data 
evaluation workflow to create a comprehensive overview of short-term protein analytics in 
relation to long-term protein phase behavior.  
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5.1 Introduction 
Protein phase behavior characterization is necessary to identify stable formulation 
conditions for long-term storage of biopharmaceuticals. Stable biopharmaceutical product 
formulations are found via prolonged periods of storage time (6 to 60 months) of the 
biopharmaceutical compound in question under varying formulation conditions184. This 
approach of searching for optimal formulation conditions is time consuming, has a trial-
and-error nature, and experience is required for solution parameters selection. Therefore, 
it is desired to reduce development time and costs by rational design of protein 
characterization experiments and move towards long term protein phase behavior 
prediction12,185. This can be done by identifying short-term measurable protein properties 
which correlate to long-term protein phase behavior. This requires that short-term protein 
properties capture protein-protein, protein-solvent, and protein-cosolute interactions that 
induce long-term physical instability. The strength and type of these interactions are 
dependent on intrinsic protein properties, which are in turn influenced by physical and 
chemical parameters of the formulation and the protein itself 18,26,104. Observed protein 
phase behavior can result from various aggregation pathways due to different underlying 
aggregation mechanisms20,29. In this study, physical instability refers to insoluble and 
optically visible aggregate formation, such as crystals or amorphous precipitates.   
 
The Derjaguin-Landau-Verwey-Overbeek (DLVO) theory describes the dependency of 
intermolecular protein-protein interactions (i.e., colloidal stability) on long-range 
electrostatic repulsion and weak, short-range van der Waals attraction27. High protein 
concentration formulations have shown that non-DLVO forces, such as hydrophobic forces 
and hydrogen bonding, influence colloidal stability as well as excluded volume186–189. In 
addition to colloidal stability, conformational stability plays a key role in protein 
aggregation as well and is dependent on solvation and intramolecular properties47. 
Therefore, a quantification of colloidal and conformational stability is necessary to 
characterize protein aggregation. Analytical techniques to assess colloidal and 
conformational stability are elaborately discussed in available reviews23,46,190. Specific 
protein properties, such as protein charge and surface hydrophobicity, should be taken into 
account as well when investigating long-term protein aggregation. These properties can 
determine the occurrence and degree of colloidal or conformation stability and are 
therefore an important part of investigating cause and consequence of protein physical 
instability21,191. Therefore, investigation of the correlation between short-term empirical 
protein properties and long-term physical stability requires multiple analytical techniques. 
The requirement of combining analytical techniques has been recognized and has been 
used to investigate protein phase behavior as a function of formulation conditions in several 
different studies47,77,82,139,188,192–195. These combinations of experiments can increase 
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protein phase behavior understanding, which in its turn aids rational formulation screening 
design and predictive parameter identification23. Some studies have already used empirical 
short-term properties to investigate the predictive power in relation to long-term protein 
phase behavior82,193,195,196. Based on the reported combinations of analytical techniques it 
can be stated there is a continuing need to generate data and knowledge on formulation-
dependent long-term protein physical stability. In particular, there is a need to continue this 
type of research while simultaneously eliminating specific shortcomings. Reported studies 
show limitations that can be described with one or more of the following four issues: (1) 
incomplete datasets by including only conformational stability or colloidal stability, or a 
general lack of protein properties measurements to determine properties such as protein 
surface charge; (2) relative small datasets (n < 30); (3) analytical techniques that require 
formulation condition adjustments, such as dyes or sample dilution; (4) simplistic data 
analysis techniques which hinders data visualization and interpretation.  
 
This study seeks to overcome these limitations while investigating the correlation between 
short-term empirical protein properties and long-term protein phase behavior. To avoid 
incomplete and small data sets, the first and second shortcoming, the model protein chicken 
egg white lysozyme was formulated in 150 unique solution conditions and analyzed using 
six different analytical techniques. The employed analytical techniques included dynamic 
light scattering (DLS), Fourier-transform infrared (FTIR) spectroscopy, static light 
scattering (SLS), intrinsic fluorescence (IF) spectroscopy, mixed-mode measurement 
phase analysis light scattering (M3-PALS), and stalagmometry to represent formulation 
condition effects on inter-particle interactions, secondary structure, colloidal stability, 
conformational stability, surface charge, and surface hydrophobicity, respectively. None 
of the employed techniques required formulation adjustments, thereby eliminating the third 
shortcoming. The extracted short-term empirical protein properties were lysozyme’s 
apparent hydrodynamic radius, FTIR peak region areas, aggregation onset temperature, 
melting temperature, zeta potential, and normalized surface tension. Formulations were 
designed to cover a wide range of conditions. The conditions covered 4 pH values (pH 3.0, 
5.0, 7.0, and 9.0), 2 salts (ammonium sulfate and sodium chloride), 4 ionic strengths (0, 
50, 175, and 275 mM) and 5 lysozyme concentrations (25, 50, 75, 100, and 125 g/L). Long-
term phase behavior of lysozyme under identical formulation conditions was monitored 
with 96-well format microbatch experiments, where formulations were stored for 40 day 
at 20 °C 115,180. The fourth shortcoming, data visualization and interpretation, was resolved 
by using an advanced method of compiling multidimensional data into a comprehensive 
figure called the empirical phase diagram (EPD)78,89. Reducing multidimensional empirical 
data to three dimensions provides the means to visualize and interpret data more easily by 
making use of color clustering. Colors were used to distinguish differences in empirical 
data as a function of formulation conditions. Radar charts can complement EPDs by 
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providing an overview of underlying empirical data for each color cluster. The 
effectiveness of this visualization technique was demonstrated with protein structural 
data91. Both the short-term and long-term dataset were visualized with the EPD method. 
Visualization of the large formulation dataset required a systematic data processing 
workflow, which resulted in a comprehensive presentation, exploration, and discussion of 
the correlation between evaluated short-term empirical protein properties and long-term 
phase behavior. 
 
5.2 Material and Methods 
5.2.1 Buffer preparation 
A multicomponent buffer with 10 mM buffer capacity was used to exclude buffer 
component effects on protein phase behavior 145. Buffer components were CHES 
(Applichem, 6.13 mM), TAPS (Applichem, 14.61 mM), MOPS (Roth, 7.00 mM), sodium 
acetate trihydrate (Merck, 3.01 mM) and citric acid monohydrate (Merck, 13.86 mM). 
Buffer pH was adjusted using a 5-point calibrated pH-meter (HI-3220, Hanna Instruments, 
Woonsocket, RI, USA) equipped with a SenTix 62 pH electrode (Xylmen Inc., White 
Plains, NY, USA) using 4 M sodium hydroxide (Merck) as titrant. The pH was adjusted to 
3.0, 5.0, 7.0, or 9.0 with 0.05 pH unit accuracy. Equal ionic strength between buffers with 
different pH values was obtained by addition of sodium chloride (Merck) or ammonium 
sulfate (Applichem) while stirring and monitoring the conductivity with a conductivity 
probe (Radiometer Analytical, Lion, France). After conductivity adjustment, the buffers 
were filtered over a 0.2 μm cellulose acetate filter (Sartorius, Göttingen, Germany). These 
buffers served as buffers with a relative ionic strength of 0 mM. Buffers with a relative 
ionic strength of 50, 175, 275, and 1050 mM were made with either sodium chloride or 
ammonium sulfate. The buffers were stored for a maximum of one month and the pH was 
routinely checked. 
 
5.2.2 Protein stock preparation 
A 150 g/L stock solution of lysozyme from chicken egg white (Hampton Research, Aliso 
Viejo, USA) was made in the appropriate 0 mM ionic strength buffer. The obtained protein 
solution was filtered over a 0.2 μm cellulose acetate prefilter (VWR, Radnor, PA, USA). 
After filtering, the protein solution was desalted with a PD-10 column (GE Healthcare Life 
Sciences, Uppsala, Sweden). Depending on the volume of the protein solution a mini or 
normal PD-10 column was used, employing the centrifugation protocol as provided by the 
manufacturer. Lysozyme stock solution concentration was determined with a Nanodrop 
2000c UV-Vis spectrophotometer (ThermoFischer Scientific, Waltham, MA, USA). An 
E1% (280 nm) extinction coefficient of 22.00 g-1·L·cm-1 was used.  
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5.2.3 Sample preparation 
Samples for protein analytical measurements were prepared on the same day as the 
experiments and measured within 6 hours. A mixing ratio of 5:1 (protein:salt) was used to 
obtain protein samples with a protein concentration of 125, 100, 75, 50 and 25 g/L and a 
relative ionic strength of 0, 50, 175 and 275 mM sodium chloride or ammonium sulfate. 
To obtain the desired protein concentration and ionic strength for the 5:1 mixing ratio, 
protein and salt stock solutions were pre-diluted with the appropriate relative 0 mM ionic 
strength buffer.  
 
5.2.4 Stalagmometry 
Protein surface hydrophobicity was determined by measuring solution surface tension 
using a fully automated liquid handling station based high-throughput stalagmometer 76. 
The following changes in the setup have been made to reduce the sample volume and 
decrease experimental time: samples were measured with four technical replicates using a 
sample volume of 80 μL and repeating sample drop-wise dispense twice using low volume 
PTFE coated tips (Tecan, Crailsheim, Germany). Sample volume reduction and fewer 
repeat dispenses showed a 3.4% increase in relative standard deviation of measured water 
drop masses (data is shown in Supplementary Figure C1). This was considered an 
acceptable error as the total relative standard deviation remained below 5% while reducing 
sample volume a six-fold and experimental time to 3.5 hours, instead of ~9.5 hours, for a 
complete 96-well microtiter plate. Samples were transferred and measured in round, clear 
bottom 96-well microtiter plates (Greiner Bio-One GmbH, Frickenhausen, Germany). 
Plates were sealed with Duck Brand HD Clear sealing tape (ShurTech Brands, Avon, OH, 
USA) to prevent evaporation. Scalpel slits were made in the sealing tape prior to 
measurements. Ultrapure water, purified with a PURELAB Ultra (ELGA LabWare, Bucks, 
UK), was used as a reference solution with a surface tension of 72.62 mN/m197. Data 
processing and evaluation was preformed using an in-house developed MATLAB script 
(version R2017b, MathWorks, Natick, MA, USA). Obtained protein solution surface 
tensions were normalized with the corresponding buffer surface tension. 
 
5.2.5 Dynamic light scattering (DLS) 
DLS measurements were performed with a Zetasizer Nano ZSP (Malvern Instruments Ltd, 
Malvern, United Kingdom) using a ZEN2112 quartz cuvette (Hellma GmbH & Co. KG, 
Muellheim, Germany). Each sample was measured in duplicate, where each measurement 
contained two runs with 15 sub runs. Cuvettes were washed once with ddH2O and twice 
with 40 μL of the appropriate buffer before each measurement. A sample volume of 40 μL 
was used. Zetasizer software used the default distribution analysis to obtain a diffusion 
coefficient distribution from the correlogram. An in-house developed MATLAB script 
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(version R2017b, MathWorks, Natick, MA, USA) was used to calculate the radius 
distribution from the obtained diffusion distribution and correct for sample viscosity61. The 
radius distributions were used to obtain the apparent hydrodynamic radius (RH App) of 
lysozyme by extracting intensity peak between 0.5 nm and 4 nm.  
 
5.2.6 Mixed-mode measurement, phase analysis light scattering (M3-PALS) 
Electrophoretic mobility was measured with the Zetasizer Nano ZSP (Malvern Instruments 
Ltd, Malvern, United Kingdom). Folded capillary cells (DTS1070, Malvern Instruments 
Ltd, Malvern United Kingdom) were filled with the corresponding buffer and 20 μL of the 
samples was pipetted into the bottom of the cell with a 200 μL round 0.5 mm thick Corning 
Costar gel-loading pipet tip (Corning Incorporated, Corning NY, USA) to employ the 
diffusion barrier technique. Each sample was measured twice at 25 °C, where each 
measurement consisted of 120 seconds equilibration time and two runs with a maximum 
of 15 sub runs. The applied voltage was set to 60 mV and the automatic measurement mode 
was selected. A reflective index of 1.45 and absorption of 0.01 was used. The dispersant 
was set equal to water. An in-house developed MATLAB script (version R2017b, 
MathWorks, Natick, MA, USA) was used to extract the average electrophoretic mobility 
and calculate the average zeta potential. The average zeta potential was calculated with the 
corresponding sample solution viscosity61, a dielectric constant of 78.54 and 
Smoluchowski’s approximation of 1.5198. Due to the varying conductivity of the samples, 
only the average electrophoretic mobility was extracted. An electrophoretic mobility 
distribution can only be obtained in the automated mode when the sample solution 
conductivity is below 5 mS/cm, which was not the case for all samples.  
 
5.2.7 Static light scattering (SLS) and intrinsic fluorescence (IF) 
SLS and IF were used to determine the aggregation onset temperature (TAgg) and melting 
temperature (TM), respectively, using an Optim2 (Avacta Analytics, Yorkshire, UK). A 
temperature range from 20 °C to 90 °C with a 1 °C per minute step gradient and a 
temperature hold time of 60 seconds was set. The UV 266 nm and blue 473 nm laser 
attenuation was set to filter 4 and filter 1, respectively. The samples were loaded into a 
micro-cuvette array (MCA) in three-fold, with a sample volume of 9 μL. Each MCA also 
contained a 2 g/L lysozyme solution (dissolved in water) as a reference sample to monitor 
the measurement quality. The peak position of the barycentric mean of fluorescence as a 
function of temperature was extracted from the IF measurement. The maximum gradient 
of the slope, which defines TM, was found using an in-house developed MATLAB script 
(version R2017b, MathWorks, Natick, MA, USA). Light scattering counts at 473 nm as a 
function of temperature were obtained from SLS measurements. An in-house MATLAB 
script (version R2017b, MathWorks, Natick, MA, USA) was used to determine the start of 
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the intensity gradient, which defines TAgg. The start of the intensity gradient was defined 
based on a linear fit of at least three data points for which intensity increased consecutively 
between the minimum and maximum intensity and for which the first data point showed a 
minimum of 10% intensity increase from the starting intensity. The identified data points 
were fitted to a linear equation to extract the x-intercept (TAgg) at the starting intensity.  
 
5.2.8 Fourier transform infrared (FTIR) spectroscopy 
FTIR spectroscopy was used to determine changes in protein secondary structure. A 
Nicolet iS5 with an iD7 ATR detector (Thermo Fischer Scientific, Waltham, MA, USA) 
was used. Sample and blank absorbance were scanned 150 times with a spectral resolution 
of 2 cm-1 from wavenumber 3500 to 1000 cm-1. Each blank was measured once and each 
protein sample was measured twice, using a volume of 5 μL. A background spectrum was 
recorded with 254 scans. An in-house developed MATLAB script (version R2017b, 
MathWorks, Natick, MA, USA) was used for data evaluation. The average protein sample 
single beam spectrum was calculated using the duplicate single beam spectral data. The 
transmittance spectrum of the average protein sample and blank sample were obtained via 
normalization using the background single beam spectrum. The transmittance spectrum 
was converted to an absorbance spectrum and the blank spectrum was subtracted from the 
corresponding protein sample spectrum. The subtracted spectrum was vector normalized 
(i.e., standard normal variate normalization)199, the second derivative was calculated and 
smoothed with Savitsky-Golay smoothing using a 3rd order polynomial and a window 
length of 33. Within the amide I range (1600 to 1700 cm-1) the absolute area under 1648 ± 
2 cm-1, 1656 ± 2 cm-1, and 1667 ± 1 cm-1 was extracted using the trapz function available 
in MATLAB version 2017b. These areas were selected based on a data-dependent 
wavenumber absorption variation analysis.  
 
5.2.9 Empirical phase diagram construction 
Each experimental protein property was normalized between zero and one. Before 
visualization, internal correlation between all experimental protein properties was 
evaluated using the Pearson correlation coefficient with a cut-off value of 0.750 and -0.750 
for positive and negative internal correlation respectively. The selected experimental 
protein properties were used to build an EPD. The EPD construction method used is 
described in literature78,91. In brief, singular value decomposition (SVD) was used to reduce 
dataset dimensionality to three dimensions. The three-dimensional (3D) data was clustered 
to identify formulation conditions that display similar experimental protein properties. The 
optimal number of clusters was determined by iterating 100 times over the evalcluster 
function available in MATLAB version R2017b (MathWorks, Natick, MA, USA). For 
each iteration, an optimal cluster number between 5 and 10 was selected using the k-means 
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cluster algorithm with a silhouette criterion based on squared Euclidean distance metric. 
The final cluster number was selected as the mode optimal cluster number. The 3D SVD 
data was clustered with the k-means clustering function (kmeans, available in MATLAB 
version 2017b), using the optimal cluster number, a maximum of 1000 iterations, and 
randomly chosen initial cluster centroid positions. A RGB color for each data point was 
calculated by normalization of (x,y,z)-values between zero and one. The average cluster 
RGB color value was defined as the mean RBG color based on each data point within the 
cluster. With R (version 1.0.136, using ggplot2 and fmsb library) the 3D color data was 
visualized. The mean cluster color was plotted against all solution conditions (pH, salt, 
ionic strength and protein concentration). A radar plot was constructed for each cluster to 
represent the median value of empirical protein properties, as well as the median absolute 
deviation to represent distribution of empirical protein properties within the cluster. 
 
5.3 Results and Discussion 
5.3.1 Data processing 
Extraction of multiple empirical protein properties may lead to internal correlation between 
features due to overrepresentation of a single system property within the dataset. To 
prevent this, internal correlation between all empirical protein properties was evaluated 
with the Pearson correlation coefficient. The obtained correlation coefficient matrix is 
shown in Supplementary Table C1. The set threshold of a Pearson correlation coefficient 
of 0.750 and -0.750 for positive and negative linear dependency, respectively, was not 
reached. Data dimension reduction and clustering was therefore preformed with all 
features: 3 FTIR region areas (1648 ± 2.0 cm-1; random coil, 1656 ± 2.0 cm-1; α-helix, 1667 
± 1.0 cm-1; β-turn), apparent hydrodynamic radius of lysozyme (RH App), melting 
temperature (TM), aggregation onset temperature (TAgg), normalized surface tension (γN), 
and mean zeta potential (ζ-potential). An overview of the used empirical protein properties, 
corresponding short descriptions, and value range within the dataset are shown in Table 
5.1. Before these empirical protein properties could be used to cluster formulation 
conditions, dataset dimensionality was reduced with SVD. After data dimension reduction 
an energy value of 96.8% was obtained. This implies an information loss of 3.2%. This 
percentage of information loss falls within the general rule of thumb for SVD, where a 10% 
loss is considered the maximum147. A number of six formulation clusters was determined 
to be optimal with the obtained 3D data set.  
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Table 5.1: List of symbols and description of empirical protein properties used to compile the empirical 
protein property diagram, including the absolute value range. 
Symbol Min Max Description 
R
H App
 1.0 3.2 Apparent hydrodynamic radius of lysozyme [nm] 
ζ -14.1 9.5 Zeta potential charge [mV] 
γN 0.99 1.21 Normalized surface tension of the protein solution [-] 
T
Agg
 20 90 Aggregation onset temperature [°C] 
T
M
 61 82 Melting temperature [°C] 
β-turn 1.9 24.3 Area under 1666 – 1668 cm
-1
 [AU/(cm
-1
)
2
] ·10
5
 
α-helix 34.5 134.5 Area under 1654 – 1658 cm
-1
 [AU/(cm
-1
)
2
] ·10
5
 
Coil 9.9 66.3 Area under 1646 – 1650 cm
-1
 [AU/(cm
-1
)
2
] ·10
5
 
 
5.3.2 Empirical protein property diagram (EPPD) 
Figure 5.1a shows the EPPD and six radar charts based on empirical protein property data. 
Each radar chart represents a cluster of formulations that resulted in similar empirical 
protein properties. The median value of each empirical protein property for each 
formulation cluster is represented by the radar chart using a colored surface. Value 
distribution within each formulation cluster is represented by the median absolute deviation 
(MAD), shown as a dashed line in the radar chart. Exact median and MAD values of each 
identified cluster can be found in Supplementary Table C2. Cluster colors and characters 
were used to visualize formulations in the EPPD below the radar charts. Grid columns refer 
to formulation pH value (pH 3.0-9.0), where the top grid row refers to formulations with 
ammonium sulfate (NH4(SO4)2) and the bottom grid row refers to formulations with 
sodium chloride (NaCl). Individual diagrams show lysozyme concentration (25-125 g/L) 
on the y-axis and ionic strength (0-275 mM) of the respective salt type on the x-axis. Figure 
5.1b shows previously published data that was used to construct a multidimensional protein 
phase diagram (MPPD)180. The MPPD is based on experimental long-term stability data 
obtained for similar formulations stored in duplicate at 20 °C for 40 days. Image-based 
data obtained during storage, describing aggregate dimensions and time-dependent 
aggregation features, was extracted and visualized with the EPD method. Table 5.2 lists 
the extracted image-based features, corresponding short descriptions, and the obtained 
value range.  
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Table 5.2: List of symbols and description of image features obtained from long-term microbatch 
experiments used to compile the multidimensional protein phase diagram, including the absolute value 
range. Data obtained from180. 
Symbol Min Max Description 
L
C
 0 192 Absolute crystal size. Defined as average length of four crystals [μm] 
Ɖ
L:W
 0 3.1 Diversity in crystal shape. Defined as inter quartile range of four crystal 
axial ratios [-] 
Δt
P
 0 520 Growth time precipitate [h] 
t
P
 0 324 Onset time precipitate [h] 
D
P
 0 920 Absolute precipitation size. Defined as diameter of precipitate [μm] 
Δt
C
 0 959 Growth duration [h] 
t
C
 0 696 Onset time crystal [h] 
n
C
 0 100 Number of crystals. Scored between 0 and 100, where 100 is a well filled 
with crystals 
 
The observed phase behavior morphology based on extracted image-based features is 
stated above the radar charts. Results of Figure 5.1b will only be briefly discussed in this 
study as the data was solely used to investigate the correlation between empirical protein 
properties obtained directly after formulation preparation and observed physical stability 
of identical formulations after 40 days of storage at 20 °C. In short, Figure 5.1b shows 
physically stable formulations as part of cluster I and instable formulations were identified 
as cluster II, III, IV, and V. Increasing supersaturation was assigned from cluster II to 
cluster V based on the crystal size, crystal amount, and crystal growth time. Formulations 
with sodium chloride showed salting-out behavior for all pH values, while formulations 
with ammonium sulfate showed salting-in behavior for pH 7.0 and pH 9.0.  
 
Correlating short-term empirical protein properties to long-term physical stability via EPDs 
starts with the comparison of identified formulation clusters. A uniform identification of 
stable formulations (cluster I) during 40 days storage at 20 °C for all pH 3.0 and pH 5.0 
ammonium sulfate formulations is shown in Figure 5.1b, the MPPD. Figure 5.1a, the 
EPPD, shows four clusters for similar formulations based on empirical protein properties, 
namely cluster A, B, C, and D. Identification of multiple EPPD clusters for stable 
formulations is due to a higher resolution and diversity of the obtained empirical data. The 
difference between EPPD clusters A, B, C, and D is mainly defined by RH App, but also by 
secondary structure (α-helix region area and random coil region area), TAgg, γN, and ζ-
potential. The identification of four different formulation clusters that correspond to 
physical stability over time emphasizes the multidimensionality of protein phase behavior. 
Formulations with sodium chloride were also grouped in multiple EPPD clusters at pH 3.0 
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and pH 5.0, while the MPPD shows crystal formation (cluster IV) in addition to stable 
formulations (cluster I). At pH 3.0, the crystallized formulation with 275 mM sodium 
chloride and 125 g/L lysozyme was identified as EPPD cluster E. This corresponds to the 
identification of cluster E for other crystallized formulations. However, formulations with 
sodium chloride at pH 5.0 that crystallized at 125 g/L and 100 g/L lysozyme with 275 mM 
sodium chloride were identified as EPPD cluster A and cluster B. This is not in agreement 
with other formulations, where cluster A and cluster B formulations remained stable over 
time. These observations indicate there is at least a certain degree of positive correlation 
between the EPPD and MPPD for this dataset. This is also demonstrated by EPPD cluster 
C and cluster D formulations. Cluster C and cluster D were identified at pH 5.0 and pH 7.0 
for both salt types. All ammonium sulfate and sodium chloride formulation at pH 5.0 
identified as cluster C or cluster D remained stable during 40 days of storage at 20 °C, 
while at pH 7.0 both salt types showed physical instability for cluster C and cluster D 
formulations. Similar discrepancies are seen for EPPD cluster E and cluster F. 
Formulations at pH 9.0 for both salt types show a correlation between increasing 
supersaturation (MPPD transformation from cluster IV to V) and EPPD cluster E and 
cluster F. A comparable trend is seen for formulations at pH 7.0 with sodium chloride but 
not for formulations at pH 7.0 with ammonium sulfate. At pH 7.0 with ammonium sulfate, 
cluster E and cluster F were identified as stable formulations.  
 
Initial MPPD and EPPD evaluation showed a partial correlation between observed phase 
behavior after 40 days of storage at 20 °C and the empirical protein properties measured 
directly after formulation preparation. To discuss this correlation as a function of 
formulation conditions, a stability percentage for each EPPD cluster was calculated. The 
stability percentage in this context is defined as the percentage of stable formulations after 
storage within each EPPD cluster. A decrease in stability percentage is seen from cluster 
A (95.3%) and cluster B (96.4%) to cluster F (8.0%). Cluster C, D and E have a stability 
percentage of 74.3%, 62.5% and 18.7%, respectively. Small increments of ionic strength 
showed EPPD cluster transformations for both salt types. For example, a cluster transition 
from cluster A to cluster B can be seen for formulations at pH 3.0 for increasing sodium 
chloride. The stability percentage for these clusters is similar, but the ionic strength 
increase from 50 mM to 175 mM by sodium chloride causes a lower colloidal stability 
(TAgg), a decrease in ζ-potential, and a larger RH App. Salt type dependent cluster 
transformations were also observed. For example, the previously mentioned transformation 
of cluster A to cluster B by sodium chloride at pH 3.0 is also seen for ammonium sulfate 
formulations at pH 3.0, but was already present between 25 mM and 50 mM ionic strength. 
This indicates that ionic strength increases at pH 3.0 by sodium chloride has a similar effect 
on lysozyme as ionic strength increase by ammonium sulfate, but the evaluated protein 
properties were more sensitive to the latter.  
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Figure 5.1: (a) Empirical protein property diagram (EPPD) and (b) multidimensional protein phase diagram 
(MPPD) for varying lysozyme concentrations (y-axis), ionic strength (x-axis), formulation pH value (grid column), 
and salt type (grid row). The MPPD is adjusted from data presented in180. Clusters are indicated with a cluster 
color and character within each diagram. Dashed lines are used to guide the eye between adjacent clusters within 
the diagrams. A legend radar chart is given to indicate the position of the properties compiled in the EPPD and 
MPPD radar charts. The colored surface of the radar charts shows the normalized median value for each property 
within the cluster and the dotted line indicates the median absolute deviation for each property. 
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Cluster transformations for increasing lysozyme concentration were identified as well. 
Formulations at pH 7.0 in the presence of 275 mM ammonium sulfate showed such a 
transformation, where cluster E transforms in cluster F for increasing lysozyme 
concentration. This illustrates how a higher protein concentration can influence properties 
such as secondary structure. Cluster transformations are visible for each separate grid 
diagram but formulation pH dominates cluster transformations. This is indicated by the 
identification of similar EPPD clusters for each salt type for each formulation pH value, 
which is a result of the relatively large pH range used in this study.  
 
Growing supersaturation zones were identified for increasing formulation pH value, as 
shown in the MPPD by increased identification of cluster V. Supersaturation increase was 
attributed to the loss of positive charge, as the formulation pH moves towards lysozyme’s 
isoelectric point (pI) of ~11.3148. Formulation pH affects amino acids residue protonation 
and can thereby diminishing the repulsive electrostatic forces closer to the protein’s pI 26,34. 
This is in accordance with the decreasing stability percentage seen in the EPPD clusters, 
shown by the transformation from cluster A to cluster F. This trend was independent of the 
salt type. Lysozyme’s RH App also showed a trend from formulation cluster A to cluster F, 
as seen for stability percentage, where it increased from 1.4 ± 0.2 nm (cluster A) to 2.6 ± 
0.3 nm (cluster F). Note that the mentioned empirical protein property values are median 
± MAD, which represents the central tendency and distribution within each formulation 
cluster. Lysozyme’s RH App dependence on changing formulation pH is in agreement with 
literature, where a RH App increase above pH 6.0 was measured using dielectric 
spectroscopy200,201. It was stated that lysozyme’s RH App increased from approximately 1.8 
nm at pH 4 to approximately 2.6 nm at pH 10, which was interpreted as an index of 
aggregation due to loss of positive charge along lysozyme’s surface as the formulation pH 
shifts towards its pI200. Loss of electrostatic repulsive forces may be identified upon further 
inspection of RH App as a function of lysozyme concentration using the data from individual 
formulations202. In Supplementary Figure C2, four examples are shown where a shift from 
repulsive to attractive protein-protein interactions as a function of pH and ionic strength 
can be observed. This indicates that an increasing RH App resulted from diminishing 
electrostatic repulsive forces which allows for attractive protein-protein interactions. This 
is also reflected by a decrease in colloidal stability, represented by TAgg, from cluster A 
(88.5 ± 0.9 °C) to cluster F (35.2 ± 4.6 °C). Nevertheless, a similar stability percentage was 
found for cluster A and cluster B formulations. This shows that the corresponding 
formulations remained physically stable during the long-term experiment despite short-
term observed changes in RH App (from 1.4 ± 0.2 nm to 1.8 ± 0.3 nm, respectively) and TAgg 
(from 88.5 ± 0.9 °C to 56.7 ± 5.9 °C, respectively). A further increase of RH App (2.2 ± 0.2 
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nm) and corresponding decrease in TAgg (37.4 ± 3.2 °C) for cluster C formulations resulted 
in decreased stability percentage (74.3%). This indicates a threshold for the short-term 
parameters which results in critically low colloidal stability causing an increased 
aggregation propensity. 
 
The loss of electrostatic repulsion is also partially confirmed by the measured surface 
charge. In the EPPD, lysozyme surface charge is represented by the ζ-potential. The median 
ζ-potential decreased from cluster A (3.8 ± 2.1 mV) to cluster E (-1.5 ± 1.8 mV), but cluster 
F formulations showed a ζ-potential of 3.1 ± 1.9 mV while displaying the largest RH App 
(2.6   0.3 nm). Lysozyme’s secondary structure can be used to obtain a more detailed 
understanding of RH App and ζ-potential. FTIR peak regions were used in this study to 
represent secondary structural changes. The FTIR peak regions have been empirically 
assigned to secondary motifs, where a decrease in FTIR spectral region area indicates a 
loss of the corresponding secondary structure 64,203. The EPPD shows similar median values 
for FTIR region areas in formulation cluster A, B, and C. This suggests that there was no 
secondary structural change due to corresponding changes in formulation conditions. 
Cluster D formulations showed secondary structure changes and a further decrease in 
stability percentage (62.5%). Secondary structure changes were quantified by a maximum 
median random coil region of 34 ± 8.0 AU/(cm-1)2 and a maximum median α-helix region 
area of 97.3 ± 13.6 AU/(cm-1)2. These structural properties were accompanied by the 
dataset maximum γN, with a median value of 1.17 ± 0.02, a RH App of 2.1 ± 0.3 nm, and a 
ζ-potential of 0.2   1.7 mV. A γN of 1.17 reflects a 17% increase of surface tension after 
adding lysozyme to the formulation in question. Presumably, surface tension increased as 
a result of water molecules entering the altered lysozyme structure 204,205. Cluster D 
formulations also resulted in a low colloidal stability, represented by a median TAgg of 39.0 
± 3.5 °C, but a conformational stability (TM of 68.9 ± 3.5 C) comparable to cluster A, B, 
and C. The obtained median TM for cluster A, B, C, and D formulations (~67 °C) is 
relatively lower compared to reported literature values (approximately between 68 – 82 °C 
) 206–208. This may be due to the use of a multicomponent buffer system 208. In addition, it 
should be noted that for cluster C to cluster F the obtained TAgg lies ~30 °C below TM. This 
may indicate that thermal aggregation mainly consists of native lysozyme structures, or 
that aggregation already starts when only small amount of unfolded structures was present 
209.  
 
In contrast to cluster D, cluster E formulations resulted in a dataset minimum for the median 
random coil region area (16.4 ± 3.0 AU/(cm-1)2) and median α-helix area (73.1 ± 12.8 
AU/(cm-1)2). Secondary structure loss presumably contributed to the relatively low median 
TAgg (33.1 ± 1.9 °C) obtained for cluster E formulations. Next to low colloidal stability, 
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secondary structure changes may also be the reason for the observed γN decrease (median 
value of 1.04 ± 0.03). A decrease in surface tension due to protein unfolding was previously 
observed for whey protein isolate dispersions. The observed decrease in surface tension 
was attributed to an increase in structure flexibility that led to an increased air-water 
interface adsorption210. This suggests that the observed γN decrease may represent (partial) 
structural unfolding under cluster E formulation conditions. Cluster F formulations resulted 
in a dataset maximum for the median β-turn region area (18.9 ± 1.1 AU/(cm-1)2), while all 
other clusters show a comparable median β-turn region area (~16 AU/(cm-1)2). The median 
random coil FTIR peak region obtained in cluster F formulations was comparable to cluster 
E, while the median α-helix FTIR peak region was comparable to cluster A, B, and C. 
Compared to cluster E, cluster F displayed a similar γN (1.04 ± 0.02), TM (63.2 ± 2.6 °C), 
and TAgg (35.2 ± 4.6 °C). Considering the combination of secondary structure changes and 
corresponding effects on γN, colloidal stability, and conformation stability, it is assumed 
that lysozyme aggregated directly after formulation preparation under the corresponding 
conditions.   
 
The evaluated formulation conditions resulted in different protein structural conformations. 
Formulations part of cluster A, B, and C did not show secondary structural change, based 
on the similarities in FTIR peak region areas. A stability percentage decrease was observed 
from cluster A to cluster C, which was presumably a result of decreased repulsive 
electrostatic forces causing increased protein-protein interaction. Cluster D formulations 
resulted in a secondary structure change which showed similar conformational stability as 
the structures found for cluster A, B, and C. On the contrary, cluster E and F resulted in 
(partially) unfolded structures, which was reflected by secondary structure changes and 
surface tension decrease. Structural unfolding is regarded as the main reason for the 
stability percentage drop of cluster E and cluster F (<19%) compared to the other EPPD 
clusters (>62%). Coupling back to the correlation between the EPPD and the MPPD, 
supersaturation was identified in the MPPD by a large amount of fast growing, small 
crystals after 40 days of storage. Crystal growth cessation is proposed to be an effect of 
improper implementation of lysozyme molecules or surface poisoning155. With EPPD data 
showing lysozyme’s unfolding for supersaturated formulations, surface poisoning by 
incorporation of unfolded molecules is considered the reason for crystal growth cessation.  
 
In general, it is expected that near the protein’s pI solubility increases for low ionic strength 
and decreases for higher ionic strength 211. However, sodium chloride formulations show 
solely increasing physical instability for increasing ionic strength and increasing 
formulation pH. This phase behavior has been reported by other studies as well150,152,212. 
The lack of salting-in behavior for lysozyme formulations with sodium chloride was 
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attributed to screening of electrostatic repulsive forces150. The EPPD depicts that sodium 
chloride formulations at pH 9.0 showed no influence of ionic strength, represented by the 
uniform identification of cluster E and cluster F for different ionic strengths. This 
observation is also in accordance with work by Retailleau et al., where it was hypothesized 
that chloride ion adsorption caused a pI shift to approximately pH 9.5150. A recent 
molecular dynamics (MD) simulation study attributed an apparent unfolded state to 
dominant interactions with the sodium ion compared to interactions with the chloride 
ion213. Despite the lack of direct evidence of specific protein-ion interactions in the EPPD, 
observations obtained from the reported MD simulations correspond to changes in the 
secondary structure for increasing sodium chloride ionic strength seen in the EPPD.  
 
Interactions at the basis of salting-in behavior, as observed for ammonium sulfate 
formulations, remains speculative as well. Salting-in effects primarily occur because of 
interactions between the protein and salt ions153. Ammonium sulfate formulations show 
lysozyme unfolding for pH 7.0 at higher ionic strength which resulted in physical stability 
over time, while formulations at lower ionic strength containing more stable structures 
showed crystallization. Salting-in behavior observed for ammonium sulfate formulations 
at pH 7.0 corresponds to work regarding the effect of anions on salting-in and salting-out 
behavior, where an inverse Hofmeister series was identified for positively charged 
lysozyme under relatively low ionic strength (<300 mM) conditions42. The underlying 
anion interactions are dependent on the positive protein charge, and therefore it can be 
assumed that salting-in becomes less pronounced towards lysozyme’s pI. This may cause 
the observed decrease in physical stability for ammonium sulfate formulations for 
increasing pH value, as seen when moving from pH 5.0 to pH 7.0 and from pH 7.0 to pH 
9.0 for similar ionic strength. For ammonium sulfate formulations at pH 9.0, structural 
unfolding is seen for all formulations but it is more pronounced for lower ionic strength. 
Decreased supersaturation at pH 9.0 formulations for increasing ionic strength by 
ammonium sulfate may be due to ammonium ions adsorption to hydrophobic amino acid 
side-chains. This was demonstrated to cause aggregation deceleration in a thermal 
unfolding study of lysozyme 192.  
 
The use of the empirical phase diagram method as visualization technique resulted in a 
comprehensive overview of multidimensional data, which allowed for an uncomplicated 
investigation of the correlation between long-term phase behavior and short-term empirical 
protein properties. The transition from long-term stable formulations to long-term instable 
formulations was partially represented, but short-term empirical protein properties were 
unable to fully capture the observed phase behavior. Inclusion of additional empirical 
properties could lead to a closer match between EPPD formulation clusters and MPPD 
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phase behavior clusters. Possible additional empirical properties to extend the 
multidimensional dataset could include quantification of protein-protein interaction 
strength (e.g., rheological data122,187,214), identification of multimeric protein species, or 
quantification of protein-salt ion interactions. Based on the presented dataset it is evident 
that there is not a single straightforward combination of analytical techniques to evaluate 
long-term physical stability using short-term analytics. The required combination of 
analytical techniques cannot be determined beforehand without prior knowledge of the 
aggregation pathway. An advantage of the data evaluation workflow presented in this study 
is its applicability for other proteins, different formulation conditions, and various 
analytical techniques. Further investigation of different experimental designs in 
combination with the presented data evaluation workflow can expand understanding of 
underlying cause and consequence regarding long-term protein phase behavior, which is 
required to move towards knowledge-based formulation screenings and phase behavior 
prediction. 
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5.4 Conclusion 
This study employed the EPD method to correlate long-term physical stability of 150 
unique lysozyme formulations to empirical protein properties that can be determined right 
after formulation preparation. This was done to overcome commonly seen protein phase 
behavior evaluation limitations involving dataset completeness and size, sample 
adjustment prior to analysis, and subsequent data visualization and interpretation. For this 
purpose, six different analytical techniques were used to determine the effects of 150 
unique formulation conditions on the lysozyme’s colloidal and conformational stability, 
secondary structure, as well as surface charge and hydrophobicity. The EPD method 
allowed for the representation of both the long-term and the short-term dataset in a single 
figure. This resulted in a systematic and comprehensive visualization and interpretation of 
MPPD data in relation to EPPD data for all 150 unique formulations. A correlation between 
short-term and long-term data was found based on increased formulation cluster 
supersaturation and decreased formulation cluster stability percentage. The decrease of 
long-term storage stability was found mainly a result of loss of repulsive electrostatic 
interaction and loss of secondary structure. It was shown that changing formulation 
conditions leaves a different fingerprint in terms of structural properties, colloidal stability, 
conformation stability, and surface properties. Both physically stable and instable EPPD 
clusters showed varying protein property sets, which emphasizes the multidimensionality 
of protein properties determining protein phase behavior. Biopharmaceutical formulation 
screening studies can benefit from the presented multidimensional data evaluation 
workflow as it allows for a comprehensive overview and uncomplicated interpretation of 
large datasets. There are no limitations regarding screening targets, analytical techniques, 
or conditions that can be evaluated with this method. For protein phase behavior studies, 
trends observed throughout multidimensional datasets can provide detailed insight, but it 
can also provide targets for phase behavior optimization through combined information on 
aggregation kinetics and empirical protein properties. Detailed insight and optimization 
targets can guide knowledge-based formulation screening design and aid short-term 
predictive parameters development for long-term protein phase behavior. 
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Abstract 
Redesigning existing food protein formulations is necessary in situations where food 
authorities propose dose adjustments or removal of currently employed additives. 
Redesigning formulations involves evaluating substitute additives to obtain similar long-
term physical stability as the original formulation. Such formulation screening experiments 
benefit from comprehensive data visualization, understanding the effects of substitute 
additives on long-term physical stability, and identification of short-term optimization 
targets. This work employs empirical phase diagrams to reach these benefits by combining 
multidimensional long-term protein physical stability data with short-term empirical 
protein properties. A case study was performed where multidimensional protein phase 
diagrams (1152 formulations) allowed for identification of stabilizing effects as a result of 
pH, methionine, sugars, salt, and minimized glycerol content. Corresponding empirical 
protein property diagrams (144 formulations) resulted in the identification of normalized 
surface tension as a short-term empirical protein property to reach long-term physical 
stability presumably similar to the original product, namely via preferential hydration. 
Additionally, changes in pH and salt were identified as environmental optimization targets 
to reach stability via repulsive electrostatic forces. This case study shows the applicability 
of the empirical phase diagram method to rationally perform formulation redesign 
screenings, while simultaneously expanding knowledge on protein long-term physical 
stability. 
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6.1 Introduction 
Food additives are used to enhance and ensure product quality aspects such as sensory, 
microbial, enzymatic, and long-term physical stability215,216. The safety of food additives 
for these purposes is assessed by the European Food Safety Authority (EFSA). Re-
evaluations occur when changes, such as new scientific findings, come to light217. In the 
period from 2013 to 2018, over 130 reports were produced by the EFSA concerning re-
evaluation of food additives218. Re-evaluation mainly results in confirmation of the existing 
regulations219–221 or dose adjustments222–224. If re-evaluation results in a regulatory change 
such as a dose adjustment, it may be necessary to (partially) remove the food additive in 
question from the current formulation. When an existing product formulation needs to be 
redesigned, the new formulation should meet product quality aspects similar to the original 
formulation. An example of a recent dose adjustment is glycerol223. The re-evaluation 
report states that side effects, such as headaches and nausea, can be induced from a dose of 
125 mg/kg body weight per hour. It was noted that this dose is easily reached in infants 
and toddlers upon consumption of a 330 mL flavored drink. Glycerol is a food additive 
whose properties include, but are not limited to, enhancing microbial and long-term 
physical stability225–227. Complete, or even partial removal of glycerol from an existing 
product formulation requires the addition of one or more substitute additives to obtain a 
similar microbial and long-term physical stability compared to the original formulation.  
 
This case study investigates glycerol-poor (75 g/L instead of 1050 g/L) and glycerol-free 
protein formulations with respect to long-term physical protein stability. In this case study, 
long-term physical instability is defined by the formation of visible, insoluble aggregates, 
such as crystals or amorphous precipitates. Protein-protein, protein-solvent, and protein-
additive interactions determine long-term physical stability228–230. These interactions are 
governed by protein properties such as protein structure, surface charge, conformational 
stability, and colloidal stability21,191,231. In turn, these protein properties are influenced by 
formulation additives, environmental conditions, and the protein itself104,229,232. Glycerol, 
like other polyols, is known to enhance a protein’s conformational stability via preferential 
hydration189,227,233. Preferential hydration is used to describe the depletion of additives, 
such as glycerol, from the protein surface. The exclusion of glycerol is thermodynamically 
unfavorable, as it increases the protein’s chemical potential. This leads to a protein surface 
area minimization in order to reduce unfavorable interactions between the protein and the 
solvent. Thus, the native folded protein state is thermodynamically favorable over unfolded 
state, which results in a higher conformational stability227. In addition to preferential 
hydration, it has been demonstrated that in some cases glycerol can decrease attractive 
interactions between protein molecules via preferential interaction with hydrophobic 
patches on the protein surface234,235. Preferential hydration of protein molecules can also 
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be caused by sugars48. It has been shown that a variety of sugars can increase protein 
conformational stability236–238. Sugar effects are dependent on the sugar type (e.g., 
monosaccharide or disaccharide)48,236 and sugar concentration236,238. For these reasons, two 
monosaccharides (fructose, glucose) and two disaccharides (lactose and sucrose) were 
considered in this case study as glycerol substitutes at three different concentrations (30, 
60, and 80 g/L).  
 
Long-term physical stability can decrease via protein oxidation239,240. Non-site-specific 
oxidation, such as oxidation by the presence of oxidants, is dependent on the exposure of 
amino acids to the environment. Oxidation can be limited or prevented by addition of an 
antioxidant240. For example, free methionine molecules can act as sacrificial agent that will 
be oxidized instead of the product241,242. In the presented case study, approximately 15% 
of the total solvent accessible amino acids residues of the investigated protein are made up 
from amino acids prone to oxidation, namely cysteine, methionine, tryptophan, histidine, 
and tyrosine240. To investigate the effectiveness of methionine to improve long-term 
physical stability in glycerol-poor and glycerol-free formulations, methionine was tested 
at two different concentrations (1.45 g/L and 9.50 g/L) in this case study. The methionine 
concentration of 1.45 g/L was used as it is comparable to the concentration of the original 
formulation. To determine the potential beneficial effect of an increased methionine 
concentration, a formulation with 9.50 g/L methionine was evaluated.  
 
Other environmental conditions, such as formulation pH and salt, can affect physical 
stability as well34,229. Formulation pH determines protein charge, which plays an important 
role in physical stability as it influences both conformational stability and colloidal 
stability21,191. For this case study it was chosen to stay above the protein isoelectric point 
(pI) and relatively close to the pH of the original formulation. In total three pH values (pH 
5.0, 5.5, and 6.0) were included in the formulation search space. Salts can influence long-
term physical stability via various mechanisms such as preferential exclusion, preferential 
interaction with the protein surface, and screening of repulsive electrostatic forces239. The 
mechanism at action depends on the formulation conditions, salt type, and salt 
concentration211,243,244. Therefore, this case study included two salts (sodium chloride and 
potassium chloride) at four different concentration ratios (100:0, 60:37, 40:55, 0:90 g/L, 
sodium chloride to potassium chloride, respectively).  
 
As mentioned before, glycerol is also used to increase microbial stability. Sodium lactate 
can be used as a substitute for glycerol to enhance the microbial stability aspect245. Even 
though sodium lactate is typically used to ensure microbial stability, but not protein 
stability, it was still added to the formulation search space in this case study. This was done 
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because a substitute additive that enhances one aspect of formulation stability, such as 
microbial stability, may adversely influence another, such as protein stability246,247.  
 
The number of considered substitutes for glycerol-poor and glycerol-free formulations 
illustrates the multidimensionality and magnitude of such screening experiments. This 
results in a considerable experimental workload and a large amount of data which 
complicates data evaluation. To reduce the experimental workload, a high-throughput 
storage setup was employed to monitor long-term physical stability via automated imaging, 
where formulations were stored for 30 days at 20 °C115. This experimental setup results in 
a multidimensional output by combining final physical stability data after storage and 
aggregation kinetics during storage 180. Formulation conditions that lead to long-term 
physical instability can be found with the final physical stability data, while the aggregation 
kinetics allows for the identification of potential formulation optimization targets by 
quantifying the degree of instability as a function of the applied conditions. Processing and 
evaluation of such multidimensional data was facilitated by employing the empirical phase 
diagram (EPD) method78,89 to construct a multidimensional protein phase diagram (MPPD) 
180.  
 
Faster, smaller, and efficient screening methods can reduce experimental workload, but the 
necessary storage time remains equally long. The desire for accelerated screenings resulted 
in the search for long-term physical stability predictors from short-term empirical protein 
properties82,121,193,195. Screenings for new formulations can also benefit from short-term 
predictors as these can minimize time and efforts to reach original formulation quality, as 
well as provide insight on the responsible interactions. Therefore, short-term empirical 
properties (apparent hydrodynamic radius of the protein, mean apparent hydrodynamic 
radius of high weight species, protein surface hydrophobicity, conformational stability, and 
colloidal stability) were experimentally determined directly after formulation preparation 
to investigate the correlation between the original formulation and new formulations, as 
well as the corresponding long-term physical stability. The obtained multi-source empirical 
protein property dataset encounters issues concerning data evaluation as well. These issues 
were resolved with a systematic and data-dependent workflow, which also employs the 
EPD method for visualization. This approach combines all multi-source data into one 
single empirical protein property diagram (EPPD)248.  
 
This case study presents an MPPD screening dataset including 1152 formulations to 
investigate the influence of 4 sugars at 3 different concentrations, 3 pH values, 2 salts at 4 
different ratios, 2 methionine concentrations, and sodium lactate, on long-term protein 
stability in glycerol-poor and glycerol-free formulations. A corresponding EPPD was 
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constructed with a subset of 144 formulations. This subset of formulations was selected 
based on physical stability transitions in the MPPD. The aim of this case study was to 
identify new formulations which have similar long-term stability compared to the original 
formulation. It was investigated whether short-term empirical properties are similar 
between long-term stable redesigned formulations and the original formulation, as it is 
assumed that similar short-term properties lead to similar long-term behavior. An 
additional aim was to use the MPPD and EPPD approach to identify short-term empirical 
properties that are not similar to the original formulation, but still display similar physical 
stability after long-term storage. This was done to create a better understanding of 
underlying interactions that determine long-term physical stability. Thus, this study 
combined multidimensional long-term physical stability data with multi-source empirical 
protein property data to rationally approach screening for new formulations by means of a 
case study with glycerol-free and glycerol-poor formulations. 
 
6.2 Material and Methods 
6.2.1 Buffer preparation 
Buffer solution with a pH value of 5.0, 5.5, and 6.0 were made with 0.1 mol/L citric acid 
(Merck KGaA, Darmstadt, DE) and 0.1 mol/L sodium acetate (Merck KGaA, Darmstadt, 
DE) solutions. Buffer pH was adjusted with a 0.05 pH unit accuracy using a five-point 
calibrated pH-meter (HI-3220, Hanna Instruments, Woonsocket, RI) equipped with a 
SenTix 62 pH electrode (Xylmen Inc., White Plains, NY, USA) using either 0.1 mol/L 
citric acid or 0.1 mol/L sodium acetate as titrant.  
 
For each pH, 1.45 g/L and 9.50 g/L L-methionine (Alfa Aesar, Haverhill, MA, USA) buffer 
solutions were made. This corresponds to roughly 0.1% (w/w) and 1.0% (w/w) of L-
methionine, where % (w/w) refers to the weight percentage of the respective compound 
per total weight of the formulation. For each pH and methionine concentration, a buffer 
was made with 100 g/L sodium lactate (Sigma-Aldrich, Saint Louis, MO, USA), 
corresponding to roughly 8.50% (w/w).  
 
For each of the 12 obtained buffer solutions (that is 3 pH values, with 1.45 g/L or 9.50 g/L, 
and with or without 100 g/L sodium lactate) four different sugars were added with a 
concentration of 30 g/L, 60 g/L, and 80 g/L (corresponding to roughly 2% (w/w), 4% 
(w/w), and 6% (w/w), respectively). The employed sugars were D-fructose (Merck KGaA, 
Darmstadt, DE), D(+)-glucose monohydrate (Merck KGaA, Darmstadt, DE), sucrose 
(Thermo Fisher Scientific, Waltham, MA, USA) and lactose monohydrate (Merck KGaA, 
Darmstadt, DE). In addition, four different mixtures of sodium chloride (NaCl) (Merck 
KGaA, Darmstadt, DE) and potassium chloride (KCl) (Alfa Aesar, Haverhill, MA, USA) 
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were made. Mixing ratios of NaCl:KCl were as following: (1) 100 g/L:0 g/L, (2) 60 g/L:37 
g/L, (3) 40 g/L:50 g/L, (4) 0 g/L:90 g/L. The ratios correspond to roughly (1) 7.5:0.0, (2) 
5.0:2.5, (3) 2.5:5.0, and (4) 0.0:7.5% (w/w). The maximum salt and sugar concentrations 
were determined based on the solubility limit. The systematic dilution was chosen to 
capture the effect of different salt and sugar concentrations on long-term physical protein 
stability. All the obtained mixtures were also prepared with the additions of 75 g/L glycerol 
(Merck KGaA, Darmstadt, DE), which corresponds to roughly 5% (w/w). Prior to use, all 
buffer solutions were filtered over a 0.2 μm cellulose acetate filter (Sartorius, Göttingen, 
Germany) and the pH value was checked, and adjusted when necessary. 
 
6.2.2 Protein solution preparation 
Freeze-dried protein, an enzyme (30-45 kDa) referred to as protein I, was kindly provided 
by DSM Biotechnology Center (Delft, NL). For protein phase diagram preparation, a 12 
g/L protein I solution was prepared for each pH value, in combination with each L-
methionine concentration and each sodium lactate concentration. For analytical 
measurements a concentration of 3 g/L protein I was prepared in the identical solution as 
mentioned for the protein phase diagram. Lyophilized protein I was dissolved and filtered 
using a 13 mm 0.2 μm Supor® pre-syringe filter (Pall Corporation, New York, NY, USA). 
The resulting concentration of protein I was determined with a Nanodrop 2000c UV-Vis 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).  
 
6.2.3 Long-term storage 
Protein crystallization plates were prepared with a Tecan liquid handling (LiHa) station 
(Tecan, Maennedorf, CH). Sugar and salt stock solutions were prepared in 1.5 mL 
Eppendorf tubes (Eppendorf, Hamburg, DE) and mixed with the LiHa to obtain appropriate 
mixing ratios. Protein stock of 12 g/L was mixed 1:1 with the appropriate buffer, with and 
without 150 g/L glycerol. Salt and sugar solutions were mixed with the diluted protein 
solutions using a 1:1 mixing ratio to obtain 3 g/L protein I in a final volume of 24 μL in a 
96-well crystallization plate (Swissci, Neuheum, CH). The long-term storage experiment 
was carried out according to the method developed in our lab115 with the following 
adaptation: protein solutions were stored in duplicate for 30 days at 20°C in a Rock Imager 
54 (Formulatrix, Bedford, MA, USA). The employed imaging method was similar to 
previous work180. Protein phase behavior was evaluated after storage based on aggregation 
surface coverage in the well, aggregation onset time, and aggregation growth time. In this 
case study, aggregation could be in the form of crystals or precipitates. For crystalline 
aggregation the crystal length and crystal width were extracted. The image-based features 
where processed with MATLAB (version 2017b, Mathworks, Natick, MA, USA) and 
served as data for the multidimensional protein phase diagram construction. All further 
81 
 
operations performed with MATLAB mentioned in this work also used version 2017b and 
in-house developed scripts.  
 
6.2.4 Short-term empirical protein properties 
Five short-term empirical protein properties (apparent hydrodynamic radius of protein I 
and high weight species, aggregation onset temperature, melting temperature, and 
normalized surface tension) were obtained with four different analytical techniques 
(dynamic light scattering, static light scattering, intrinsic fluorescence, stalagmometry). All 
applied operational settings and corresponding data analysis have been described 
elsewhere248, unless stated otherwise. 
 
Dynamic light scattering was used to determine the apparent hydrodynamic radius of 
protein I and high weight species, using a Zetasizer Nano ZSP (Malvern Instruments Ltd, 
Malvern, United Kingdom). The intensity peak between 1 nm and 10 nm was used to 
extract the apparent hydrodynamic radius of protein I. The mean apparent hydrodynamic 
radius of high weight species was based on the mean intensity peaks above 10 nm. Before 
extraction of hydrodynamic radii, all radius distributions were corrected with the 
corresponding bulk viscosity. Buffer viscosity was determined with duplicate samples (200 
μL sample volume) at 25  C using a density sensor (Integrated Sensing Systems, Inc., 
Ypsilanti, MI, USA) and pure water as a reference viscosity value. Viscosity was 
determined for all buffers at pH 6.0 with 1.45 g/L methionine. The viscosity of buffers with 
a methionine concentration of 9.50 g/L was not determined, as it was established that 
buffers containing 9.50 g/L methionine returned similar viscosity values compared to 
buffers containing 1.45 g/L methionine (data not shown). Obtained viscosity values for all 
buffers at pH 6.0 with 1.45 g/L methionine can be found in Supplementary Table D1.  
 
Static light scattering and intrinsic fluorescence were used to determine the aggregation 
onset temperature and melting temperature, using an OPTIM2 (Avacta Analytics, 
Yorkshire, UK). These short-term empirical protein properties were used to represent 
colloidal and conformational stability, respectively. Device settings and data extraction 
protocols were similar to those presented in previous work248.  
 
Normalized surface tension was determined with a fully automated LiHa station-based 
high-throughput stalagmometer74. This short-term empirical protein property was used to 
represent apparent surface hydrophobicity. The experimental procedure was carried out as 
presented in previous work248 but with a sample volume of 120 μL.  
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6.2.5 Data handling 
Data (pre)processing and visualization was performed with MATLAB and R (version 
1.0.136), respectively. The multidimensional protein phase diagram was constructed as 
described in previous work180, selecting the optimal number of clusters between five and 
eight clusters. The empirical protein property diagram was constructed as described in248, 
selecting the optimal cluster number between three and ten clusters. 
 
6.3 Results and Discussion 
6.3.1 Multidimensional protein phase diagram (MPPD) 
Figure 6.1 depicts the extracted image features for all 1152 conditions monitored during 
30 days of storage at 20 °C. The absolute value range for each image feature and 
corresponding description is shown in Figure 6.1a. Data processing resulted in a 3D dataset 
with an energy value of 95.5%. This means there was a 4.5% information loss due to 
singular value decomposition (SVD) dimension reduction. This information loss is 
considered acceptable as it falls within the general rule, where 10% information loss is 
considered the maximum147. Based on this 3D dataset, the optimal number of formulation 
clusters was determined to be eight. For each of the eight clusters, image feature median 
values were calculated and depicted as a colored surface in the corresponding radar charts 
in Figure 6.1b. The median absolute deviation (MAD) of the image features was calculated 
for each cluster as well, shown as a dotted line in the radar charts in Figure 6.1b. A 
representative image for each cluster can be found in Supplementary Figure D1 and an 
overview of median ± MAD image feature values per MPPD cluster can be found in 
Supplementary Table D2. 
 
The MPPD allows for identification of different supersaturation zones based on 
aggregation kinetics and aggregation dimension data, as was shown in a previous study 
using hen egg-white lysozyme180. Cluster 1 represents undersaturated formulations that 
showed long-term physical stability, as all extracted image features (shown in Figure 6.1b) 
are equal to zero when no precipitates or crystals are observed. Cluster 2 and 3 correspond 
to relatively high supersaturation, reflected by precipitate formation. This was identified 
by a crystal size (LC) and crystal width (WC) equal to zero in Figure 6.1b. Both cluster 2 
and 3 represent formulations that precipitated directly after preparation, indicated by an 
onset time (tO) of 0 h. 
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Figure 6.1: (a) Symbols, description, and absolute value range of image features. (b) Cluster radar charts 
with a legend to indicate the position of image features. The normalized median value of each image 
feature is represented with a colored surface. The dotted line represents the median absolute deviation 
within each cluster for each image feature. (c) Multidimensional protein phase diagram (MPPD) for 
changing sodium lactate content (major grid columns), pH values (major grid rows), methionine 
concentrations (minor grid columns), glycerol-poor or glycerol-free conditions (minor grid rows), sodium 
chloride (NaCl) to potassium chloride (KCl) ratios (y-axis), and sugar types and concentration (x-axis). 
The eight identified clusters are visualized in the MPPD using the mean cluster color and cluster number 
similar to the radar charts in (b). MPPD cluster regions are highlighted with a dashed line to guide the eye. 
 
Lower supersaturation was found for cluster 2 compared to cluster 3, based on the amount 
of aggregation (nAGG of 9.3 ± 9.3 % versus 52.5 ± 7.4 %, respectively) and growth time (tG 
of 361 ± 2 h versus 2 ± 1 h, respectively). Note that all mentioned cluster values consist of 
the median ± MAD for representation of the distribution within a formulation cluster. 
Differences in supersaturation can also be identified for crystallized formulations, which 
were found for cluster 4, 5, 6, 7, and 8. A combination of increased nucleation rate (i.e., a 
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larger nAGG), earlier crystal onset time (tO) and decreased growth time (tG) indicates 
increasing supersaturation. These properties were identified for MPPD cluster 8, where 
41.2 ± 7.4 % of the well was covered by relatively small crystals which formed at 0 h and 
grew for 361 ± 10 h. Contrarily, MPPD cluster 4 shows a relatively low nucleation rate 
(0.5 ± 0 %) and little crystal growth (onset at 174 ± 62 h and growth of 198 ± 62 h), which 
indicates low supersaturation. Based on the clusters found in the MPPD, the order of crystal 
clusters regarding level of supersaturation is proposed to be the following: 8>7>6>5>4, 
where cluster 8 represents the highest supersaturation level. Transformations to lower 
supersaturation identify optimization targets to reach physical stability with minor 
formulation adjustments. For example, glycerol-free formulations at pH 5.0 with 9.50 g/L 
methionine and 0 g/L sodium lactate show a transformation to lower supersaturation 
(MPPD cluster 6 to 5 to 4) for increasing KCl concentration. This indicates that similar 
formulations with a higher KCl concentration or lower ionic strength are likely remain 
physically stable over time. Another example of such a cluster transformation is seen for 
increasing formulation pH. Glycerol-free formulations at pH 5.5, with 1.45 g/L methionine 
and 100 g/L sodium lactate, were mostly identified as high supersaturation formulations 
(cluster 8 and 6). Similar formulations at pH 6.0 showed a shift towards MPPD cluster 5 
identification. This indicates that a higher formulation pH is likely to result in long-term 
physical stability, even though long-term physical stability was not observed in the 
evaluated formulation condition range. 
 
6.3.1.1 Stability percentage 
Solutions depicted in Figure 6.1c present 77% physically stable new formulations as a 
result of different formulation conditions. To discuss the effects of each formulation 
variable on long-term physical stability, a percentage was calculated per formulation 
variable representing formulations that remained physically stable during long-term 
storage (i.e., formulations part of MPPD cluster 1). This stability percentage is listed in 
Table 6.1. This percentage was calculated with the number of formulations that showed an 
MPPD cluster transformation upon changing the respective variable. This means that the 
listed percentage is not a percentage of all 1152 formulations, but a percentage of 
formulations that were affected by the respective variable. For example, 96 formulations 
with 9.50 g/L methionine at pH 6.0 remained physically stable independent of the addition 
of sodium lactate. This means sodium lactate did not affect these 96 formulations. Similar 
formulations, but with 1.45 g/L methionine, showed cluster transitions for 44 out of 96 
formulations. The formulations that showed a cluster transformation were considered 
affected by sodium lactate. Formulation selection took into account any type of cluster 
transformation as an effect of the respective formulation variable. For example, this 
selection resulted in a total of 220 formulations that were affected by sodium lactate. An 
overview of percentages for all MPPD clusters per formulation variable and the number of 
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formulations taken into account per formulation variable can be found in Supplementary 
Table D3.  
 
Table 6.1: List of stability percentages per formulation variable. The stability percentage is calculated 
based on the number of formulations that showed a cluster transformation upon changing the respective 
variable in the multidimensional protein phase diagram. 
 
Variable Unit Value Stable [%] 
Sodium lactate [g/L] 
0 79 
100 0 
Glycerol [g/L] 
0 0 
75 86 
pH 
 5.0 5 
- 5.5 68 
 6.0 75 
Methionine [g/L] 
1.45 37 
9.50 40 
Salt ratio 
NaCl:KCl 
[g/L:g/L] 
100:0 6 
60:37 20 
40:55 20 
0:90 31 
Sugar type - 
Fructose 37 
Glucose 14 
Lactose 19 
Sucrose 20 
Sugar concentration [g/L] 
30 19 
60 10 
80 38 
 
6.3.1.2 Glycerol 
Glycerol showed the largest physical stability increase, reflected by a stability percentage 
of 86% upon addition of 75 g/L glycerol listed in Table 6.1. This indicates that partial 
removal of glycerol (75 g/L instead of 1050 g/L) still resulted in long-term physical 
stability. Protein aggregation inhibition upon glycerol addition corresponds to previous 
research235,249,250. This may be an effect of preferential hydration resulting in higher 
conformational stability227 or a reduction in attractive protein-protein interactions due to 
preferential interaction with hydrophobic patches on the protein surface234,235.  
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6.3.1.3 pH  
Increasing the formulation pH value resulted in an increase of physical stability as well, 
represented by stability percentages of 5% (pH 5.0), 68% (pH 5.5), and 75% (pH 6.0). 
Increased physical stability of formulations for pH values further away from the pI of 
protein I correlates well with general protein aggregation theory. Electrostatic repulsive 
forces become stronger as a protein becomes more charged which results in higher colloidal 
stability 21.  
 
6.3.1.4 Sodium lactate 
Figure 6.1 shows that addition of 100 g/L sodium lactate resulted in 0% stable 
formulations. It has been observed that sodium lactate decreases protein conformational 
stability via surface tension decrease due to formation of lactoyl lactic acid251. However, 
the concentration of 100 g/L sodium lactate (~8.5% (w/w)) which was used in this case 
study is lower than the range for which this effect was observed (>20% (w/v)). According 
to the same study, concentrations below the range for which lactoyl lactic was formed, 
were found to increase conformational stability. This observation does not correspond to 
data published in another study, where millimolar addition of lactic acid, which is present 
when sodium lactate is dissolved in an aqueous solution, resulted in protein denaturation 
252. Lactic acid was also investigated for its effectiveness of whey protein gelation, a 
process that requires protein denaturation253,254. Despite the divergent information of 
sodium lactate effects on protein denaturation, our results, as presented in Figure 6.1c, 
confirm long-term physical instability upon sodium lactate addition. Based on the 
previously mentioned protein denaturation studies, this effect is assumed to be a result of 
a destabilized conformation of protein I. This would also support the stabilizing effect of 
glycerol, as glycerol can increase conformational stability via preferential hydration.  
 
6.3.1.5 Methionine 
A 3% stability percentage difference between the two tested methionine concentrations 
reflects a weak influence of an increase in methionine concentration on long-term physical 
stability. However, this number is does not fully represent the trends seen in Figure 6.1c as 
increased long-term physical stability is shown for both concentrations. For pH 5.5 and pH 
6.0, an increase in long-term physical stability is seen upon addition of 9.50 g/L 
methionine, while for pH 5.0 formulations a decrease was observed for the same 
methionine concentration. Increased long-term physical stability for increasing methionine 
concentration at pH 5.5 and pH 6.0 was expected. Free methionine can act as sacrificial 
agent and has shown to increase physical stability255–257. This contradicts the decrease in 
physical stability for pH 5.0 formulations. Decreasing methionine oxidation rate can be 
excluded because methionine oxidation rates were found stable between pH 2 and pH 8258. 
87 
 
It has been demonstrated that solvent accessibility can control oxidation rates, but this 
would not influence free methionine258,259. It has been stated that antioxidant additives can 
also influence local dynamics and solvent accessibility of reactive groups, which may lead 
to instability23. However, to the best of our knowledge, no prior studies have described the 
loss of physical stability for increasing methionine concentration under comparable 
conditions. For other amino acids which are often used to enhance long-term stability, such 
as arginine, different optimal concentrations and destabilizing effects have been reported 
for two IgG1 monoclonal antibodies260. Nevertheless, the nature, use, and mechanism of 
stabilization of arginine is not comparable to methionine261. At pH 5.0, the formulation pH 
is closest to the pI of protein I. It can be speculated that methionine influences the solubility 
or conformational stability independent of its antioxidant effects, due to a close to neutral 
protein net charge. It can be speculated that methionine influences the colloidal or 
conformation stability, independently of its antioxidant effects, due to a close to neutral 
protein net charge. A neutral protein charge allows for enhanced protein-protein interaction 
due to the reduction of electrostatic repulsive forces. Protein-protein interactions may be 
further promoted by methionine as a result of preferential exclusion from the protein 
surface. This is just speculative as the molecular mechanism behind the observed decrease 
in long-term physical stability for higher methionine concentrations at pH 5.0 remains 
unknown based on the data obtained in this case study. 
 
6.3.1.6 Salt 
Different salt compositions were also evaluated in the formulation search space. The 
highest physical stability percentage (31%) was found for formulations with 90 g/L 
potassium. Mixed salt ratios (60:37 and 40:55 g/L) of sodium chloride and potassium 
chloride resulted in a physical stability percentage of 20% and formulations with 100 g/L 
NaCl resulted in a physical stability percentage of 6%. The effect of salt on physical 
stability is often related to its position in the Hofmeister series262. Under the evaluated 
formulations, it is assumed that protein I carries a net negative charge as the solution pH 
lies above its pI. A negative net protein charged combined with salt concentrations >1.0 
mol/L means a direct Hofmeister series applies263. Salts used in this case study differ in 
cation (potassium and sodium) while the anion (chloride) remains constant. The direct 
Hofmeister series shows that potassium is slightly more kosmotrope. This indicates 
potassium is slightly more prone to promote conformational stability and salting-out 
compared to sodium. However, this is not reflected by a higher long-term stability 
percentage for potassium (31%) compared to sodium (6%). It should be noted that the 
Hofmeister series positions of potassium and sodium are relatively close, which means 
other factors influencing the observed stability difference should be considered as well. 
Based on the used salt concentrations it can be calculated that the employed ratios resulted 
in different formulation ionic strength. Gram per liter ratios, ordered from high to low NaCl 
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content, correspond to approximately 1.7 mol/L, 1.5 mol/L, 1.4 mol/L, and 1.2 mol/L ionic 
strength. Increasing ionic strength is known to increase aggregation propensity by 
screening electrostatic repulsion, as it lowers a protein’s colloidal stability239. Screening 
effects support the decrease in stability percentage for increasing formulation ionic 
strength. In addition, such screening effects diminish close to the pI, which supports lack 
of influence of the salt ratio on physical stability seen in Figure 6.1c for glycerol-free 
formulations at pH 5.0 with sodium lactate. 
 
6.3.1.7 Sugar 
Evaluating the influence of sugar type resulted in the highest stability percentage for 
fructose (37%) and lowest for glucose (14%), while lactose and sucrose resulted in a similar 
stability percentage (~20%). Sugar concentrations resulted in a minimum stability 
percentage for 60 g/L (10%), and the highest stability percentage was found for 80 g/L 
(38%). As previously stated, sugars can increase conformational stability due to 
preferential hydration of protein molecules48, where disaccharides were found more 
effective236. In this work, the higher effectiveness of disaccharides cannot be confirmed 
due to the use of similar concentrations of monosaccharides (fructose and glucose) and 
disaccharides (lactose and sucrose). From a molar perspective, roughly twice as many 
fructose and glucose (0.16 mol/L and 0.44 mol/L, respectively) molecules are present in 
the formulations compared to lactose and sucrose (0.08 mol/L and 0.23 mol/L, 
respectively). The relatively high stability percentage for fructose concurs with other 
research, where fructose was compared to glucose and sucrose236. Increasing stability 
percentage for increasing sugar concentration was also in accordance with previous 
research, where it was reported that a minimum amount of sugar is needed to induce 
preferential hydration effects238. 
 
6.3.2  Empirical protein property diagram 
Moving towards faster identification and possibly prediction of long-term physically stable 
formulations requires short-term predictive parameters which can be obtained right after 
formulation preparation. In this study, the applicability of such short-term empirical protein 
properties for the use of screening for new formulations was investigated from two 
perspectives. The first perspective is based on the original formulation, which is known to 
remain physically stable during long-term storage. Therefore, it is desired for glycerol-poor 
and glycerol-free formulations to display similar short-term empirical protein properties as 
the original formulation, because similar properties are thought to result in similar long-
term physical stability. The second perspective relies on the multidimensionality of 
physical stability. Different mechanisms may lead to long-term physical stability, which 
can be a result of different protein properties or different combinations of these properties. 
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This means that glycerol-poor and glycerol-free formulations displaying different 
empirical properties than the original formulation may still show long-term physical 
stability. Multiple analytical techniques were used to generate information on the apparent 
hydrodynamic radius of protein I (RH App), the mean apparent hydrodynamic radius of high 
weight species (RH HWS), normalized surface tension (γN), melting temperature (TM) and 
aggregation temperature (TAgg) for a subset of 144 formulations right after formulation 
preparation.  
 
The selected formulations contained 100 g/L sodium lactate for all three pH values. 
Fructose, glucose, lactose, and sucrose were tested at 30 g/L and 80 g/L in combination 
with either 100 g/L sodium chloride or 90 g/L potassium chloride. These formulations were 
tested glycerol-free in combination with 1.45 g/L and 9.50 g/L methionine. Glycerol-poor 
formulations were also tested, but only in combination with 1.45 g/L methionine. Figure 
6.2a lists the empirical properties, a short description, and the corresponding value range. 
Data dimension reduction of empirical protein property data resulted in a 3.5% information 
loss. Clustering of the 3D dataset resulted in an optimum of five clusters.  
 
Figure 6.2b shows a legend, five EPPD cluster radar charts (Roman numerals I to V), and 
a radar chart displaying empirical protein properties obtained for the original formulation. 
The radar charts representing cluster I to V depict the median value of each empirical 
property as a colored surface and the empirical property cluster MAD as a dotted line. An 
overview of median ± MAD values for each empirical property per EPPD cluster can be 
found in Supplementary Table D4. Radar charts in Figure 6.2b can be used to identify 
glycerol-free and glycerol-poor formulations that show empirical properties similar to the 
original formulation. In addition, a stability percentage for each formulation cluster is 
shown below the corresponding radar chart. The stability percentage is defined as the 
formulation percentage within each respective EPPD cluster that showed long-term 
physical stability (i.e., formulations that were also part of MPPD cluster 1). For example, 
cluster II has a stability percentage of 45% which means that 45% of the formulations part 
of cluster II remained physically stable during the long-term storage experiment. Further 
elucidation of the MPPD cluster content of each EPPD cluster can be found in 
Supplementary Table D5. Visualization of the clusters for each considered formulation 
variable is shown in Figure 6.2c, the EPPD. 
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Figure 6.2: (a) Symbols, description, and absolute value range of empirical protein properties (EPPs). (b) 
Cluster radar charts with a legend to indicate the position of each EPP. The normalized median value of 
each EPP is represented with a colored surface. The dotted line represents the median absolute deviation 
within each cluster for each EPP. The EPPs obtained for the original formulation are shown in the Orignal 
radar chart. (c) Empirical protein property diagram (EPPD) for 100 g/L sodium lactate (major grid 
column), varying pH values (major grid rows), different methionine concentrations (minor grid columns), 
glycerol-poor or glycerol-free conditions (minor grid rows), 100 g/L sodium chloride (NaCl) or 90 g/L 
potassium chloride (KCl) (y-axis), and different sugar types at 30 g/L or 80 g/L (x-axis). The five identified 
clusters are visualized in the EPPD using the mean cluster color and cluster Roman numeral similar to the 
radar charts in (b). EPPD cluster regions are highlighted with a dashed line to guide the eye. 
 
The EPPD shows a near uniform identification of cluster V for glycerol-poor formulations 
at pH 5.0 and pH 5.5, while at pH 6.0 glycerol-poor formulations show an almost uniform 
identification of cluster III. Both EPPD clusters show a relatively high stability percentage 
(V = 75% and III = 65%), indicating that the measured empirical protein properties relate 
to long-term physical stability. Cluster III and cluster V show a relatively high value for γN 
(0.97 ± 0.04 and 0.95 ± 0.03, respectively) and a similar RH App of ~3.2 nm. The RH App of 
the original formulation is smaller (2.4 nm) but γN is comparable (1.01). In this case study, 
RH App was assumed to differ between new formulations and the original formulation as a 
result of inter-particle interactions because the measurements were corrected for the bulk 
viscosity61,264. A relative smaller RH App for the original formulation, compared to new 
formulations, was attributed to interaction between glycerol and the protein surface234,235. 
The higher glycerol content in the original formulation was assumed to result in a greater 
loss of attractive protein-protein interactions. The γN is comparable between cluster III, 
cluster V, and the original formulation, where a γN of ~1.00 indicates there is no effect on 
the formulation surface tension upon addition of protein I. As previously mentioned, 
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glycerol influences physical stability via preferential hydration or preferential interaction 
with hydrophobic patches on the protein surface. Both effects would minimize the apparent 
protein surface hydrophobicity and thereby minimize the surface tension change upon 
addition of protein I74,265. Some glycerol-free formulations have also been identified as 
being part of cluster III or V, which means these formulations result in similar short-term 
empirical protein properties without the addition of glycerol. Such glycerol-free 
formulation can be found at pH 5.5 with 90 g/L potassium chloride, where each formulation 
with 80 g/L sugar was identified as cluster V.  
 
Cluster V and cluster III showed comparable values for yN and RH App, but differences were 
observed for TM (76.1 ± 2.3 °C to 72.9 ± 1.4 °C, respectively) and TAgg (62.3 ± 2.6 °C to 
55.1 ± 1.5 °C, respectively). The decrease in conformational and colloidal stability was 
caused by an increased formulation pH. This effect can also be observed for glycerol-free 
formulations, represented by cluster IV at pH 6.0. Cluster IV is characterized by the lowest 
TM (67.7 ± 1.2 °C) and TAgg (56.1 ± 1.1 °C), when compared to all other EPPD clusters. 
Nevertheless, TM and TAgg of cluster IV were still comparable to the original cluster (TM = 
65.5 °C and TAgg = 54.2 °C), which means that colloidal and conformational stability were 
comparable. Different from the original formulation, cluster IV formulations show a 
relatively low γN of 0.88 ± 0.03. The relatively low γN was considered a consequence of 
glycerol’s absence and confirms that apparent protein surface hydrophobicity was 
minimized upon addition of glycerol in glycerol-poor formulations. Despite the differences 
in γN and TM, cluster IV and cluster III have comparable stability percentages (67% and 
65%, respectively). Cluster III’s long-term physical stability was attributed to either the 
prevention of denaturation and subsequent aggregation via preferential hydration or 
reduction of attractive protein-protein interaction by hydrophobic interaction between the 
protein surface and glycerol, while cluster IV formulations are assumed to remain 
physically stable due to repulsive electrostatic forces obtained by the increased positive net 
charge of protein I239. These repulsive forces diminished for increasing ionic strength (from 
90 g/L potassium chloride to 100 g/L sodium chloride) and for lower formulation pH 
values. This is reflected by the increased identification of cluster I and cluster II for these 
formulation condition changes. Cluster II and cluster I show a decreasing stability 
percentage of 45% and 6%, respectively. Based on the large RH HWS (796 ± 120 nm) and 
lack of RH App, it can be concluded that cluster I formulation conditions caused immediate 
aggregation. Cluster II formulations resulted in a RH App of 3.4 ± 0.5 nm and a RH HWS of 
396 ± 213 nm. This indicates that aggregation was present immediately after formulation 
preparation, as seen in cluster I formulations, but to a lesser extent. The effect of methionine 
can be observed by cluster I and cluster II as well. For glycerol-free formulations at pH 
5.5, the addition of methionine causes a decrease in cluster I identification frequency. This 
indicates that aggregation tendency decreases for a higher methionine concentration. A 
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similar cluster transformation can be observed for glycerol-free formulations at pH 6.0. At 
pH 5.0 a decrease in long-term physical stability was observed for 9.50 g/L methionine in 
the MPPD. A corresponding increase in aggregation propensity (i.e., a transformation from 
cluster II to cluster I) is not unambiguously reflected by the EPPD at pH 5.0 between the 
two methionine concentrations.  
 
Cluster V and III represent glycerol-poor and glycerol-free formulations that showed a γN 
comparable to the original formulation, in combination with a stability percentage of 75% 
and 65%. This indicates that screening new formulations for a γN close to 1.00 should result 
in physical long-term stability which is reached via the same mechanism as the original 
formulation. However, none of these new formulations displayed a similar RH App value. 
Presumably, the decrease of inter-particle attraction or increased conformational stability, 
as seen for the original formulation, could not be reached with the relatively low glycerol 
and sugar concentrations used in this case study. Formulation adjustments to optimize and 
match this property of the original formulation might result in higher stability percentages. 
Glycerol-free formulations part of cluster IV at pH 6.0 showed a relatively high stability 
percentage as well (67%). These formulations displayed a lower γN, but TM and TAgg values 
comparable to the original formulation. Based on the corresponding formulation 
conditions, it was assumed that long-term physical stability for cluster IV is obtained via 
repulsive electrostatic forces. Further characterization of new formulations by including 
additional short-term analytical techniques might confirm these results and resolve open 
questions about the observed effects on long-term physical stability as a function of the 
evaluated formulation conditions. Such analytical techniques could include quantification 
of the secondary structure, strength of protein-protein interactions, or surface charge 
measurements. Nevertheless, this case study demonstrates the application of short-term 
empirical data to rationally screen for new formulations based on short-term empirical data 
of a stable original formulation. The use of MPPDs and EPPDs for such an application was 
not shown before. In addition, this case study underlines the ability to obtain an increased 
understanding of observed long-term physical stability due to correlation of MPPD data to 
EPPD data. This allowed for the identification of possible alternative long-term protein 
stabilization routes compared to the original formulation, as well as environmental 
conditions that can be used as a target for optimization of the system under investigation. 
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6.4 Conclusion 
The presented work applied a combination of multidimensional long-term physical 
stability data (1152 formulations) and multi-source short-term empirical protein property 
data (144 formulations) to redesign a protein food formulation containing 1050 g/L 
glycerol. The empirical phase diagram method was applied to present and analyze the 
multidimensional data. The obtained results were employed to identify redesigned 
formulations that resulted in similar long-term stability, but with minimized glycerol 
content. Long-term stability of redesigned formulations was found for two instances. In the 
first instance, redesigned formulations showed a similar short-term normalized surface 
tension compared to the original formulations. This short-term property was found for all 
glycerol-poor (75 g/L) formulations, and for glycerol-free formulations at pH 5.5 and pH 
6.0, containing 90 g/L potassium chloride and 80 g/L sugar. This was observed for all sugar 
types. The comparable short-term empirical property profile and corresponding long-term 
stability of these redesigned formulations indicated a similar stabilization pathway as the 
original formulation. For the second instance, glycerol-poor formulations at pH 6.0 in 
combination with 90 g/L potassium chloride showed a relatively high long-term stability 
percentage (67%) as well. This was attributed to the increasing net protein charge as a 
result of a formulation pH value further away from its isoelectric point, thereby inducing 
repulsive electrostatic forces. This indicated that the combination of the MPPD and EPPD 
identified a different stabilization pathway compared to the original formulation.  
 
The case study illustrated the potential of the multidimensional data visualization and 
analysis methods to rationally design screening experiments for new formulations of an 
existing product. In addition, straightforward identification of underlying short-term 
empirical protein properties provided a more detailed insight to long-term protein physical 
stability. In a broader perspective, the applied method can also be used to screen 
formulations for other product quality aspects that are sensitive to formulation additives, 
such as enzymatic stability studies. Further development of multidimensional data analysis 
might lead to knowledge-based long-term screening experiments, which can include 
predictive cluster classification models using short-term empirical protein properties as 
input. 
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Abstract 
Knowledge-based experimental design can aid biopharmaceutical high-throughput 
screening (HTS) experiments needed to identify critical manufacturability parameters. 
Prior knowledge can be obtained via computational methods such as protein property 
extraction from 3-D protein structures. This study presents a high-throughput 3-D structure 
preparation and refinement pipeline that supports structure screenings with an automated 
and data-dependent workflow. As a case study, three chimeric virus-like particle (VLP) 
building blocks, hepatitis B core antigen (HBcAg) dimers, were constructed. Molecular 
dynamics (MD) refinement quality, speed, stability, and correlation to zeta potential data 
was evaluated using different MD simulation settings. Settings included 2 force fields 
(YASARA2 and AMBER03) and 2 pKa computation methods (YASARA and H++). MD 
simulations contained a data-dependent termination via identification of a 2 ns Window of 
Stability, which was also used for robust descriptor extraction. MD simulation with 
YASARA2, independent of pKa computation method, was found to be most stable and 
computationally efficient. These settings resulted in a fast refinement (6.6 – 37.5 hours), a 
good structure quality (-1.17 - -1.13) and a strong linear dependence between dimer surface 
charge and complete chimeric HBcAg VLP zeta potential. These results indicate the 
computational pipeline’s applicability for early-stage candidate assessment and design 
optimization of HTS manufacturability or formulability experiments. 
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7.1 Introduction 
Virus-like particles (VLPs) are macromolecular assemblages, which in their simplest form 
consist of multiple copies of one viral structural protein266. Their particulate and highly 
repetitive structure invokes an immune response similar to that of native viruses, but VLPs 
are incapable of reproduction as viral nucleic acids are lacking266,267. VLPs can therefore 
provide immunization against the virus they were derived from, as was done for hepatitis 
B virus (HBV; Engerix B, Recombivax)268 and human papilloma virus (HPV: Cervarix, 
Gardasil)269. Immunization unrelated to the native virus can be achieved with chimeric 
VLPs, which are VLPs containing a foreign antigenic epitope. These antigenic epitopes 
can be inserted into a capsid forming protein at either the N-terminus, C-terminus, or major 
immunodominant region (MIR)270. This insertion aims to trigger an immune response, 
adjuvanted by the particulate and repetitive VLP structure271. Chimeric VLPs are 
increasingly used in preclinical and clinical studies272. An example of a chimeric VLP that 
received positive opinion of the European Medical Agency is a malaria vaccine based on 
a HBV surface antigen VLP with an inserted segment of the Plasmodium falciparum 
circumsporozoite protein273. Another platform for chimeric antigen display is the HBV 
core antigen (HBcAg) protein. Chimeric HBcAg VLPs with foreign and self-epitopes have 
been shown to induce strong B cell responses, a characteristic that can be used to develop 
VLPs for the treatment of cancer274–276.  
 
Chimeric VLP development involves screening large numbers of candidate epitope 
insertions277. During screenings, chimeric VLPs are evaluated based on immunogenicity, 
structure stability, and assembly-competence267,278. For example, fewer than 50% of 
inserted peptides in the HBcAg platform resulted in a properly assembled and soluble VLP 
279. Structural stability and solubility are not only desired in the final formulation to ensure 
product efficacy, quality, and safety, but also throughout downstream processing to ensure 
manufacturability278,280,281. During manufacturing, VLPs are exposed to different 
environmental conditions such as changes in pH, ionic strength, and temperature. These 
conditions influence physicochemical properties of VLPs, which in turn determine critical 
evaluation parameters such as the structural stability and assembly-competence282. High-
throughput screening (HTS) experiments allow for workload reduction in virus and VLP 
studies to determine optimal processing283,284 and formulation285 parameters. HTS design 
for VLP studies can be further optimized by search space minimization and 
manufacturability assessment using prior knowledge of physicochemical properties 
obtained computationally from 3-D protein structures278,286,287. Physicochemical properties 
that are most important for virus particles include electrostatic surface charge288–290. 
Research on bacteriophage MS2 showed correlation between experimentally determined 
virus surface charge using zeta potential measurements and computationally calculated 
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protein charge291. Moreover, experimentally determined protein zeta potential showed 
stronger correlation with calculated protein charge using only capsid surface atoms 
compared to protein charge calculated using all MS2 capsid atoms. Other research showed 
that calculated protein charge using the surface of a single MS2 capsid protein was in 
agreement with theoretically determined protein surface electrostatic potential of the entire 
MS2 capsid292. Ionizable groups of a protein determine protein properties such as surface 
charge, structure, and stability293. Therefore, both 3-D structure preparation and in silico 
determination of surface charge require an estimation of the pKa of titratable groups. Fast 
and fairly accurate pKa estimation methods have been developed, such as methods to 
monitor pKa shifts during an MD simulation294 or to process a large number of structures 
parallelized in a short time295. 
 
Candidate chimeric VLP 3-D structures have to be available for computational 
physicochemical property extraction. As it would be impractical to produce all candidates 
and experimentally determine their 3-D structures, an in silico 3-D structure preparation 
approach is needed. This approach would require an automated and high-throughput 
framework to support screening a large number of chimeric VLPs to minimize manual 
effort. These requirements can be met with homology modeling, also known as 
comparative modeling. With this method, unknown 3-D protein structures are created 
based on known template structures296. Homology modeling can be performed using 
several approaches297,298, but all resulting 3-D structures remain only an estimation of 
reality. Further model refinement is needed to meet structure quality requirements and 
should therefore include a molecular dynamics (MD) simulation step99. Structure 
refinement requires the selection of a force field. The choice depends on the application 
and it can be notoriously difficult to identify the best-performing force field for a particular 
application. Novel self-parameterizing knowledge-based force fields, such as YASARA2, 
have been developed to improve the calculation of torsional angles and have shown to be 
useful and accurate for the physical correction of proteins by energy minimization299. 
Several authors have analyzed the performance of different open-source force fields by 
comparing in silico structural data to NMR experimental data300–302. In general, modern 
force fields perform reasonably accurate and reproducible for MD simulation of 
proteins303.  
 
For VLPs, in silico experiments have most frequently been applied to study capsid stability 
using complete VLP capsid 3-D structures. All-atom MD simulations of complete capsids 
are as challenging as they are computationally expensive and can only be done using 
relatively short in silico timescales. Reported simulations reach <10 ns per day on super-
computers304–306 or 30 ns/day when using constrained bond-lengths307. However, modeling 
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VLP structural transitions (e.g., self-assembly, capsid disintegration) requires a much 
larger timescale (μs or ms)308. Compared to all-atom MD simulations, computational 
expense has been reduced to reach these relatively large timescales using coarse-grained309–
311 or multi-scale312–316 models in various capsid studies. Supercomputers, such as the Blue 
Waters supercomputer with 128000 cores, were used and a simulation duration of several 
days for a single capsid was reported306. In silico candidate screening would require an 
equal amount of simulations as available chimeric VLP candidates. Depending on the 
application, this could involve screening of hundreds of chimeric VLP candidates. In this 
case, simulation time would increase to a timespan of a year, even with the use of a 
supercomputer. Time requirement, super computer availability, and respective expertise 
hamper the implementation of these methods in computational high-throughput candidate 
screenings. Simulation simplification, by using only a single capsid protein or capsid 
building block models317,318, aids in resolving these limitations. Monomers and pentamers 
were compared to an entire VLP 3-D capsid model to evaluate the applicability to 
immunogenicity prediction314. Joshi and coworkers showed that the immunogenicity 
predictor (epitope flexibility) was dependent on the complete capsid construct and thus a 
complete VLP capsid 3-D model was required to capture this effect. This requirement is 
not expected for the evaluation of surface charge as it has been shown that MS2 capsid 
protein surface charge descriptors have a high correlation to experimental zeta potential 
data of the entire structure291,292. In addition, this case study used chimeric HBcAg 
structures that differ only in the epitope located on the outer VLP surface. Therefore, the 
influence of dimer contact area on possible zeta potential changes observed for entire 
chimeric HBcAg VLP structures was considered to be minimal. Thus, surface charge after 
3-D structure preparation of HBcAg dimers was evaluated based on its correlation to 
experimental zeta potential obtained for entire HBcAg VLP structures. Monomers were 
not considered as model simplification, since only dimers or larger assemblies (i.e., 
capsids) are present under physiological conditions319.  
 
This study presents a computationally inexpensive, high-throughput, and entry-level 
pipeline to obtain 3-D protein structures. Time and computational effort were minimized 
by automated homology modeling including novel, data-dependent, and stepwise MD 
simulation for homology model refinement. Refinement termination was determined data-
dependently via identification of a 2 ns Window of Stability (WoS) consisting of 1000 
structural snapshots. The WoS was used to calculate the median structure quality and 
median surface charge based on all 1000 structural snapshots to account for MD simulation 
fluctuations. As a case study, three chimeric HBcAg dimer structures were processed under 
similar environmental conditions, each with a unique antigenic epitope insert. Homology 
model construction and subsequent refinement performance was evaluated based on 
simulation quality, speed, and stability. The median surface charge was used to investigate 
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the application of the prepared structures for surface property extraction. This was 
evaluated based on the correlation between in silico calculated surface charge extracted 
from chimeric HBcAg dimers and experimental zeta potential obtained with complete 
chimeric HBcAg VLPs. To identify performance sensitivity, MD simulations using 2 
different force fields (YASARA2 and AMBER03) and 2 high-throughput methods for pKa 
value computation (H++ and YASARA) were compared. The presented case study of three 
chimeric HBcAg dimers was performed to show the potential of the proposed high-
throughput and automated structure preparation pipeline to explore computationally 
determined physicochemical protein surface properties. 
 
7.2 Material and Methods 
7.2.1 Sample preparation 
Recombinant chimeric HBcAg constructs used in this study (referred to as VLP A, VLP 
B, and VLP C irrespective of being a HBcAg dimer or VLP) were modified in the MIR to 
display foreign epitopes on the VLP surface. Constructs were expressed and purified 
according to the production protocol generously provided by BioNTech Protein 
Therapeutics GmbH (Mainz, DE). Purified and assembled VLPs were stored at -20 °C and 
dialyzed into a 50 mM Tris (Merck KGaA, Darmstadt, DE) buffer at pH 7.2 containing 
100 mM NaCl (Merck KGaA, Darmstadt, DE) for analysis. Buffer was prepared with 
ultrapure water (PURELAB Ultra, ELGA LabWater, Lane End, UK) and filtered through 
a 0.20 μm pore size Supor® filter (Pall, Port Washington, NY, USA). Samples were 
brought to room temperature and filtered through a 0.20 μm polyethersulfone (PES) filter 
(VWR International, Radnor, PA, USA) before measurements. Required VLP sample 
concentrations were obtained using Vivaspin® 20 filters with a 30 kDa pore rating 
(Sartorius, Goettingen, DE). VLP concentration was determined with a NanoDrop2000c 
UV-Vis spectrophotometer (Thermo Fischer Scientific, Waltham, MA, USA). The E1% 
(280 nm) extinction coefficient was calculated by the online Swiss Institute of 
Bioinformatics ProtParam tool (https://web.expasy.org/protparam.html) based on the 
primary structure of the HBcAg monomer320.  
 
7.2.2 Zeta potential 
Electrophoretic mobility measurements were performed with the Zetasizer Nano ZSP 
(Malvern Instruments Ltd., Malvern, UK). Folded disposable capillary cells (DTS1070, 
Malvern Instruments Ltd., Malvern, UK) were filled with the appropriate buffer and 50 μL 
of a 1 g/L VLP sample. VLP samples were inserted by employing the diffusion barrier 
technique321 using a 200 μL round, 0.5 mm thick Corning Costar gel-loading tip (Corning 
Inc., Corning NY, USA). Six replicates were measured at 25 °C in automatic mode, where 
each measurement consisted of 120 seconds equilibrium time and five runs with a 
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maximum of 15 sub runs. The applied voltage was set to 60 mV and the dispersant was set 
to water. A material refractive index of 1.45 and absorption of 0.001 AU was used. The 
average zeta potential was calculated by Zetasizer Software (version 7.12, Malvern 
Instruments Ltd., Malvern, UK) with the measured average electrophoretic mobility, a 
viscosity of 0.8872 mPas, a dielectric constant of 78.54, and Smoluchowski’s 
approximation of 1.5198. For each VLP sample, outlier detection was performed with 
MATLAB (version 2017b, MathWorks, Natick, MA, USA), using the interquartile range 
rule with a whisker length of 0.75322, followed by median zeta potential calculation.   
 
7.2.3 Computational methods 
Figure 7.1 depicts the computational pipeline used to compute surface property information 
from dimer chimeric HBcAg structures. Required input is a template 3-D structure, the 
target sequences, and experimental conditions (i.e., oligostate, pH, and salt concentration). 
3-D structure curation and MD scene preparation, described in section 7.2.3.1 (p. 100), 
were performed fully automated by employing an in-house developed MATLAB script 
(version 2017b, MathWorks, Natick, MA, USA).  
 
All depicted steps in section Curation and Preparation in Figure 7.1 were an automated 
operation of either MATLAB, YASARA (version 16.9.23, YASARA Biosciences GmbH, 
Vienna, AT), Modeller (version 9.18, University of California, San Francisco, CA, 
USA)323, H++ (Virginia Tech, Blacksburg, VA, USA, biophysics.cs.vt.edu) or Python 
(version 2.7.13, Python Software Foundation, Wilmington, DE, USA) sub scripts. These 
steps resulted in prepared scenes for MD simulation of each VLP construct. MD simulation 
of the prepared scene is described in section 7.2.3.2 (p.102) and extraction of VLP surface 
properties is described in section 7.2.3.3 (p.103). The 3-D structure quality was monitored 
throughout the workflow with the quality Z-score. This is the mean value of the WHAT IF 
parameters Packing1, PhiPsi and Backbone299,324. Quality parameters were calculated 
using the YASARA2 force field in a TIP3P water filled cubic cell325, with walls extended 
10 Å from the 3-D structure.  
 
7.2.3.1 Structure and scene preparation 
The three HBcAg structures used in this study were based on C-terminally truncated and 
histidine(His)-tagged HBcAg, which were modified in the MIR. All experimental 
structures have an identical C-terminus. Therefore, it was assumed that the His-tag would 
not have a significant impact on the relative assessment of 3-D structural biophysical 
parameters. To avoid homology modeling of the His-tag, the C-termini of the input target 
sequences matched the template structure C-terminus. 
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Figure 7.1: Computational pipeline for high-throughput homology model surface property data extraction. 
Four stages are depicted: (1) Curation: epitope insertion using homology modeling (Modeller), followed 
by an energy minimization run (YASARA); (2) Preparation: computed pKa values (H++) are assigned, 
followed by an energy minimization in a simulation cell (YASARA); (3) Simulation: 3-step data-
dependent molecular dynamics (MD) simulation (YASARA) terminated by identification of a 2 ns 
window of stability (WoS); (4) Evaluation: surface area selection and extraction of surface property data 
for each snapshot in the WoS (YASARA). 
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The 3-D crystal structure of C-terminally truncated (1-149) hexameric HBc Y132A was 
obtained from the online research collaborator for structural bioinformatics protein data 
bank (RCSB PDB, www.rcsb.org), under PDB ID 4BMG with a resolution of 3 Å326,327. 
All non-protein molecules were removed and the hydrogen bonding network was 
optimized with YASARA 328. The multimeric state was corrected to obtain a dimeric 3-D 
structure, which resulted in the template structure shown in Figure 7.1. Subsequently, 
homology modeling was performed to adjust the template structure to the target sequence 
using Modeller. The automodel function constructed five homology models, where gap 
initiation and extension penalties for sequence alignment were set to -600 and -400, 
respectively. Obtained homology models were superposed in YASARA and their atom 
coordinates averaged (referred to as homology structure). The hydrogen network was 
optimized and an energy minimization was run with the averaged structure at experimental 
pH and using the AMBER99 force field329. After steepest descent minimization, the 
procedure continued by simulating annealing using 2 fs time steps. Atom velocities scaled 
down by 0.9 every 10th step until the energy improved by less than 0.05 kJ/mol per atom 
during 200 steps. The resulting structure is referred to as the curated structure in Figure 
7.1. The curated structure was uploaded to the H++ webserver using a Python web scraping 
algorithm (selenium library) to compute pKa values295. The external and internal dielectric 
constant were set to 80 and 10, respectively, and salinity and pH were set equal to 
experimental conditions (i.e., 0.1 molar salinity and pH 7.2). Obtained pKa values and the 
resulting 3-D structure were automatically downloaded and used to build an MD simulation 
cell. Additionally, to investigate the effect of H++ computed pKa values, pKa values 
computed by YASARA were used instead of H++294. The simulation cell contained the 
prepared 3-D structure, which included computed pKa values as well as (de)protonated 
termini based on the experimental pH and computed pKa values. Cell walls were built at a 
distance of 10 Å from the refined 3-D structure. After simulation cell construction, a 
neutralization run was performed. TIP3P water molecules325 were added to the simulation 
cell (water density was set to 0.997) as well as salt ions (set to experimental conditions).The 
final step of MD scene preparation was an energy minimization using identical settings as 
described before. This resulted in the prepared MD scene depicted in Figure 7.1. 
 
7.2.3.2 Molecular dynamics 
Prepared MD scenes with H++ pKa values were simulated using the YASARA2 or the 
AMBER03 force field330, and with YASARA pKa values using YASARA2299,331, with a 
cutoff of 7.86 Å332 and long range Coulomb interactions using the particle mesh Ewald 
method333. Temperature was controlled by rescaling velocities using a modified Berendsen 
Thermostat332,334. Hardware consisted of two Windows 10 computers with an Intel i7-6700 
CPU and a GeForce GTX 1080 GPU. Results of the second computer are shown in 
Supplementary Material Figure E2, Figure E3, Figure E4, and Figure E5. Intramolecular 
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forces were calculated every 2 fs (1 fs for AMBER03) and intermolecular, non-bonded 
Van der Waals, and electrostatic forces every 4 fs (2 fs for AMBER03) to improve 
performance and subsequently scaled by 2335. MD scene snapshots were saved every 2 ps 
and superposed on the prepared structure to calculate a root-mean-square deviation 
(RMSD) of atom coordinates. The simulation was automatically performed in three 
RMSD-controlled steps. In step 1, only the epitope and five adjacent amino acids were 
simulated. All other amino acid atom positions were constrained. In step 2, 18 additional 
amino acids towards the N-terminus and ten amino acids towards the C-terminus (i.e., the 
dimer spike consisting of two alpha-helical hairpins) were simulated without position 
constraints. Other amino acids were simulated with free side chain atoms but fixed 
backbone atom positions. In step 3, all atom positions were unconstrained. All H-bonds 
were constrained during step 1 and step 2 using the linear constraint solver (LINCS) 
algorithm336. In step 3, all H-bond constraints were removed after 0.2 ns and the time steps 
for intermolecular forces and intramolecular forces were reduced to 2 fs and 1 fs, 
respectively. The simulation advanced to the next step when the moving average (window: 
0.15 ns, sampling rate: 10 ps) RMSD change was below a set threshold of 0.75 Å/ns for 
0.1 ns. A penalty of 0.02 ns was used if the rate of RMSD change was above the threshold. 
Step 3 was terminated based on the RMSD coefficient of variance (CV) in a window of the 
last 2 ns of simulation. MD simulation was terminated when the window CV fell below 
2.5%, using a sampling rate of 2 ps. The snapshots of the obtained window of stability 
(WoS) were used for the calculation of quality and descriptors. Simulations that did not 
reach a WoS within 30 ns were manually stopped. 
 
7.2.3.3 Data processing 
The homology structure and all MD snapshots of the WoS obtained with H++ or YASARA 
pKa values and YASARA2 or AMBER03 force field were analyzed based on their solvent 
accessible surface area (SASA). Structure SASA was calculated by finding all points a 1.4 
Å water probe’s oxygen nucleus can reach while rolling over the protein surface 
approximated by YASARA’s numeric algorithm. Contribution of the intra-dimer surface 
was excluded. Molecular parameters were automatically extracted using similar settings as 
in the MD simulation. Surface charge was calculated for all atoms contributing to the 
SASA and the resulting surface charge was divided by the total SASA. This was done to 
exclude size effects that can occur between different epitope insertions. In silico zeta 
potential values were obtained via linear transformation of surface charge data. Linear 
transformation included normalization of in silico data between 0 and 1 and transformation 
using the minimum and maximum of the experimental data, as shown by Equation 7.1. 
 
𝑦   𝑛𝑠 𝑜    [?̃?𝑛𝑜   ∙   𝑦  𝑥 − 𝑦 𝑖𝑛 ] + 𝑦 𝑖𝑛 (7.1) 
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Normalized in silico data is indicated as ỹnorm, experimental minimum and maximum data 
are represented by ymax and ymin, respectively. Descriptors derived from each snapshot in 
the WoS are reported as medians and corresponding median absolute deviation (MAD). 
Correlation between linear transformed in silico data and experimental data was evaluated 
based on the Pearson correlation coefficient (PCC). PCC was calculated with the corrcoef 
function available in MATLAB. The error between in silico and experimental data was 
evaluated with the mean squared error (MSE), obtained with Equation 7.2.  
 
𝑀𝑆𝐸   
1
𝑛
 ∑ 𝑦𝑖 − ?̃?𝑖 
 
𝑛
𝑖=1
  (7.2) 
 
where n is the sample size, yi experimental data, and ỹi in silico generated data. 
 
7.3 Results and Discussion 
7.3.1 Quality 
Figure 7.2 shows an overview of structural quality Z-scores during curation, preparation, 
and simulation of each chimeric HBcAg dimer. The structural quality Z-score is an average 
of three parameters: (1) 3-D direction-dependent packing normality, (2) position normality 
of residues and secondary structural motifs in the Ramachandran plot, and (3) backbone 
conformation normality299. A value below -2 is considered to represent a poor structure 
and Z-scores close to or above zero indicate more reliable structures. Separate parameter 
values can be found in Supplementary Material Figure E1.  
 
Quality Z-score differences were observed throughout the structure preparation workflow 
and between different identified windows of stability. The template structure quality Z-
score (-1.18, gray dashed line) increased after homology modeling with 0.12 and 0.16 for 
VLP B and VLP C, respectively. VLP A showed a 0.03 quality Z-score decrease compared 
to the template structure. Underlying parameters showed that VLP A’s backbone 
conformation quality decreased roughly 1.5 times more than the other constructs. This is 
attributed to the amount of additional atoms included in the homology model. VLP A 
contains 17% additional atoms compared to the template structure, while VLP B and VLP 
C contain 13% and 11% additional atoms, respectively. The other two underlying quality 
parameters (packing normality and Ramachandran plot position normality) show a similar 
trend between VLP constructs when comparing the template and homology structure (data 
shown in Supplementary Material Figure E1). 
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The observed quality improvement of homology structures VLP B and VLP C, which is 
dominated by Ramachandran position normality parameter improvement, might be an 
effect of the restraint-based homology modeling and knowledge-based loop modeling used 
by Modeller298,337. Quality Z-scores of curated and prepared structures were between -1.44 
and -1.62, which is between 22% and 37% lower compared to the template structure. Both 
structures are evaluated after energy minimization at experimental pH, where prepared 
structures included H++ computed pKa values and the curated structures did not. Energy 
minimization is used to remove global errors in 3-D structures, such as steric clashes. 
However, optimization of global and local structural quality with an energy minimization 
run is not trivial. Energy minimization may result in lower quality structures because global 
errors are removed but local errors accumulate299,338. This may explain quality decrease of 
curated and prepared structures, when compared to the template and homology structures. 
A similar decrease in quality Z-score after energy minimization with an AMBER99 force 
field has been reported before 299. Structural issues present in curated and prepared 
structures were resolved by running an MD simulation with the YASARA2 force field, 
independent of the used pKa computation method. Mean quality Z-scores of all VLP 
constructs for MD simulation WoS without H++ (-1.17) and MD simulation WoS with 
H++ (-1.13) were comparable to the template. This shows there is no quality loss after 
 
Figure 7.2: Overview of quality Z-scores for the template, homology structure, curated structure, window 
of stability (WoS) without H++ and the YASARA2 force field (“WoS w/o H++”), the prepared structure, 
WoS obtained with H++ and the AMBER03 force field (“WoS A03”), and WoS obtained with H++ and 
the YASARA2 force field (“WoS”). The quality Z-score is an average value of the WHAT IF quality 
factors 3-D packing (QUACHK), Ramachandran Z-score (RAMCHK) and backbone conformation 
(BBCCHK)299. A median value and median absolute deviation as error bar is shown for the WoS quality 
Z-scores. The gray dashed line represents the quality Z-score of the template structure. 
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completing the proposed structure preparation pipeline with the YASARA2 force field. 
Additionally, the coefficients of quality Z-score variance of 4.72% and 1.79% for the MD 
simulation with and without H++ pKa values, respectively, reflected that there is no quality 
influence of the inserted epitope length. However, a decrease in quality is seen for the WoS 
obtained with the MD simulation using the AMBER03 force field (WoS A03), represented 
by a mean quality Z-score of -1.86 considering all VLP constructs. This corresponds to 
observations previously reported about diverse structure quality values obtained with 
different force fields 339. Quality Z-scores for intermediate structures and final MD 
simulation WoS showed that chimeric HBcAg dimer structure quality in this dataset was 
mostly influenced by the force field and an MD simulation, independent of the used pKa 
computation method.  
 
7.3.2 MD simulation 
All chimeric HBcAg homology models were refined with MD simulations. This was done 
because MD simulations correct structural errors present in homology models99. An MD 
simulation results in a change of atom coordinates, which is measured by the RMSD of 
those atom coordinates. Structure refinement is achieved upon stabilization of atom 
positions, referred to as the equilibrium state. This state is identified by a plateau of the 
RMSD value over simulation time. Plateau identification is frequently done subjectively 
based on visual inspection of RMSD plots. This approach is not recommended as it was 
shown to be biased in a survey among researchers in the field340. To avoid subjective 
plateau identification, this study employed automated equilibrium state determination 
based on the average RMSD slope or CV. Automated determination was used within a 3-
step MD simulation. In each step, a growing part of the chimeric HBcAg dimer structure 
was refined until an equilibrium was identified. Separate refinement of structure parts was 
used to reduce simulation time in addition to automated identification of the equilibrium 
state. The simulation was terminated when equilibrium was reached for the full chimeric 
HBcAg dimer structure. This state is referred to as the WoS, which was defined as a 2 ns 
simulation window where the RMSD CV in step 3 was below 2.5%. The 3-step MD 
simulation was specifically implemented for the HBcAg dimer structure, as sequences 
differ only in the MIR. For other applications, (i.e., formulation condition screening of a 
single protein or a diverse protein dataset) a 3-step MD simulation may not be necessary 
and a WoS could be determined in one simulation step.  
 
Figure 7.3 shows the progress of 3-step MD simulations with the YASARA2 force field 
and H++ computed pKa values for all three VLPs. The atom coordinate RMSD was 
calculated every 0.002 ns by superposing a simulation snapshot on the prepared structure.  
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Figure 7.3: Progress of molecular dynamics (MD) simulations for VLP A, B, and C presented by root-
mean-square deviation (RMSD) of atom coordinates (Å) over simulation time (ns). Three different 
simulation steps are separated by vertical lines, where vertical lines indicate simulation transition points. 
From 0 ns to dotted line: simulation of epitope and five adjacent amino acids; from dotted to dashed line: 
simulation of Hepatitis B core antigen (HBcAg) dimer spike; from dashed line to the end of simulation: 
full dimer simulation. The highlighted area is defined as the 2 ns window of stability (WoS). 
 
Overall simulation time ranged from 4.0 ns to 19.9 ns and the absolute RMSD increased to 
2.10 ± 0.04 Å to 7.52   0.15 Å during MD simulation. The in silico time span difference 
between structures to reach the WoS is in agreement with other work, where structure 
stability was achieved earlier, later, or not at all, depending on the protein99. VLP C showed 
the lowest RMSD increase (2.1 Å ± 0.04 in the WoS) and shortest simulation time (6.6 h; 
in silico: 4.01 ns). VLP A resulted in the largest RMSD increase (7.52   0.15 Å in the WoS) 
and longest simulation time (37.5 h; in silico: 19.89 ns). Simulation time increased from 
VLP C to VLP B to VLP A, which corresponds to the number of inserted atoms of 11%, 
13%, and 17%, respectively. Step 1, which simulates the inserted epitope and five adjacent 
amino acids, showed 32.1% to 69.2% of the total RMSD change. This is a relatively large 
percentage considering step 1 accounted for 3.6% to 12.5% of the total simulation time. 
The epitope was not part of the template 4BMG crystal structure and therefore it was 
inserted with homology modeling. Homology models typically have errors in the 
secondary structure and atomic packing which should be resolved during MD simulation99. 
This is presumably one factor contributing to the relatively large RMSD change observed 
in step 1, which only refined the inserted epitope and five adjacent amino acids. Another 
VLP A
VLP B
VLP C
Start Step 2
Start Step 3
WoS
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factor that can influence the observed RMSD profile of the epitope is its flexible design. It 
was stated that epitope flexibility allows for efficient presentation to the immune system341, 
but increased structure flexibility can also result in larger RMSD change during MD 
simulation. Other parts of the HBcAg dimer are less flexible. Therefore, only small 
deviations in atom coordinates of the less flexible and conserved region of chimeric HBcAg 
(i.e., the molecule base and lower part of the spike) were observed when comparing MD 
simulation steps. This is also illustrated by Figure 7.4, where the RMSD per residue number 
is shown. Figure 7.4 shows that regions around the epitope have higher RMSD values than 
other regions.  
 
Figure 7.4: Local structural changes during molecular dynamics (MD) simulation represented by root-
mean-square deviation (RMSD) of atom coordinates (Å) over residue number (-). Initial structures were 
compared with last MD simulation snapshots of VLP A, B, and C, respectively, with the YASARA2 force 
field and H++ computed pKa values. Vertical lines mark the inserted epitope exemplarily for VLP A. 
 
Simulation speed improved due to bond and regional atom constraints and due to an 
increased time step for force calculation in the first two steps of the simulation. On average, 
step 1 was 72% (21.26 ns/day) and step 2 was 69% (20.82 ns/day) faster compared to step 
3 without constraints and with a smaller time step (12.32 ns/day). This supports the 
expected simulation speed improvement by employing a data-dependent 3-step method. 
This corresponds to the previous statement that simulation design should be adjusted to the 
application and starting structure to obtain optimal speed and stability output. With the 
used simulation approach, the 2 ns WoS of three chimeric HBcAg dimers were created on 
a Windows 10 computer with an Intel i7-6700 CPU and a GeForce GTX 1080 GPU in 
66.0 h of computational time using the YASARA2 force field and H++ computed pKas. 
Simulations with H++ pKa values and YASARA2 as force field were also run on another 
computer containing similar hardware to evaluate reproducibility. No significant difference 
in simulation outcome was found, including calculation of quality and surface charge. 
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More detailed information on reproducibility can be found in Supplementary Material 
Figure E2 to Figure E5. 
 
Two additional simulations were performed, the first to evaluate the effect of different pKa 
value computation methods, and the second to compare MD simulation with YASARA2 
to a standard force field for protein simulations, AMBER03. Figure 7.5a shows the 
progress of MD simulations using the YASARA2 force field and with YASARA computed 
pKas (without H++; w/o H++) and Figure 7.5b shows MD simulations with the AMBER03 
force field with H++ computed pKas (A03).  
 
During MD simulations w/o H++, RMSD increased by 2.46 ± 0.05 Å to 8.95 ± 0.17 Å in 
5.5 ns to 12.6 ns corresponding to 11.0 h to 30.5 h of computational time. The total 
computational time of 59.6 h for MD simulations without H++ computed pKa values was 
comparable to 66.0 h for MD simulations with H++ pKa values. This shows that the pKa 
calculation method did not have a significant influence on MD simulation performance. 
MD simulations with AMBER03 resulted in RMSD values of 5.10 ± 0.16 Å to 13.66 ± 
0.25 Å. MD simulation took 18.42 ns to 30.0 ns which corresponds to a total computational 
time of 156 h. For A03, the MD time step had to be reduced to 1 fs for intramolecular and 
to 2 fs for intermolecular forces to avoid simulation failure. Structure instability also 
prevented the transition to MD simulation step 3 for VLP A, which is elucidated by a 
fluctuating RMSD curve in Figure 5. Furthermore, VLP C did not reach a WoS within 
30 ns. Both results indicated that using AMBER03 resulted in less stable simulations 
 
Figure 7.5: Progress of molecular dynamics (MD) simulation for VLP A, B, and C presented by root-
mean-square deviation (RMSD) of atom coordinates (Å) over simulation time (ns) for (a) MD simulation 
without H++ with YASARA2 as force field (“w/o H++”) and (b) MD simulation with H++ and 
AMBER03 as force field (“A03”). Three different simulation steps are separated by vertical lines, where 
vertical lines indicate simulation transition points. From 0 ns to dotted line: simulation of epitope and 
five adjacent amino acids; from dotted to dashed line: simulation of Hepatitis B core antigen (HBcAg) 
dimer spike; from dashed line to the end of simulation: full dimer simulation. The highlighted area is 
defined as the 2 ns window of stability (WoS). 
VLP A
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compared to simulations with YASARA2. Simulations with H++ or YASARA computed 
pKa values using the YASARA2 force field have shown the best performance based on 
simulation time, simulation stability, and overall completion of the 3-step MD simulation 
method. This indicates that MD simulations evaluated in this study benefitted from the 
empirical data that is embodied in a force field containing knowledge-based 
potentials299,342. Evaluation of this method based on other (refined) force fields and other 
software platforms would give more detailed insight into simulation performance. 
 
7.3.3 Zeta potential 
Zeta potential was experimentally determined for all three HBcAg VLP constructs and 
compared to in silico determined total surface charge based on the HBcAg dimer structures. 
This was done to determine the applicability of the prepared structures for computational 
surface property extraction. It was assumed that the observed zeta potential differences that 
occur due to the changes on the outer surface of the entire VLP structure are captured by 
the dimeric HBcAg structure343. The obtained in silico surface charge extracted from the 
homology model and three different WoS, for each of the three chimeric HBcAg dimer 
structures, are shown in Figure 7.6.  
 
Figure 7.6: In silico computed zeta potential (mV) plotted against experimentally determined zeta potential 
(mV). Symbols represent in silico data based on the homology structure (“Homology”, red open circle), 
window of stability (WoS) obtained without H++ and with YASARA2 (“WoS w/o H++”, purple diamond), 
WoS obtained with H++ and AMBER03 (“WoS A03”, purple square), and WoS obtained with H++ and 
YASARA2 (“WoS”, blue filled circle). The diagonal line represents theoretical data with a Pearson 
correlation coefficient of 1 (PCC = 1). X-axis error bars represent the median absolute deviation (MAD) 
of experimental data and y-axis error bars represent MAD for in silico data points. For each in silico data 
series the PCC and mean squared error (MSE) are calculated (n = 3) and listed. 
 
Linear transformation of in silico data was applied to obtain comparable scales and 
different MD simulation refinement settings were used to determine the effects on in silico 
Structure MSE PCC
Homology 0.64 0.915
WoS w/o H++ 0.38 0.954
WoS A03 0.58 0.922
WoS 0.45 0.946
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generated data and the respective correlation to experimentally determined zeta potential. 
Linear transformation resulted in ranking three VLPs according to their zeta potential. 
Figure 7.6 shows that zeta potentials of complete chimeric VLPs were ranked correctly by 
all dimer structures, which causes overlaying symbols at [-11.70, -11.70] and [-7.94, -7.94]. 
The main difference is seen for VLP C, which has an experimental zeta potential of -9.50 
± 0.69 mV. This data point was used to evaluate the influence of pKa value computation 
method and force field selection on in silico surface charge calculations. The evaluation 
parameters, PCC and MSE, are listed for each data series in Figure 7.6. A PCC value above 
0.900 indicates a strong linear dependency with experimental data344. This was seen for all 
evaluated data series because of the limited dataset size, but small differences were 
observed for VLP C’s surface charge. WoS simulated without H++ pKa values and WoS 
with H++ pKa values showed the highest PCC, with values of 0.954 and 0.946, 
respectively. Transformed VLP C surface charges for WoS w/o H++ (-8.44 ± 1.18) and 
WoS with H++ (-8.33 ± 1.43) were also comparable, which resulted in a 0.07 MSE 
difference in favor of WoS w/o H++. The WoS transformed surface charge distribution, 
represented by the MAD, shows an overlap between these two values. This indicates there 
is no significant influence of the used pKa value computation methods in correlation to 
experimental data. This result was reproducible (data shown in Supplementary Material 
Figure E2 to Figure E5). Transformed surface charges based on the homology structure (-
10.89) and WoS A03 (-10.82 ± 1.11) showed a weaker correlation than the WoS previously 
discussed. This is shown by MSE values of 0.64 and 0.58, respectively. Linear dependency 
is also weaker compared to the other two WoS, where the homology structure showed a 
PCC of 0.915 and WoS obtained with AMBER03 showed a PCC of 0.922. As mentioned 
during the discussion of the MD simulations, VLP A did not complete step 2 and VLP C 
did not reach a WoS when the AMBER03 force field was used during MD simulation. 
Presumably this also caused the decreased correlation to experimental data. This leads to 
the conclusion that for this case study the largest positive effect was obtained with the 
YASARA2 force field, regardless of the used pKa values, when evaluating the correlation 
between in silico HBcAg dimer surface charge and complete chimeric VLP zeta potential. 
The observed force field effect should be confirmed with a larger dataset. Nevertheless, 
results indicate that surface properties extracted from structures obtained with the presented 
pipeline can represent experimental behavior. It should be noted that the applicability of 
chimeric dimer 3-D structure surface charge to quantitatively predict complete chimeric 
VLP zeta potential lies outside the scope of this case study, and should be investigated 
using a more diverse sample space.   
 
All evaluated WoS show a relatively large coefficient of variation (10% – 16%) regarding 
the in silico zeta potential, which means there is a significant variation in protein surface 
property value within the WoS. For example, VLP A simulated with H++ pKa values and 
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the YASARA2 force field resulted a maximum in silico zeta potential of -5.74 mV and 
minimum of -11.07 mV within its 2 ns WoS. This emphasizes cautiousness regarding the 
use of a single MD simulation snapshot because a snapshot can theoretically take any 
random value within the WoS. The use of a single snapshot can decrease correlation 
accuracy and thereby reduce the reliability of computational protein structure-based 
models. Therefore, a robust central tendency describing statistic which is less sensitive for 
outliers, such as the median345, is considered appropriate for the extraction of protein 
surface property information within a WoS. The presented computational pipeline did not 
only show the potential of a high-throughput approach for 3-D structure preparation, but 
also how a WoS can provide an objective MD simulation termination to reduce 
computational effort and a robust descriptor extraction platform. The approach could be 
used for other proteins, such as antibodies, and other prediction targets, such as assembly 
competence, solubility, or surface hydrophobicity. A variety of proteins and other 
prediction targets should be investigated to determine the full potential of the proposed 
computational 3-D structure preparation pipeline. 
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7.4 Conclusion 
A computationally inexpensive, fully automated, and data-dependent pipeline for high-
throughput 3-D protein structure preparation and refinement was constructed and evaluated 
using a case study of three chimeric HBcAg dimers. Structure quality, computational 
speed, simulation stability, and zeta potential correlation have been evaluated for three 
different simulation settings. This was done by homology modeling and subsequent 
structure refinement with 2 different force fields (YASARA2 or AMBER03) and 2 
different pKa values (H++ or YASARA computed pKa values). All evaluation parameters 
showed to be mainly influenced by the choice of force field, where YASARA2 showed a 
more stable performance than AMBER03. YASARA2 simulations using either pKa 
computation method resulted in comparable average quality Z-score (-1.17 and -1.13). All 
three chimeric HBcAg dimer structures, modelled and refined with YASARA2, were 
obtained within 59.6 to 66.0 hours (in silico time of ~4 ns to ~20 ns per structure) on a 
powerful yet ordinary desktop computer. These simulation times were ~2.4 times shorter 
than simulations using the AMBER03 force field. Computational efficiency was achieved 
by designing a 3-step MD simulation refinement complementary to the structures in 
question. This design resulted in simulating 31.2% to 69.2% of the total RMSD change in 
3.6% to 12.5% of the simulation time. In addition, homology model refinement included a 
data-dependent simulation termination based on a 2 ns window of stability, which was also 
used for robust surface property descriptor extraction. Validity of the calculated surface 
property was exemplarily evaluated by correlating in silico determined surface charge, 
based on the chimeric HBcAg dimer structures, to experimental zeta potential of the entire 
VLP structure. The use of dimers instead of entire VLP structures contributed to the relative 
short simulation time, while a high correlation (PCC of ~0.950) to experimental zeta 
potential was maintained. The case study showed promising results for high-throughput in 
silico surface property screening, but its full potential should be further explored with a 
larger dataset. The simple, standardized, and automated framework allows for the 
implementation of the computational pipeline in manufacturability and formulability 
screening studies for early candidate assessment. 
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8  Conclusion 
 
This thesis focused on the design and implementation of computational methods applicable 
for the analysis of long-term protein phase behavior. The employed computational methods 
include unsupervised and supervised machine learning approaches, with an emphasis on 
data-dependent automation of what were previously manual procedures. Unsupervised 
multidimensional data visualization was applied for a comprehensive and complete 
representation of data obtained from long-term protein phase behavior experiments. The 
resulting MPPDs allowed for the identification of subtle kinetic and morphological changes 
as a function of applied environmental conditions. A supervised image recognition 
algorithm was implemented to reduce the manual effort required for image-based feature 
extraction, a necessary step to construct MPPDs. To improve image recognition accuracy 
for automated evaluation of long-term protein phase behavior studies, the combination of 
three light sources (visible, cross polarized, and UV light) and kinetic features was 
investigated. The additional information returned by cross polarized light, UV light, and 
kinetic data resulted in a 17.3 percent point increase in balanced accuracy compared to the 
use of only end point visible light images. Subsequent connection of the supervised image 
recognition algorithm to unsupervised multidimensional MPPD construction resulted in an 
automated workflow that mines raw images to classify protein phase diagrams and 
constructs MPPDs.  
 
Unsupervised multidimensional data visualization was also applied to investigate the 
correlation between empirical properties obtained directly after formulation preparation 
and long-term protein phase behavior. This resulted in the construction of an EPPD, a 
figure containing short-term data from six different analytical techniques. The EPPD 
showed partial correlation to long-term protein phase behavior represented by the MPPD. 
This indicated the applicability of short-term empirical data for the design of rational and 
knowledge-based long-term stability screenings. The developed workflow was 
subsequently applied to an industry case study to identify long-term stable glycerol-poor 
and glycerol-free food protein formulations. This led to the identification of apparent 
protein surface hydrophobicity and electrostatic repulsive forces as product-specific targets 
to enhance stability.  
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To construct predictive models for long-term protein phase behavior based on in silico 
generated protein properties by means of MD simulations, an automated pipeline for high-
throughput 3-D structure preparation and refinement was developed and evaluated. Due to 
its computational inexpensiveness and data-dependent framework, the largest structural 
errors were refined within only 3.6-12.5% of the total computational time, leading to an 
automated refinement within 6.6-37.5 hours. A case study was performed with a relatively 
small set of three dimeric VLP capsid protein structures, which indicated the advantages 
of the presented automated structure preparation pipeline for large scale screening 
purposes.  
 
In conclusion, this thesis explored and applied computational methods to automatically 
extract data from protein phase behavior experiments and visualize such multidimensional 
dataset for straightforward interpretation. The obtained information was used to assess the 
correlation between long-term protein phase behavior and short-term multidimensional 
empirical data sets. In addition, a contribution was made for the in silico generation of 
protein properties by developing of a high-throughput 3-D protein structure preparation 
pipeline. The efforts reported in thesis and in literature, in combination with the challenges 
that still need to be resolved, shape an outline of the computer-supported and knowledge-
based infrastructure required to rationally and systematically develop long-term stable 
protein formulations in a shorter time frame.  
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The correlation between short-term empirical properties and long-term protein phase 
behavior was shown retrospectively in this thesis, as long-term protein phase behavior 
experiments were performed for the verification of the found short-term empirical profiles. 
This time-consuming step will still be required when other proteins are investigated due to 
the unique stability behavior of different proteins, or when different additives are used 
which may lead to different stabilizing pathways. Thus, an internal standard representing 
the protein and its corresponding potential stabilizing pathways is currently necessary in 
order to verify the correlation between short-term empirical data and long-term phase 
behavior. A standard-free and indisputable verification of the predictive capacity of short-
term measurable or computable properties is the most challenging task to complete in order 
to eliminate the long experimental time required for the demonstration of protein-product 
shelf life. Without a reliable correlation between short-term effects and results obtained 
with the established long-term methods, short-term protocols cannot be accepted by 
regulatory agencies as a stand-alone product assessment. To verify the correlation, 
advanced, well-defined, physically realistic in silico simulations are required, in addition 
to short-term empirical measurements and machine learning approaches trained on 
previous protein-product formulations results. Key to the construction of such an 
infrastructure is the collaboration between the biotechnology industry and academia. Over 
the past decades a large amount of data for successful long-term formulation has been 
generated. In addition, there is even more data available on the many failed attempts, which 
should not be considered unimportant. Currently, this large amount data acquired on 
successes, and even more failures, in long-term protein phase behavior studies is not shared 
between industry and academia. One of the first steps to solve this mutual knowledge gap 
is mining these important sources.  
 
The presented short-term characterization and visualization of protein phase behavior 
under a variety of environmental conditions is not only applicable to study long-term 
protein phase behavior for effective formulation development. In fact, environmental 
conditions are continuously changed during downstream processing (DSP) in order to 
obtain a pure product. In addition, fluctuations in the environment during upstream 
processing (USP) influence product stability due to variations in system properties such as 
9 
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impurity content. A correlation between USP and DSP environmental conditions, short-
term empirical properties, and protein stability would be interesting to investigate. This 
may lead to machine learning approaches that do not only select process parameters 
optimized towards yield and purity, as is currently done for USP and DSP, but also 
incorporate protein stability as an optimization target.  
 
As mentioned above, the prediction of protein stability will undoubtedly include in silico 
generated protein properties. However, standardized guidelines and quality control 
protocols for the development of MD simulation workflows to reliably extract the desired 
in silico protein property data are currently missing. The know-how of computational 
workflows should be more widely discussed in order to obtain higher quality studies which 
focus on the generation and exploration of these in silico generated protein properties. The 
guidelines should include, but are not limited to, the required number of protein structures 
in training sets, an assessment on a representative variety of biophysical protein properties 
in training sets, standardized protocols for probing MD simulation settings, and comparable 
evaluation parameters. Once a well-defined infrastructure is realized, it would be desired 
to generate an in silico protein property diagram to complement the EPPD and MPPD. In 
addition, the generation of predictive models for analytical techniques, such as for M3-
PALS to obtain the zeta potential or the stalagmometric method to obtain the apparent 
surface hydrophobicity, would be of interest to move towards an in silico predicted EPPD.  
 
In general, machine learning is increasingly applied in the biotechnological field. 
Currently, so-called black box algorithms, such as artificial neural networks, are used to 
identify data patterns in dimensions experimenters cannot comprehend or interpret. 
However, the obtained patterns should be translated to biologically relevant and transparent 
information, which will allow experimenters to move away from black box approaches. In 
turn, pattern interpretation allows for data utilization to control and predict current 
biological uncertainties. Inherent to the use of machine learning approaches for pattern 
recognition or data utilization, is the need for consistent data acquisition in order to retrieve 
reliable information. Experimental deviations should be minimized via reproducible, high-
throughput, automated, and systematic approaches. In addition, limitations of applied 
algorithms should be carefully evaluated and discussed in order to prevent an under- or 
overestimation of its applicability. To reach the desired understanding and control, future 
research requires a continuing exploration and expansion of the symbiotic relationship 
between experimenters, robotics, sensors, and data handling algorithms in all stages of 
biotechnological product development. 
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Appendix A  
 
Supplementary Material Chapter 3 
A.1 Internal feature correlation 
Strong internal correlation between image features is not desired, as two (or more) 
correlated features may over represent a phase behavior property compared to a phase 
behavior property represented by one feature. The Pearson correlation coefficient is used 
as a measure of internal correlation strength. A threshold of 0.850 for either positive or 
negative correlation is used in this work. Supplementary Table A1 shows the results for 
each of the extracted image features. With the set threshold the precipitation diameter and 
the precipitation intensity are strongly correlated, indicated in red. This led to the removal 
of the precipitation intensity from the feature dataset. 
 
Table A1: Pearson correlation coefficient matrix between all extracted image features. Red highlighted 
numbers indicate a violation of the set threshold (-0.850 < x < 0.850). 
 
 
  
1 2 3 4 5 6 7 8 9
1 Length crystal
2 Number of crystals 0.826
3 Crystal onset time 0.334 0.289
4 Crystal growth time 0.802 0.625 0.475
5 Precipitation diameter 0.319 0.327 0.266 0.212
6 Precipitation intensity 0.297 0.319 0.240 0.207 0.952
7 Precipitation onset time 0.269 0.295 0.429 0.218 0.794 0.752
8 Precipitation growth time 0.136 0.168 0.223 0.089 0.528 0.536 0.581
9 IQR ratio crystal length-width 0.531 0.478 0.441 0.489 0.184 0.184 0.253 0.108
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A.2 Feature reproducibility 
Each stored condition was made in duplicate. To show the level of reproducibility of the 
phase behavior, an overview of 6 image features for each of the duplicate conditions for 
lysozyme at pH 9 in the presence of ammonium sulfate is shown in Supplementary Figure 
A1. 
 
Figure A1: Untreated extracted image features for replicates plates containing lysozyme at pH 9 in the 
presence of ammonium sulfate. The crystal length (LC) in μm, number of crystals (nC), crystal onset time 
(tC) in hours, crystal growth time (ΔtC) in hours, precipitation onset time (tP) in hours and precipitation 
diameter (DP) in μm are colored according to their value. White indicates the minimum value and blue 
indicates the maximal value. 
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A.3 Visible and UV light images 
UV light imaging is used to distinguish between protein and non-protein crystallization 
and/or precipitation based on UV light signal. In Supplementary Figure A2 example images 
for visible and UV light are shown for 5 different observations. 
 
 
Figure A2: Examples of visible light (first column) and UV light (second column) images for (A) clear 
solution, (B) crystallized protein, (C) precipitated protein, (D) non-protein precipitation, and (E) 
crystallized protein in the presence of non-protein precipitation. 
  
White light UV light
A. Clear
B. Crystal
D. Non-protein precipitate
C. Protein precipitate (20 g\L lysozyme, 2.2M NaCl)
E. Crystal + non-protein precipitate
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Appendix B 
 
Supplementary Material Chapter 4 
B.1 Example class images 
An overview of example images can be found in Figure B1.  
 
 
Figure B1: Examples of visible light (first column), cross polarized light (second column), and UV light (third column) 
images for the employed classification classes “clear”, “crystal”, “precipitate”, and “other”. For the class “other”, 
three examples are shown.  
 
Figure B1 shows examples of obtained images for each class. The class “other” shows 
three different examples, where the first example shows light precipitation, which does not 
light up in the corresponding UV image. The second example shows microbial instability 
and the third example shows the presence of a hair/dust particle in the formulation well.  
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B.2 Image schedule 
The employed image schedules are listed in Table B1. 
Table B1: Detailed overview of the imaging schedule used per storage time, for each light source. 
 
The imaging schedules in Table B1 resulted in a total of 57 images per well for 14 days of 
storage and 67 images per well for 30 days of storage.  
 
B.3 Image masking 
Images obtained with visible light and cross polarized light were cropped with black pixels 
(also known as a mask) to remove irrelevant data from the images. The well walls and part 
of the plate were considered to be irrelevant. Masking was also used for visible light and 
cross polarized light images after edge detection. The second mask was used to remove 
sharp lines a mask leaves in an image, which are often recognized as edges. An example 
of the first and second mask is shown in Figure B2, for all light sources. 
 
Figure B2: Example images during image feature extraction. First column, “Original”: original image for 
each light source (visible, cross polarized, and UV light); second column, “Cropped”: cropped visible light 
and cross polarized light images; third column, “Edge detection”: edge detection results for all light images 
using the image in the previous column; fourth column, “2nd cropping”: removal of the mask wall for 
visible light and cross polarized light images. 
 
14 days 30 days 
Visible light 
Cross polarized and 
UV light 
Visible light 
Cross polarized and 
UV light 
Day 0 to 1: Every 2 hours 
Day 1 to 2: Every 4 hours 
Day 2 to 6: Every 6 hours 
Day 6 to 14: Every 24 hours 
Hours: 0 and 4 
Day: 1, 4, 7, 10, and 14 
Day 0 to 2: Every 2 hours 
Day 2 to 6: Every 6 hours 
Day 6 to 30: Every 24 hours 
Hours: 0 and 22 
Days: 5, 10, 20, and 30 
Original Cropped
Visible
Cross polarized
UV
Edge detection 2nd cropping
152 
 
Figure B2 shows different images throughout the image extraction workflow, for each light 
source. The original image shows that visible light and cross polarized light capture the 
liquid formulation and a part of the plate well. UV light images are obtained with a larger 
zoom, 7x instead of 2.5x. Therefore, a close up of what is seen in visible light and cross 
polarized light images is visible in UV light images. This is also the reason why cropping 
is not needed for UV light images. The cropped version of visible light and cross polarized 
light images is seen in the second column, “Cropped”. The cropped image is used for edge 
detection, the result is shown in the third column (“Edge detection”). Edge detection with 
visible light and cross polarized light images resulted in a mask edge as well. This was 
resolved by masking the result of edge detection once more. The fourth column (“2nd 
cropping”) shows the final image. 
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B.4 Overview all image features 
Table B2 lists all image features that were extracted for each light source image.  
Table B2: Overview of all image features extracted for each light source. 
Histogram features Description 
ER Entropy of the red color level image 
EG Entropy of the green color level image 
EB Entropy of the blue color level image 
EGray Entropy of the gray image  
MR Mean pixel level of the red color level image 
MG Mean pixel level of the green color level 
MB Mean pixel level of the blue color level 
MGray Mean pixel level of the gray image  
VR Variance of the image histogram for the red color level 
VG Variance of the image histogram for the green color level 
VB Variance of the image histogram for the blue color level 
VGray Variance of the image histogram for the gray image 
SDR Standard deviation of the image histogram for the red color level 
SDG Standard deviation of the image histogram for the green color level 
SDB Standard deviation of the image histogram for the blue color level 
SDGray Standard deviation of the image histogram for the gray image 
SkR Skewness of the image histogram for the red color level 
SkG Skewness of the image histogram for the green color level 
SkB Skewness of the image histogram for the blue color level 
SkGray Skewness of the image histogram for the gray image 
KtR Kurtosis of the image histogram for the red color level 
KtG Kurtosis of the image histogram for the green color level 
KtB Kurtosis of the image histogram for the blue color level 
KtGray Kurtosis of the image histogram for the gray image 
GLMC features Description 
autoc Autocorrelation 
contr Contrast 
corm Correlation (MATLAB) 
corrp Correlation 
cprom Cluster prominence 
cshad Cluster shade 
dissi Dissimilarity 
energy Energy 
entro Entropy 
homom Homogeneity (MATLAB) 
homop Homogeneity 
maxpr Maximum probability 
sosvh Sum of squares (variance) 
savgg Sum of average 
svarh Sum of variance 
senth Sum of entropy 
dvarh Difference variance 
denth Difference entropy 
inf1h Information measure of correlation1 
infh2 Information measure of correlation2 
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indnc Inverse difference normalized 
idmnc Inverse difference moment normalized 
Blob features Description 
BlobArea The total area of all identified blobs 
BlobAmount The total number of identified blobs 
Features over time Description 
Intensity  Total sum of pixel intensity of the gray scale image, for each time point 
Intensity difference Total sum of pixel intensity of the obtained difference image t0 - tx, for each time point 
 
B.5 Overview of multidimensional protein phase diagram 
features 
Table B3 lists all image features that were extracted to construct the multidimensional 
protein phase diagrams.  
 
Table B3: Image-based features extracted from visible, cross polarized, and UV light images for the 
automated construction of a multidimensional protein phase diagram. 
Blob  Description Extraction class 
Aggregation area Sum of the area of all blobs Crystal/Precipitate 
Crystal area Mean area of all blobs Crystal 
Crystal count Total number of blobs  Crystal 
Crystal length Mean blob major axis length  Crystal 
Intensity  Description Extraction class 
Intensity difference Total pixel intensity of the difference between the last and first 
image (tend – t0) 
Crystal/Precipitate 
Start intensity Total pixel intensity of the first image  Crystal/Precipitate 
Time-dependent Description Extraction class 
Growth time Time point at which a plateau in the intensity change was identified Crystal/Precipitate 
 
The extraction class is indicated to show for which predicted class the features were 
extracted. 
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B.6 Number of trees determination 
The number of trees that are needed to construct a random forest classification model was 
determined by investigating the effect of the number of trees on the Out-of-Bag 
classification error. This was investigated with the Vis+CP+UV+Time feature set and the 
results are shown in Figure B3.  
 
Figure B3: Out-of-Bag classification error over the number of trees. 
 
Based on the results shown in Figure B3, the number of trees was set to 100. 
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B.7 Selected features per feature set 
Image feature selection was performed for each fold and each image feature set during 
internal 10-fold cross validation. Between different folds for the same image feature set, 
similar features were selected. The selected features are listed in Table B4 per feature set.  
 
Table B4: Overview of features selected during 10-fold cross validation for all evaluated feature sets. 
 
 
  
 Vis Vis+Time Vis+CP Vis+UV Vis+CP+UV Vis+CP+UV+Time 
1 EB_Vis EG_Vis ER_Vis ER_Vis ER_Vis ER_Vis 
2 MR_Vis MR_Vis EG_Vis EG_Vis EG_Vis EG_Vis 
3 VR_Vis VR_Vis EB_Vis EB_Vis EB_Vis EB_Vis 
4 KtR_Vis AmountBlobs_Vis MR_Vis BlobArea_Vis VR_Vis VR_Vis 
5 BlobArea_Vis contr_Vis VR_Vis AmountBlobs_Vis VB_Vis BlobArea_Vis 
6 AmountBlobs_Vis energ_Vis VB_Vis contr_Vis BlobArea_Vis AmountBlobs_Vis 
7 contr_Vis inf2h_Vis KtR_Vis dissi_Vis AmountBlobs_Vis contr_Vis 
8 energ_Vis EndInt_Vis BlobArea_Vis inf2h_Vis contr_Vis corrm_Vis 
9 inf2h_Vis EndInt_CP AmountBlobs_Vis ER_UV corrm_Vis dissi_Vis 
10  EndInt_UV contr_Vis MR_UV cprom_Vis energ_Vis 
11   energ_Vis SkR_UV cshad_Vis entro_Vis 
12   inf2h_Vis KtR_UV dissi_Vis inf2h_Vis 
13   EB_CP BlobArea_UV entro_Vis EndInt_Vis 
14   VR_CP AmountBlobs_UV inf2h_Vis ER_CP 
15   VB_CP contr_UV AmountBlobs_CP AmountBlobs_CP 
16   SkB_CP corrm_UV ER_UV EndInt_CP 
17   BlobArea_CP cshad_UV MR_UV ER_UV 
18   AmountBlobs_CP  SkR_UV MR_UV 
19   corrm_CP  KtR_UV VR_UV 
20     BlobArea_UV SkR_UV 
21     AmountBlobs_UV KtR_UV 
22     contr_UV BlobArea_UV 
23     corrm_UV AmountBlobs_UV 
24     cshad_UV contr_UV 
25     energ_UV corrm_UV 
26     inf1h_UV cshad_UV 
27     inf2h_UV inf2h_UV 
28      EndInt_UV 
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B.8 Evaluation parameters per class per feature set 
Recall, precision, accuracy, and balanced accuracy were obtained for each class separately 
during 10-fold cross validation. Table B5 lists all evaluation parameters per class for each 
feature set. 
 
Table B5: Overview of all evaluation parameters (recall, precision, accuracy, and balanced accuracy) for 
all evaluated feature sets, shown per classification class. The values are given as mean ± standard 
deviation, obtained by each fold during 10-fold cross validation.  
Feature set: Vis 
 Recall [%] Precision [%] Accuracy[%] Balanced accuracy [%] 
Clear 95.0 ± 1.0 81.0 ± 1.5 82.8 ± 1.5 88.0 ± 0.9 
Precipitate 63.4 ± 12.2 81.7 ± 7.7 97.8 ± 0.4 72.5 ± 5.8 
Crystal 64.1 ± 4.9 85.6 ± 3.5 89.1 ± 1.1 74.8 ± 2.8 
Non-protein 29.5 ± 8.8 53.9 ± 9.5 91.0 ± 1.0 41.7 ± 7.8 
Feature set: Vis + Time 
 Recall [%] Precision [%] Accuracy[%] Balanced accuracy [%] 
Clear 95.5 ± 1.8 83.2 ± 1.1 84.9 ± 1.2 89.3 ± 1.0 
Precipitate 64.3 ± 11.7 83.9 ± 7.3 98.0 ± 0.6 74.1 ± 8.4 
Crystal 67.1 ± 3.6 88.7 ± 3.6 90.3 ± 1.0 77.9 ± 2.5 
Non-protein 45.6 ± 4.2 65.5 ± 9.9 92.5 ± 1.1 55.5 ± 6.0 
Feature set: Vis + CP 
 Recall [%] Precision [%] Accuracy[%] Balanced accuracy [%] 
Clear 96.3 ± 1.0 81.8 ± 1.1 84.1 ± 1.3 89.0 ± 0.9 
Precipitate 61.3 ± 10.4 85.6 ± 7.6 97.9 ± 0.5 73.4 ± 7.0 
Crystal 68.9 ± 3.7 90.1 ± 2.7 90.9 ± 1.0 79.5 ± 2.4 
Non-protein 27.7 ± 7.5 54.2 ± 10.1 91.0 ± 1.1 41.0 ± 8.0 
Feature set: Vis + UV 
 Recall [%] Precision [%] Accuracy[%] Balanced accuracy [%] 
Clear 97.1 ± 0.8 87.9 ± 1.5 89.7 ± 1.2 92.5 ± 0.8 
Precipitate 82.8 ± 14.2 94.2 ± 5.8 99.1 ± 0.7 88.5 ± 8.8 
Crystal 86.5 ± 2.8 97.2 ± 1.5 96.3 ± 0.7 91.9 ± 1.5 
Non-protein 42.6 ± 7.7 69.3 ± 8.7 92.9 ± 1.0 56.0 ± 7.7 
Feature set: Vis + CP + UV 
 Recall [%] Precision [%] Accuracy[%] Balanced accuracy [%] 
Clear 97.1 ± 0.9 88.0 ± 1.2 89.8 ± 1.0 92.6 ± 0.7 
Precipitate 84.2 ± 12.7 94.5 ± 5.5 99.1 ± 0.6 89.4 ± 7.5 
Crystal 87.1 ± 2.2 96.6 ± 1.9 96.3 ± 0.7 91.8 ± 1.6 
Non-protein 41.3 ± 6.1 70.1 ± 7.9 92.8 ± 0.9 55.7 ± 6.4 
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B.9 Correlation coefficient matrix 
The first step during feature selection was filtering based on internal correlation with the 
Pearson correlation coefficient. A correlation coefficient matrix is often used to visualize 
the correlation coefficient between variables in a dataset. The correlation coefficient matrix 
consisting of all features extracted for the Vis+CP+UV+Time dataset is shown in Figure 
B4. 
 
Figure B4: Correlation coefficient matrix, based on the Pearson correlation coefficient, for all 150 
extracted image features. The color bar indicates the Pearson correlation coefficient value, where +1 (red) 
indicates a strong positive linear dependency and -1 (blue) indicates a strong negative linear dependency 
between variables. 
 
All image features with a linear dependency higher than +0.950 or lower than -0.950 have 
been removed from the dataset during feature selection.  
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B.10 Feature importance 
The second step during feature selection was selecting features based on their relative 
importance to the classification problem in question. The feature importance per evaluated 
feature is shown in Figure B5. 
 
Figure B5: Feature importance of all features that remained after feature removal based on internal 
correlation. The red line indicates the cut-off value at the 50th percentile of the feature importance. 
 
All image features depicted in Figure B5 with a feature importance below the 50th 
percentile value were removed during feature selection.  
 
B.11 Confusion matrix Vis+CP+UV+Time 
Table B6 lists all confusion matrices obtained during 10-fold cross validation using the 
Vis+CP+UV+Time feature set. 
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Table B6: List of all confusion matrices obtained during 10-fold cross validation with the Vis+CP+UV+Time feature set. 
 Fold #1 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 290 0 2 4 
Precipitate 1 19 0 0 
Crystal 14 0 95 1 
Non-protein 12 0 0 32 
 Fold #2 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 289 0 2 6 
Precipitate 3 16 1 0 
Crystal 9 0 101 0 
Non-protein 11 0 0 33 
 Fold #3 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 291 0 1 5 
Precipitate 2 18 0 0 
Crystal 12 2 95 1 
Non-protein 15 0 0 29 
 Fold #4 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 285 2 2 8 
Precipitate 2 17 0 1 
Crystal 14 1 94 1 
Non-protein 16 0 1 27 
 Fold #5 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 289 1 2 5 
Precipitate 1 16 2 0 
Crystal 17 1 89 3 
Non-protein 21 0 0 24 
 Fold #6 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 292 0 1 4 
Precipitate 4 14 1 0 
Crystal 15 0 93 2 
Non-protein 14 0 2 28 
 Fold #7 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 285 0 3 9 
Precipitate 1 18 0 0 
Crystal 13 1 94 2 
Non-protein 17 0 0 27 
 Fold #8 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 288 0 1 8 
Precipitate 1 18 0 0 
Crystal 16 0 94 0 
Non-protein 14 0 0 30 
 Fold #9 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 282 0 3 12 
Precipitate 1 17 2 0 
Crystal 9 2 97 1 
Non-protein 10 0 0 34 
 Fold #10 Predicted class 
T
r
u
e 
c
la
ss
  Clear Precipitate Crystal Non-protein 
Clear 284 0 2 10 
Precipitate 6 10 4 0 
Crystal 9 1 98 2 
Non-protein 13 0 0 31 
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Appendix C 
 
Supplementary Material Chapter 5 
C.1 Stalagmometer 
To decrease experimental time and sample volume, the high-throughput stalagmometer 
setup was adjusted to a lower sample volume and fewer repeat dispenses. The results of an 
evaluation run with water is shown in Figure C1.  
 
Figure C1: Difference between the (a) original and (b) adjusted experimental setup for stalagmometer 
measurements. The standard deviation (standard dev) and relative standard deviation (relative st. dev.) are 
used as evaluation parameters. In addition, the mean weight and number of drops is listed. 
 
Due to a lower dispense volume, the drop mass decreased from 20.4 milligram to 12.5 
milligram. The number of drops decreased from 7079 to 613 due to the decrease in sample 
volume and number of repeat dispenses. Less dispensed drops resulted in a 2.5-fold shorter 
experimental time. The adjustments resulted in 2-fold increase of standard deviation 
(3.22·10-4 to 6.18·10-4 gram) and a 3.4% higher relative standard deviation. 
  
80 µl 
2x dispensing 
Mean [gram] 0.0125
Standard dev [gram] 6.18·10-4
Relative st.dev. 4.95%
Number of drops 613
500 µl 
5x dispensing 
Mean [gram] 0.0204
Standard dev [gram] 3.22·10-4
Relative st.dev. 1.58%
Number of drops 7079
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C.2 Internal correlation 
Strong internal correlation between empirical protein properties is not desired, as two (or 
more) correlated properties may over represent a single system property. The Pearson 
correlation coefficient is often used as measure for internal correlation strength. A 
threshold of 0.750 for either positive or negative correlation is used in this study. Table C1 
shows the results for each of the extracted empirical protein properties. No properties were 
removed based on the set threshold.  
 
Table C1: Pearson correlation coefficient matrix for all empirical protein properties. 
 
  
 
RH App ζ γ TAgg TM β-turn α-helix Coil 
RH App 1 
       
ζ -0.345 1 
      
γ -0.263 -0.287 1 
     
TAgg -0.717 0.351 0.145 1 
    
TM -0.496 -0.020 0.265 0.255 1 
   
β-turn 0.185 0.122 -0.058 -0.168 -0.393 1 
  
α-helix 0.138 -0.284 0.385 -0.150 0.173 -0.069 1 
 
Coil -0.226 -0.232 0.392 0.182 0.470 -0.438 0.568 1 
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C.3 Cluster information 
An overview of the exact median and median absolute deviation values for the clusters 
presented in the empirical protein property diagram are shown in Table C2. 
 
Table C2: Overview of median ± median absolute deviation of the empirical protein properties per cluster 
identified in the empirical protein property diagram.  
 
  
 
A B C D E F 
RH App [nm]  1.4 ± 0.2 1.8 ± 0.3 2.2 ± 0.2 2.1 ± 0.3 2.3 ± 0.1 2.6 ± 0.3 
ζ [mV]  3.8 ± 2.1 2.6 ± 1.3 1.1 ± 1.1 0.2 ± 1.7 -1.5 ± 1.8 3.1 ± 1.9 
γ [-]  1.14 ± 0.02 1.07 ± 0.02 1.14 ± 0.03 1.17 ± 0.02 1.04 ± 0.03 1.04 ± 0.02 
TAgg [°C]  88.5 ± 0.9 56.7 ± 5.9 37.4 ± 3.2 39.0 ± 3.5 33.1 ± 1.9 35.2 ± 4.6 
TM [°C]  67.2 ± 4.0 68.8 ± 3.3 67.8 ± 3.4 68.9 ± 3.5 63.7 ± 2.2 63.2 ± 2.6 
β-turn [AU/(cm-1)2] · 105  16.2 ± 1.8 15.0 ± 2.1 16.2 ± 2.0 15.2 ± 3.7 16.6 ± 2.3 18.9 ± 1.1 
α-helix [AU/(cm-1)2] · 105 80.0 ± 8.1 83.2 ± 6.3 86.5 ± 7.1 97.3 ± 13.6 73.1 ± 12.8 84.2 ± 7.4 
Coil [AU/(cm-1)2] · 105 28.1 ± 6.9 28.4 ± 2.9 29.7 ± 4.0 34.0 ± 8.0 16.4 ± 3.0 16.5 ± 3.9 
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C.4 Dynamic light scattering data 
Exemplary plots of the apparent hydrodynamic radius (RH App) as a function of lysozyme 
concentration are shown in Figure C2.  
 
Figure C2: Apparent hydrodynamic radius (RH App) plotted against lysozyme concentration for (a) 0 mM 
ammonium sulfate ((NH4)2SO4); (b) 175 mM (NH4)2SO4; (c) 0 mM sodium chloride (NaCl); (d) 175 mM 
NaCl at pH 3 (gray), pH 5 (black), pH 7 (green), and pH 9 (blue). The equation for a linear fit is given for 
each data series and the error bars represent the standard deviation. 
 
Figure C2 shows the RH App plotted against lysozyme concentration for ammonium sulfate 
(Figure C2a and Figure C2b) and sodium chloride (Figure C2c and Figure C2d) at two 
different ionic strengths (0 and 175 mM) four pH values (pH 3, 5, 7, and 9). Each subplot 
shows a negative slope for pH 3 that increases for increasing formulation pH. Increasing 
ionic strength also increases the slope, but to a lesser extent compared to formulation pH. 
A negative slope for increasing lysozyme concentrations indicates repulsive electrostatic 
interactions between the protein molecules, while a positive slope represents attractive 
interactions.   
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Appendix D 
 
Supplementary Material Chapter 6 
D.1 Viscosity 
Viscosity measurements were performed to correct the intensity-size distribution plots 
obtained with dynamic light scattering. The viscosity was measured by dissolving the 
additives in a pH 6.0 buffer containing 1.45 g/L methionine. An overview of the results is 
shown in Table D1.  
 
D.2 Image examples 
Figure D1 shows a representative example for each cluster identified in the 
multidimensional protein phase diagram (MPPD).  
 
 
Figure D1: Representative example images for each identified multidimensional protein phase diagram cluster. 
 
Cluster 1 Cluster 5
(Cross polarized
light to highlight
crystals)
Cluster 2 Cluster 6
(Cross polarized
light to highlight
crystals)
Cluster 3 Cluster 7
(Cross polarized
light to highlight
crystals)
Cluster 4
(UV-light to
highlight
crystals)
Cluster 8
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Table D1: Overview of mean viscosity values (mean η in kg/m·s) obtained for the listed formulation 
conditions, including the coefficient of variation (CV in %). 
D.3 MPPD cluster information 
Sugar type Sugar [g/L] NaCl [g/L] KCl [g/L] Glycerol [g/L] Mean η [kg/m·s] CV [%] 
Fructose 30 100 0 0 0.0017 0.31 
Fructose 80 100 0 0 0.0019 0.31 
Fructose 30 100 0 5 0.0022 0.26 
Fructose 80 100 0 5 0.0026 0.23 
Fructose 30 0 90 0 0.0020 0.41 
Fructose 80 0 90 0 0.0018 0.20 
Fructose 30 0 90 5 0.0024 0.23 
Fructose 80 0 90 5 0.0023 0.30 
Sucrose 30 100 0 0 0.0019 0.35 
Sucrose 80 100 0 0 0.0019 0.33 
Sucrose 30 100 0 5 0.0024 0.30 
Sucrose 80 100 0 5 0.0025 0.20 
Sucrose 30 0 90 0 0.0020 0.49 
Sucrose 80 0 90 0 0.0017 0.31 
Sucrose 30 0 90 5 0.0019 0.32 
Sucrose 80 0 90 5 0.0022 0.31 
Glucose 30 100 0 0 0.0017 0.35 
Glucose 80 100 0 0 0.0018 0.27 
Glucose 30 100 0 5 0.0022 0.24 
Glucose 80 100 0 5 0.0023 0.28 
Glucose 30 0 90 0 0.0016 0.28 
Glucose 80 0 90 0 0.0023 0.31 
Glucose 30 0 90 5 0.0020 0.34 
Glucose 80 0 90 5 0.0023 0.29 
Lactose 30 100 0 0 0.0017 0.29 
Lactose 80 100 0 0 0.0021 0.30 
Lactose 30 100 0 5 0.0023 0.29 
Lactose 80 100 0 5 0.0028 0.72 
Lactose 30 0 90 0 0.0016 0.41 
Lactose 80 0 90 0 0.0019 0.31 
Lactose 30 0 90 5 0.0021 0.30 
Lactose 80 0 90 5 0.0023 0.31 
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Each cluster identified within the MPPD consists of six image features. Each feature has a 
median and median absolute deviation within such a cluster. An overview of these values 
is shown in Table D2, per MPPD cluster.  
 
Table D2: Overview of median ± median absolute deviation values for all image-based features per 
multidimensional protein phase diagram cluster 
 
L
C
 [μm] W
C 
[μm] W
C
:L
C
 [-] t
0
 [hours] t
G
[hours] n
AGG
 [%] 
Cluster 1 0 ± 0 0 ± 0 0.0 ± 0.0 0 ± 0 0 ± 0 0 ± 0 
Cluster 2 0 ± 0 0 ± 0 0.0 ± 0.0 0 ± 0 361 ±2  9.3 ± 9.3  
Cluster 3 0 ± 0 0 ± 0 0.0 ± 0.0 0 ± 0 2 ± 1 52.5 ± 7.4 
Cluster 4 21 ± 5 13 ± 3 1.6 ± 0.3 174 ± 62  198 ± 62  0.5 ± 0.0 
Cluster 5 64 ± 17 39 ± 13 1.5 ± 0.3 312 ± 53 384 ± 53 1.5 ± 0.7 
Cluster 6 71 ± 21 45 ± 21 1.6 ± 0.3 168 ± 44 480 ± 71 3.0 ± 3.0 
Cluster 7 75 ± 17 43 ± 7 1.7 ± 0.4 0 ± 0 648 ± 107 28.8 ± 13.0 
Cluster 8 55 ± 25 39 ± 14 1.3 ± 0.2 0 ± 0 361 ± 10 41.2 ± 7.4  
 
A stability percentage per formulation condition was calculated based on the formulation 
for which the respective formulation condition showed an influence. The stability 
percentage represents the percentage of formulations that became stable after adjustment 
of the respective formulation condition. However, more cluster transformation were 
observed which did not result in physical stability. To quantify these transformations, a 
percentile contribution of all MPPD clusters was calculated per formulation conditions. 
These values are listed in Table S3. In addition, the number of formulations that were 
influence by the respective formulation condition is listed in Table D3 as well.  
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Table D3: Overview of all formulation percentages, based on the formulations where a change in physical 
stability or morphology was observed upon changing the respective variable.  
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D.4 Empirical protein property diagram cluster information 
Each cluster identified within the empirical protein property diagram (EPPD) consists of 5 
empirical protein properties. Each empirical protein property has a median and median 
absolute deviation within such a cluster. An overview of these values is shown in Table 
D4, per EPPD cluster.  
 
Table D4: Overview of median ± median absolute deviation values for all empirical protein properties 
per empirical protein property diagram cluster. Empirical properties obtained with the original 
formulation are also listed. 
 
R
H App
 [nm] R
H HWS
 [nm] T
M
 [°C] T
Agg
 [°C] γ
N
 [-] 
Cluster I 0.0 ± 0.0 743 ± 120 72.4 ± 3.0 65.1 ± 4.9 0.92 ± 0.04 
Cluster II 3.4 ± 0.5 396 ± 213 72.8 ± 1.2 61.1 ± 4.1 0.92 ± 0.04 
Cluster III 3.2 ± 0.4 78 ± 44 72.9 ± 1.4 55.1 ± 1.5 0.97 ± 0.04 
Cluster IV 3.3 ± 0.4 110 ± 47 67.7 ± 1.2 56.1 ± 1.1 0.88 ± 0.03 
Cluster V 3.2 ± 0.4 131 ± 82 76.1 ± 2.3 62.3 ± 2.6 0.95 ± 0.03 
Original 2.4 47 65.5 54.2 1.01 
 
A stability percentage was calculated per EPPD cluster. This was based on the percentage 
of formulations that were part of MPPD cluster 1, which represented physical stability. An 
overview of the composition of each EPPD cluster in terms of all MPPD cluster is shown 
in Table D5.  
 
Table D5: Overview of the composition of empirical protein property diagram clusters shown as the 
formulation percentage per MPPD cluster 
 
Cluster I Cluster II Cluster III Cluster IV Cluster V 
Cluster 1 12% 45% 64% 67% 75% 
Cluster 2 12% 6% 7% 0% 2% 
Cluster 3 24% 18% 18% 0% 4% 
Cluster 4 0% 0% 0% 6% 2% 
Cluster 5 0% 0% 7% 17% 8% 
Cluster 6 24% 6% 0% 6% 0% 
Cluster 7 24% 18% 0% 6% 8% 
Cluster 8 6% 6% 4% 0% 0% 
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Appendix E 
 
Supplementary Material Chapter 7 
E.1 Quality parameters 
Quality Z-score for each intermediate structure and WoS obtained in the proposed structure 
preparation pipeline is defined as the mean value of three separate WHAT IF parameter. 
The separate values are shown in Figure E1 for each intermediate structure and WoS for 
each VLP construct. 
 
Figure E1: Overview of WHAT IF quality factors for the template, homology structure, curated structure, 
window of stability (WoS) without H++ and the YASARA2 force field (“WoS w/o H++”), the prepared 
structure, WoS obtained with H++ and the AMBER03 force field (“WoS A03”), and WoS obtained with 
H++ and the YASARA2 force field (“WoS”). WHAT IF quality factors 3-D packing (QUACHK, black), 
Ramachandran Z-score (RAMCHK, dark gray) and backbone conformation (BBCCHK, light grey)299. 
 
Figure E1 shows 3 quality parameters for each VLP construct for each intermediate 
structure and WoS obtained with the proposed 3-D structure preparation workflow. The 
backbone parameter shows a decrease from the template to the homology model for each 
VLP structure. The backbone and 3-D packing quality parameter values for all VLP 
constructs and obtained structures are smaller than the template. The Ramachandran 
quality parameter shows fluctuation between intermediate structures and MD simulation 
WoS. The fluctuations are similar between VLP constructs. The lowest Ramachandran 
quality parameter is found for WoS A03, followed by the curated, prepared and template 
structure. The homology structure, WoS w/o H++, and WoS show an increase of the 
Ramachandran quality parameter. 
 
  
VLP A VLP B VLP C
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E.2 Reproducibility 
To determine the reproducibility of the proposed protein 3-D structure preparation pipeline, 
all VLP constructs were simulated on two different computers using H++ computed pKa 
values and the YASARA2 force field. The hardware setup of the second computer was 
similar, using a Windows 10 computer with an Intel i7-6700 CPU and a GeForce GTX 
1080 GPU. Reproducibility is evaluated based on obtained structure quality parameters, 
RMSD course during MD simulation, and correlation between the subsequent extracted 
surface charge descriptor and experimental zeta potential data. Figure E2 shows the quality 
Z-score plot for all intermediate structures and WoS obtained with the proposed structure 
preparation pipeline. All data is similar to the data presented in the main research article, 
except the WoS which was obtained using a different computer.   
 
Figure E2: Overview of quality Z-scores for the template, homology structure, curated structure, window 
of stability (WoS) without H++ and the YASARA2 force field (“WoS w/o H++”), the prepared structure, 
WoS obtained with H++ and the AMBER03 force field (“WoS A03”), and WoS obtained with H++ and 
the YASARA2 force field (“WoS”) on the second computer. The quality Z-score is an average value of 
the WHAT IF quality factors 3-D packing (QUACHK), Ramachandran Z-score (RAMCHK) and 
backbone conformation (BBCCHK) ) 299. A median value and median absolute deviation as error bar is 
shown for the WoS quality Z-scores. A dashed line is used to guide the eye between the different quality 
Z-scores. 
 
Figure E2 shows a quality Z-score of -1.16 ± 0.13, -1.20 ± 0.13, and -1.16 ± 0.14 for VLP 
A, B, and C, respectively. These quality Z-scores have a mean difference of 0.07 compared 
to the quality Z-scored obtained with the first computer. An overview of the separate 
quality parameter obtained for the VLP constructs simulated with the second computer are 
shown in Figure E3. 
VLP A
VLP B
VLP C
Template
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Figure E3: Overview of WHAT IF quality factors for the template, homology structure, curated structure, 
window of stability (WoS) without H++ and the YASARA2 force field (“WoS w/o H++”), the prepared 
structure, WoS obtained with H++ and the AMBER03 force field (“WoS A03”), and WoS obtained with 
H++ and the YASARA2 force field (“WoS”) on the second computer. WHAT IF quality factors 3-D 
packing (QUACHK, black), Ramachandran Z-score (RAMCHK, dark gray) and backbone conformation 
(BBCCHK, light grey)299. 
 
Figure E3 shows 3 separate WHAT IF quality parameters. A mean difference of 0.06, 0.10, 
and 0.06 was calculated using all VLP constructs simulated on the second computer in 
values for 3-D packing normality, Ramachandran plot position normality, and the 
backbone conformation, respectively. This indicates that quality was not influenced by 
simulation of identical constructs on another computer. The course of the MD simulation, 
represented by the change of atom coordinates over time was monitored for the simulations 
with the second computer as well. The obtained data is shown in Figure E4.  
 
VLP A VLP B VLP C
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Figure E4: Reproducibility run of MD simulations for VLP A, B, and C presented by root-mean-square 
deviation (RMSD) of atom coordinates (Å) over simulation time (n), using a second Windows 10 computer 
with an Intel i7-6700 CPU and a GeForce GTX 1080 GPU. Three different simulation steps are separated 
by vertical lines, where vertical lines indicate simulation transition points. From 0 ns to dotted line: 
simulation of epitope and five adjacent amino acids; from dotted to dashed line: simulation of Hepatitis B 
core antigen (HBcAg) dimer spike; from dashed line to the end of simulation: full dimer simulation. The 
highlighted area is defined as the 2 ns window of stability (WoS). 
 
Figure E4 shows the MD simulation course of three VLP constructs when simulated with 
the second computer. VLP A reached the WoS after 15.08 ns instead of 19.89 ns seen in 
the main research article. VLP B and VLP C reached the WoS later compared to the first 
computer, with a difference of 1.19 ns and 4.36 ns, respectively. The simulation time is 
still in accordance with the length of epitope insertion, where VLP A contains the largest 
insert. The maximum RMSD reached for each VLP construct is different compared to the 
RMSD shown in the main research article. VLP A, B, and C have a median WoS RMSD 
of 3.21 ± 0.06 Å, 2.86 ± 0.06 Å, and 2.33 ± 0.05 Å, respectively, in the simulation on the 
second computer. This should be compared to the median WoS RMSD of 7.52 ± 0.15 Å, 
3.45 ± 0.07 Å, and 2.09 ± 0.04 Å on the first computer.  
The influence of a different simulation course is also evaluated based on the prediction of 
complete HBcAg VLP zeta potential. The results are shown in Figure E5. 
VLP A
VLP B
VLP C
Start Step 2
Start Step 3
WoS
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Figure E5: In silico computed zeta potential (mV) plotted against experimentally determined zeta potential 
(mV). Symbols represent in silico data based on the homology structure (“Homology”, red open circle), 
window of stability (WoS) obtained without H++ and with YASARA2 (“WoS w/o H++”, purple diamond), 
WoS obtained with H++ and AMBER03 (“WoS A03”, purple square), and WoS obtained with H++ and 
YASARA2 (“WoS”, blue filled circle). The diagonal line represents theoretical data with a Pearson 
correlation coefficient of 1 (PCC = 1). X-axis error bars represent the median absolute deviation (MAD) 
of experimental data and y-axis error bars represent MAD for in silico data points. For each in silico data 
series the PCC and mean squared error (MSE) are calculated (n = 3) and listed. 
 
Figure E5 shows that the WoS obtained with the second computer resulted in a in silico 
zeta potential of -8.84 ± 1.14 mV for VLP C, which shows a lower MSE (0.14) compared 
to the first computer (MSE = 0.45). The PCC also increases from 0.946 to 0.981. In silico 
zeta potential obtained with the second computer simulation also overlays with in silico 
zeta potential obtained without H++ pKa values. This supports the initial observation, 
where the used pKa values do not influence the surface charge description. 
 
 
Structure MSE PCC
Homology 0.64 0.780
WoS w/o H++ 0.16 0.998
WoS A03 0.58 0.791
WoS 0.14 0.997
